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Abstract 
Aging is a multifaceted process that is regulated by several factors and pathways, among 
which the best known are the nutrient signalling pathways. As the amount of people 
suffering from age-related diseases increases, it is of special interest to identify 
compounds and genetic factors that delay aging, thereby displaying promising 
indications for the development of anti-aging therapeutics. 
In this study, a novel high-throughput method was developed to screen for 
compounds that extend the CLS of the fission yeast Schizosaccharomyces pombe. Eight 
of the final 20 candidates that increased CLS were further characterized. We found that 
their life-extending effect was independent of caloric restriction as well as of the TOR 
signalling pathway. Furthermore, six compounds led to an increased resistance against 
oxidative stress. Individual analyses revealed that the CLS-extending effect of 
prostaglandin J2 depended on the mitochondrial fission protein Dnm1 as well as on 
components of the Git3/PKA signalling pathway. In contrast, monensin and nigericin 
required V-ATPase activity to promote longevity. The molecular targets of the other 
compounds remain to be determined. 
Additionally, we used our new CLS assay to screen an S. pombe deletion library for 
gene deletions that extend the CLS of fission yeast. However, in later experiments, we 
found that the observed increase of CLS was caused by an unknown factor in the strain 
background of the deletion library rather than by the indicated gene deletions. 
In another approach, we used a new high-throughput method established within this 
study to screen approximately 19,000 compounds for their impact on the telomeric 
silencing of the budding yeast Saccharomyces cerevisiae, as this has been associated 
with RLS. We found that nicotine increased silencing at all heterochromatic loci in 
budding yeast, namely the telomeres, the rDNA locus, and the HM loci. In vitro 
experiments indicated that nicotine might act by activating Sir2. This hypothesis was 
supported by the finding that nicotine extended the CLS of S. pombe in a Sir2-dependent 
manner. 
 
 
 
  
Zusammenfassung 
Alterung ist ein komplexer Prozess, der durch viele Faktoren und Signalwege reguliert 
wird, wobei die bekanntesten die Nährstoff-Signalwege sind. Da die Anzahl an 
Menschen, welche an alterungsbedingten Krankheiten leiden, zunimmt, ist die 
Identifizierung von Substanzen und genetischen Faktoren, die das Altern verzögern und 
dadurch vielversprechende Ansätze für die Entwicklung von Anti-Aging-Mitteln 
darstellen, von besonderem Interesse. 
In dieser Arbeit wurde eine neue High-Throughput-Methode entwickelt, um nach 
Substanzen zu suchen, welche die chronologische Lebensspanne (CLS) der Spalthefe 
Schizosaccharomyces pombe verlängern. Acht der finalen 20 lebensverlängernden 
Kandidaten wurden näher untersucht. Wir fanden heraus, dass ihr lebensverlängernder 
Effekt weder von der kalorischen Restriktion noch vom TOR-Signalweg abhängig war. 
Des Weiteren führten sechs Substanzen zu einer erhöhten Resistenz gegenüber 
oxidativem Stress. Einzelanalysen ergaben, dass der lebensverlängernde Effekt von 
Prostaglandin J2 sowohl von dem an der mitochondrialen Spaltung beteiligten Protein 
Dnm1 als auch von Komponenten des Git3/PKA-Signalweges abhängig war. Im 
Gegensatz dazu benötigten Monensin und Nigericin die Aktivität der V-ATPase zur 
Lebensverlängerung. Allerdings sind die molekularen Ziele der anderen Substanzen 
weiterhin nicht bekannt. 
Darüber hinaus haben wir den etablierten High-Throughput-Assay verwendet, um eine 
S. pombe-Deletionsbank nach lebensverlängernden Gendeletionen zu durchsuchen. 
Allerdings fanden wir in späteren Experimenten heraus, dass die beobachtete 
Verlängerung der CLS eher auf einem unbekannten Faktor im Stammhintergrund der 
Deletionsbank als auf die angegebenen Gendeletionen zurück zu führen war. 
In einem weiteren Ansatz verwendeten wir eine neue High-Throughput-Methode, 
welche im Rahmen dieser Arbeit etabliert wurde, um ca. 19.000 Substanzen auf ihren 
Einfluss auf das telomerische Silencing der Bäckerhefe Saccharomyces cerevisiae hin 
zu testen, da dieses bereits mit der replikativen Alterung in Verbindung gebracht worden 
war. Wir fanden heraus, dass Nikotin das Silencing an allen drei heterochromatischen 
Bereichen in der Bäckerhefe, sprich den Telomeren, dem rDNA-Lokus und den HM-Loki, 
verbesserte. In vitro-Experimente deuteten darauf hin, dass Nikotin über die Aktivierung 
von Sir2 wirken könnte. Diese Hypothese wurde durch die Erkenntnis gestützt, dass 
Nikotin die CLS von S. pombe Sir2-abhängig verlängerte. 
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1 Introduction 
1.1 Lifespan and aging 
Nowadays, there is an increase in the number and proportion of older people in the 
human society. In this aging population, the prevention and treatment of age-related 
diseases is becoming more and more important. Therefore, it is necessary to 
understand the mechanisms that lead to aging – starting on the molecular level. 
In the general public as well as in the scientific community, confusion exists 
regarding the precise usage of the terms aging and lifespan (Lithgow, 2006). 
Lifespan is defined by the time a given population or species has been observed to 
survive between birth and death. Maximum lifespan describes the maximum time one 
or more members of a population live, whereas mean lifespan stands for the average 
of the lifespan of all members of a population. In contrast, aging refers to the sum of 
changes that occur during later stages of life (Tollefsbol, 2010). Characteristics 
associated with aging are reduced functional capacity, increased vulnerability to 
multiple diseases, and a reduction in the ability to respond to stress or injury (Sell, 
2009). Nutrient restriction results in a delay of the aging process or, in other words, in 
an increased lifespan (see 1.3). 
There are several pathways responding to environmental influences that are 
ultimately responsible for lifespan changes. Based on the timing of their response to 
environmental changes, these pathways were grouped into general categories. The 
first category contains pathways that rapidly respond to acute stress, toxicity, and 
damage. The pathways of the second category respond moderately to nutrient 
availability, for instance the growth hormone, the insulin-like growth factor (IGF-1) 
(Wright et al., 1992), and the target of rapamycin (TOR) pathway (see 1.3). The third 
category comprises the slowly responding pathways that are critical for genome 
integrity and other basic functions like DNA damage repair (see 1.5). Mutations in 
genes encoding proteins that are involved in genomic maintenance result in reduced 
lifespan and rapid senescence phenotypes. One example is the Werner’s syndrome, 
where a DNA helicase involved in DNA repair, DNA recombination, and telomere 
maintenance is mutated (Sell, 2009). 
Budding and fission yeast are useful model organisms for aging studies. As 
unicellular eukaryotes, they are both cell and organism. Their relatively short lifespan 
in combination with the availability of straightforward genetic techniques, new high-
Introduction 
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throughput technologies, and the finding that several pathways affecting aging are 
evolutionarily conserved, provide good conditions to understand the basic 
mechanisms that alter lifespan.  
Currently, aging is in the spotlight of science. There are a multitude of studies 
about the way aging and lifespan are altered, but there are also many disagreements 
concerning the exact mechanism and the evaluation of the individual components. 
However, it seems that the complex process of aging is regulated by many complex 
pathways, which in addition seem to affect each other. To get a general overview, the 
most prominent factors affecting aging and lifespan are discussed in the next 
paragraphs (1.3 – 1.7). 
 
1.2 Replicative versus chronological lifespan in yeast 
Two different types of aging or lifespan can be distinguished. Replicative lifespan 
(RLS) means the number of mitotic divisions a cell can undergo and serves as a 
model for the aging of actively dividing cells like germ line cells and stem cells (Roux 
et al., 2010; Steinkraus et al., 2008). In contrast, chronological lifespan (CLS) has 
been linked to the aging of differentiated somatic cells, for example neurons. CLS 
refers to the time a non-dividing cell population can remain viable, as defined by their 
ability to re-enter the cell cycle after a longer period of time in stationary phase 
(Fabrizio & Longo, 2003; Roux et al., 2010). Notably, in the wild, yeast organisms are 
likely to exit the stationary phase only during the rare periods when all the nutrients 
required for growth become available. 
RLS is best studied in Saccharomyces cerevisiae. One characteristic of the 
budding yeast is its asymmetrical division. To measure RLS, aged mother cells are 
isolated by micromanipulation, and daughter cells are counted and removed after 
every division (Park et al., 2002). The mean RLS of S. cerevisiae amounts to 
approximately 20 generations and to 50 or more divisions for the maximum RLS. In 
Schizosaccharomyces pombe, the measurement of RLS is also possible but 
technically more difficult. The first three divisions of a virgin mother cell are 
morphologically symmetrical. Starting with the fourth division, the divisions are 
asymmetrical. The mother cell becomes rounder and bigger and can be distinguished 
from its daughter cells (Barker & Walmsley, 1999). Furthermore, Erjavec and 
colleagues found fission scars on the mother cells, which allow separation from the 
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very first division (Erjavec et al., 2008). In contrast to budding yeast, the maximum 
lifespan of S. pombe is approximately 20 divisions. 
CLS can be measured via staining with fluorescent dyes, like phloxine B or FUN-1 
that distinguish living from dead cells (Longo, 2010). However, the traditional method 
to determine the CLS of budding and fission yeast is to measure the ability of 
individual cells to form a colony, which is referred to as the colony forming unit (CFU) 
method (Figure 1). Most studies have been performed using haploid S. cerevisiae 
strains, which were monitored until 99.9 % of the population died. In budding yeast, 
this takes 15 - 20 days, while the CLS of S. pombe is shorter. It was found that after 
approximately 10 h of incubation, the glucose concentration in the medium reaches 
very low levels, and S. cerevisiae cells switch from fermentation- to respiration-based 
metabolism. Furthermore, incubating the yeast cells in water results in increased 
chronological survival. This procedure rules out the possibility that extended CLS is 
an artefact caused by regrowth in the liquid culture (Longo, 2010). 
Until today, the relationship between RLS and CLS is unclear, but there are at 
least the nutrient-sensing pathways that affect both RLS and CLS. 
 
 
Figure 1 Schematic illustration of the traditional method used for measuring CLS 
Aliquots of the aging cultures are taken at regular intervals and serially diluted. Multiple dilutions are 
plated on full medium plates and grown at 30 °C for 3 - 5 days. The forming colonies are then counted 
and used to calculate the number of colony forming units per ml culture (CFU/ml), which can be 
presented in a diagram. Diagram taken from (Chen & Runge, 2009). 
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1.3 Evolutionarily conserved nutrient-sensing pathways 
Several evolutionarily conserved pathways and mechanisms are known to influence 
chronological and replicative lifespan in multiple organisms. The best studied 
regimen that extends lifespan from yeast to mammals is caloric restriction (CR) 
(Fontana et al., 2010), which is defined by a moderate reduction in calorie intake. 
Due to the fact that lifespan can also be increased by changes of nutrition without 
altering the amount of calories, CR is often referred to as dietary restriction (DR). CR 
reduces the activity of various signal transduction pathways either directly, like the 
TOR pathway, or indirectly through reducing the levels of growth factors such as 
IGF-1 (worms, flies, mammals). A third pathway that affects lifespan in response to 
nutrients includes RAS, adenylate cyclase (AC), and protein kinase A (PKA) 
(Figure 2). Transcription factors like Msn2/4, DAF-16, and FOXO act downstream of 
these pathways to regulate the expression of enzymes and proteins involved in 
protective and metabolic activities that increase lifespan (Fontana et al., 2010). In the 
presence of nutrients, the conserved biochemical signalling pathways are activated 
and the anti-aging transcription factors are kept in the cytoplasm in an inactive form. 
Notably, nutrition is not the only way to affect these pathways. Their life-extending 
effect can also be influenced by deleting or overexpressing one or more of the 
involved proteins as well as by treatment with compounds such as rapamycin, which 
inhibits TOR and therefore results in increased lifespan (Huang & Houghton, 2001; 
Huang et al., 2003; Powers et al., 2006). Compounds mimicking the beneficial effects 
of nutrient restriction are of special interest, because they are not only thought to 
delay aging but also to be potential therapeutic agents against age-related diseases 
and premature aging syndromes.  
There are two major nutrient-sensing pathways in S. cerevisae (Figure 2). The first 
includes TOR and the serine-threonine kinase Sch9 (Fontana et al., 2010). Deletion 
of SCH9 promotes lifespan extension and resistance to both heat-shock and 
oxidative stress, as the inhibition or deletion of TOR does, probably by inactivating 
the downstream Sch9 (Kaeberlein et al., 2005b). In the second pathway, the signal 
for glucose availability is transduced through the G-protein-coupled receptor Gpr1 
and the Gα protein Gpa2. This results in the activation of the adenylate cyclase Cyr1. 
Upon stimulation by the Ras proteins Ras1 and Ras2, Cyr1 produces cAMP, which 
activates PKA (Dilova et al., 2007). 
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Figure 2 Schematic illustration of the conserved nutrient-sensing pathways regulating lifespan 
The three evolutionarily conserved nutrient-sensing pathways that extend lifespan when inhibited by a 
restriction of nutrients (glucose, fat, proteins, amino acids) are the TOR signalling pathway (green), the 
RAS/AC/PKA pathway (purple), and the insulin/IGF-like signalling pathway (blue). Picture based on 
(Fontana et al., 2010) and (Roux et al., 2010). 
 
In S. pombe, there are two known nutrient-sensing pathways that are affected by 
nutrient restriction, the Git3/protein kinase A (Pka1) signalling pathway and the TOR 
pathway including the serine-threonine kinase Sck2, which – like Sch9 in 
S. cerevisiae – shows similarity to the ribosomal protein S6 kinase (S6K) (Roux et al., 
2010) (Figure 2). Mutants that exhibit defects in one of these pathways like pka1Δ 
and sck2Δ display extended lifespan, but only pka1Δ (not sck2Δ) mutants are 
resistant to heat-shock and oxidative stress (Roux et al., 2006). In general, lifespan 
changes are less well characterized in fission yeast than in budding yeast. 
Although RLS and CLS are both influenced by the basic components of the 
nutrient-sensing pathways, there are also some differences that have been reported 
for S. cerevisiae. For instance, CLS is affected by TOR-controlled autophagy (Dilova 
et al., 2007). Additionally, extension of CLS by CR requires mitochondrial respiration, 
which results in the formation of reactive oxygen species (ROS). This is contrary to 
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Harman’s free-radical theory of aging, which states that free radicals lead to a 
reduced lifespan (Harman, 1956). However, recent studies showed that the 
increased formation of ROS within the mitochondria causes an adaptive reaction 
leading to an increased stress response via the transcription factors Msn2/4, Gis1, 
and the superoxide dismutase 2 (Sod2). This in turn results in a long-term reduction 
of oxidative stress. This kind of reverse effect of the response to ROS stress is called 
mitochondrial hormesis or mitohormesis and is thought to be the (or at least one) 
reason for the life-extending effect of glucose restriction (Dilova et al., 2007; Fontana 
et al., 2010; Ristow & Zarse, 2010; Ristow & Schmeisser, 2011). Extension of CLS 
by stress and the activation of stress responses has also been shown for S. pombe 
(Zuin et al., 2010). On the other hand, replicative survival via decreasing PKA activity 
requires Sir2, which inhibits the formation of extrachromosomal rDNA circles (ERCs, 
see 1.7). Furthermore, TOR regulates ribosome biogenesis and the deletion of 
ribosomal proteins increases RLS (Dilova et al., 2007; Mayer & Grummt, 2006). 
Although it is known that the TOR pathway controls many aspects of cell physiology, 
it still remains unclear precisely which aspect of TOR signalling contributes most 
significantly to aging and lifespan regulation. 
Findings from model organisms such as yeasts, Caenorhabditis elegans, 
Drosophila melanogaster and mice are currently being tested in monkeys, human cell 
lines, and also in human volunteers (Fontana et al., 2010). Multiple beneficial effects 
of reduced signalling are observed in mice. These include protection against cancer, 
diabetes, atherosclerosis, cardiomyopathy as well as protection against autoimmune, 
kidney, and respiratory diseases and reduced neurodegeneration (Fontana et al., 
2010). If these effects are confirmed in humans, drugs that block these pathways 
could be considered for the prevention of specific diseases. 
 
1.4 Impact of epigenetics on aging  
Epigenetic marks include chromatin modifications, DNA methylation, and histone 
variants that are inherited through cell divisions and alter chromatin status without 
changes in DNA or protein sequence (for details see 1.9). They are essential for 
normal development and for the maintenance of cellular functions in an adult 
organism (Allis et al., 2007), and many epigenetic mechanisms are thought to have 
an impact in the aging process and age-related diseases.  
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Acetylation of histones is generally associated with increased transcriptional 
activity, while the effect of histone methylation depends on the residue. For instance, 
methylation of H3K4 (histone H3 lysine 4) is often found in active chromatin, but 
methylation of H3K9 usually leads to transcriptional repression (Kouzarides, 2007). 
During aging, changes in histone modifications occur (Tollefsbol, 2010). One 
example is the methylation of H4K20. H4K20me1 has been linked with transcriptional 
repression (Karachentsev et al., 2005), while H4K20me2 plays an important role in 
the cellular response to DNA damage (Botuyan et al., 2006; Schotta et al., 2008). 
H4K20me3 is highly enriched at certain heterochromatic regions. Alterations in 
H4K20me3 levels correlate with important biological processes and increase with 
age (Sarg et al., 2002). In line with this, premature aging syndrome cells show 
elevated H4K20me3 levels (Shumaker et al., 2006). In contrast, reduced H4K20me3 
correlates with cancer progression (Fraga et al., 2005), perhaps due to reduced 
repression of repetitive elements and thus genomic instability (Howard et al., 2008). 
Additionally, H4K20me3 might be involved in transcriptional regulation of genes 
(Donati et al., 2008; Gurtner et al., 2008). To date, it is not known whether loss of 
H4K20me3 is a cause or consequence for the carcinogenesis process. 
DNA methylation controls the maintenance of gene expression programs. The 
DNA methylation status is balanced in mature cells, but with age this balance is 
strongly shifted in favour of loss of DNA methylation (Liu et al., 2003). Therefore, 
DNA hypomethylation that occurs during normal aging appears to be a critical risk 
factor contributing to the development of chronic age-related human pathological 
states (Tollefsbol, 2010). In many eukaryotes, DNA methylation at the cytosine-5 
position typically occurs in CpG dinucleotides. Hypermethylation is usually 
associated with transcriptional repression, while hypomethylation is generally linked 
to transcriptional activity. Nevertheless, there is also regional hypermethylation of 
specific genes whose promoters are rich in CpG islands (Liu et al., 2003; Liu & 
Rando, 2011). This has been linked to the silencing of tumour suppressor genes (Liu 
& Rando, 2011). Changes in DNA methylation occur consistently near genes 
involved in metabolism and metabolic regulation and are implicated in the 
pathogenesis of age-related diseases (Thompson et al., 2010). Notably, there is no 
DNA methylation in the yeasts S. cerevisiae and S. pombe. 
Epigenetic mechanisms, especially changes in DNA methylation, appear not only 
to influence the fundamental aspects of aging, but also to contribute significantly to 
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premature aging syndromes and the pathogenesis of several major age-related 
human diseases including cancer, atherosclerosis, Alzheimer’s disease, psychiatric 
disorders, and autoimmune pathologies (Tollefsbol, 2010). Therefore, compounds 
affecting these mechanisms can be considered potential therapeutics against these 
diseases. Notably, there is a possible link between nutrient restriction and epigenetic 
changes. For instance, epigallocatechin-3-gallate (EGCG), a component of green 
tea, is one of the natural products found to inhibit mTOR (Zhou et al., 2010) and it 
seems to nutritionally modulate DNA methylation (Tollefsbol, 2010).  
Altogether, the exact contribution of epigenetic dysregulation on aging and age-
related diseases remains unclear (Thompson et al., 2010). Additionally, some 
epigenetic modifications are secondary to DNA damage. For instance, 
phosphorylation of H2AX, a histone variant, is induced by double-strand breaks. 
There is also evidence that levels of acetylation of H3K56 and methylation of H3K79 
increase after DNA damage (Liu & Rando, 2011) This leads to the question whether 
epigenetic changes may play a causal role in cellular aging or whether they are 
merely consequences of the aging process (Liu & Rando, 2011).  
 
1.5 Defects in DNA repair as a cause of cancer and progeroid 
diseases 
As mentioned in the previous paragraph, another factor that is associated with aging 
is DNA damage and DNA repair. DNA damage due to mismatches after DNA 
replication or caused by reactive chemicals, radiation or UV light are corrected by a 
variety of repair pathways to prevent the formation of mutations and thereby maintain 
the genetic information. Nevertheless, DNA damage accumulates in normal aging 
(Dolle et al., 1997; Sedelnikova et al., 2004). Defects in DNA repair result in 
premature aging and increased susceptibility to cancer, which are also linked to 
critically short telomeres in human chromosomal instability syndromes (Blasco, 2005) 
(see 1.6). For instance, Werner’s syndrome is caused by a mutation of a helicase 
involved in DNA repair and telomere maintenance. Other DNA repair proteins with 
impact on telomere protection and telomere length regulation, such as proteins 
involved in the repair of mismatches and double-strand breaks (DSBs), are altered in 
various types of human tumour (Blasco, 2005). 
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DSBs, which can be caused by reactive oxygen species (ROS), are repaired by 
homologous recombination (HR) and non-homologous end-joining (NHEJ) (Sancar et 
al., 2004). In the case of single-strand DNA damage, there are a number of excision 
repair pathways that remove the damaged nucleotide and replace it with an 
undamaged nucleotide complementary to that found in the undamaged DNA strand. 
Mismatch repair (MMR)1 corrects errors of DNA replication and recombination that 
result in mispaired, but undamaged nucleotides in a strand-specific manner (Li, 
2008). Additionally, it repairs DNA changes that are caused by chemical agents such 
as alkylation. The majority of DNA mismatches and single base loops are recognized 
and bound by the MutSα heterodimer (hMsh2/hMsh6), while a second complex, 
MutSβ (hMsh2/hMsh3) recognizes insertion/deletion loops (IDLs). The MutS 
heterodimer forms a complex with the MutL heterodimer (hPms2/hMlh1), thus 
enhancing ATP hydrolysis-dependent translocation along the DNA (Buermeyer et al., 
1999; Marti et al., 2002). As a result, the DNA mismatch is excised, but the exact 
mechanism is still unclear. There are different proteins that are known to be involved 
in excision and synthesis of the new DNA, for instance PCNA, exonuclease 1, and 
the endonuclease FEN1 (Marti et al., 2002). There is the “futile DNA repair cycle” 
model suggesting that DNA lesions like 6MeG in the template strand induce 
misincorporation, which triggers the strand-specific MMR reaction. Since MMR only 
targets the newly synthesised strand for repair, the offending lesion in the template 
strand cannot be removed, and will provoke a new cycle of MMR upon repair 
synthesis. Such a futile repair cycle persists and activates DNA damage signalling 
pathways to promote cell cycle arrest and/or apoptosis (Li, 2008; Stojic et al., 2004). 
The importance of MMR was discovered in humans with defects in this repair 
pathway. For instance, MLH1 is mutated in the germ line of families, in which 
members are predisposed to a type of colon cancer (Liu et al., 1995). Epigenetic 
silencing of a non-mutated MLH1 gene was found in patients with non-familial colon 
cancer. In cell culture, re-expression of this silenced MLH1 gene produces 
reappearance of a functional protein that restores a considerable portion of the 
damage MMR (Herman et al., 1998). Notably, defects in MMR seem to promote 
cellular proliferation in a telomerase-independent manner (Rizki & Lundblad, 2001). 
                                            
1 Unless indicated otherwise, the mentioned proteins represent the human homologs. 
Introduction 
 26 
Nucleotide excision repair (NER)1 is a DNA repair pathway that recognizes a 
variety of DNA damages, including bulky, helix-distorting lesions such as UV-induced 
pyrimidine dimers. It is divided into two subpathways designated “global genomic 
repair” (GGR), which scans the entire genome for strand-distorting lesions, and 
“transcription-coupled repair” (TCR) (Fukumoto et al., 2002). The latter especially 
focuses on lesions that block elongating RNA polymerases. In GGR, which is 
specifically required for repair in germ cells (Lans et al., 2010), DNA damage is 
recognized by the XPC/hHR23B complex, which is also involved in the assembly and 
disassembly of NER complexes. In TCR, the blocked DNA polymerase is removed 
by CSA and CSB. The next steps are common to both GGR and TCR. TFIIH, which 
includes the helicases XPB and XPD among others, opens the DNA helix in the 
region around the lesion. Two endonucleases, XPA and ERCC1/XPF, incise the 3’ 
and the 5’ end of the damaged DNA strand, respectively, resulting in the removal of a 
25 - 30 nt DNA fragment containing the lesion. DNA polymerases fill the gap and 
DNA ligases seal the final nick (Schumacher et al., 2008). Some of the proteins 
involved in NER contain XP in their name due to the fact that defects in GGR give 
rise to the cancer-prone syndrome Xeroderma pigmentosum. This disease is 
characterized by hypersensitivity to sunlight, elevated sun-induced skin cancer, and 
accelerated skin aging caused by non-repaired UV damages (de Boer & 
Hoeijmakers, 2000). In contrast, defects in TCR cause Cockyane syndrome (CS), a 
progressive neurodevelopmental disorder (Schumacher et al., 2008). 
Base excision repair (BER)1 is primarily responsible for the genome-wide removal 
of single bases that are damaged by oxidation, alkylation, hydrolysis, or deamination 
(Wood, 1996). Damaged DNA bases are recognized and removed by lesion-specific 
DNA glycosylases resulting in the generation of apurinic/apyrimidinic (AP) sites that 
are bound by another enzyme, such as Nth1 in S. pombe, a DNA glycosylase 
associated with AP lyase activity (Kanamitsu & Ikeda, 2010). In combination with 
XRCC1, the DNA polymerase β (Polβ) fills the gap of one nucleotide. This 
mechanism is referred to as short-patch BER. In contrast, long-patch BER stands for 
the repair of single-stranded DNA breaks, where a fragment of 2 - 10 bases 
containing the lesion is incised by the FEN1 endonuclease. Different enzymes are 
involved in the synthesis of the new DNA and ligation, for instance Polβ, PCNA, and 
DNA ligase 1 (Sancar et al., 2004). Notably, DNA damage usually recognized by 
BER is corrected by TCR, if it blocks gene transcription. 
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It is already known that factors that are part of NER, also interact with BER and 
MMR components (Bertrand et al., 1998; Fleck et al., 1999; Kanamitsu & Ikeda, 
2010) and that these three DNA repair pathways exhibit partially overlapping 
functions (Fleck et al., 1999; Kunz & Fleck, 2001; McCready et al., 2000; Yonemasu 
et al., 1997; Yoon et al., 1999). 
 
1.6 Relevance of telomere length and telomerase activity in aging 
and cancer 
Telomeres are the protective ends of linear chromosomes with short, single-stranded 
DNA overhangs. They display a highly repetitive structure. The formation of 
subtelomeric heterochromatin prevents degradation, end-to-end fusions, and 
homologous recombination of the chromosome ends (see 1.10.2). The conventional 
DNA machinery is not able to fully synthesize the 3’ end of linear DNA. This is called 
end replication problem and as a consequence, the telomeres shorten with each 
round of replication. This in turn leads to impaired telomere function resulting in 
chromosomal instability, loss of genetic information, and finally cell death (Gilson & 
Geli, 2007; Smogorzewska & de Lange, 2004). In general, telomere shortening has 
been linked to reduced lifespan and premature aging (Blasco, 2005). Therefore, 
telomere length can be used as an aging marker (Lai et al., 2005). 
An evolutionarily conserved ribonucleoprotein complex, the telomerase, maintains 
telomere length. In S. cerevisiae, this complex consists of three protein subunits, 
Est1 - 3, and a RNA moiety called TLC1. The telomerase is a reverse transcriptase 
that uses the telomerase RNA as a template and adds TG repeats onto the 3’ end of 
the telomeric DNA during late S phase (Dionne & Wellinger, 1996; Wellinger et al., 
1993). Telomerase activity is coupled with conventional DNA replication to form 
double-stranded DNA by lagging strand synthesis (Diede & Gottschling, 1999; Grossi 
et al., 2004). In addition to telomerase, there are several proteins that are also 
essential for telomere length, for instance by recruiting telomerase to the 
chromosome ends. The Ku heterodimer (Ku70/80) protects telomeres from 
degradation and determines the subnuclear localization of telomeres (Laroche et al., 
1998). In addition, Ku helps Rap1 to recruit the Sir complex to the telomeres (Martin 
et al., 1999), thereby regulating telomeric silencing (Boulton & Jackson, 1996; Moretti 
et al., 1994) (see 1.10.2). Rap1 in turn is a key component of a process that 
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“measures” the telomere length in S. cerevisiae. A high number of Rap1 molecules 
bound to the telomeres inhibits telomerase activity, whereas a low number of Rap1 
molecules facilitates telomerase action (Marcand et al., 1997).  
In humans, germ line cells have high telomerase activity, resulting in the 
maintenance of telomere length. In contrast, somatic cells possess a low or no 
telomerase activity and their telomeres shorten with age (Blasco, 2005). Studies with 
human patients and tissues linked degenerative diseases, both inherited and 
acquired, and premature aging syndromes to aberrant telomerase expression (Lai et 
al., 2005). For instance, Werner’s syndrome fibroblasts show accelerated telomere 
attrition and undergo premature aging that can be rescued by enforced expression of 
the catalytic subunit of telomerase, the telomerase reverse transcriptase (TERT) 
(Wyllie et al., 2000). Although the epigenetic control of the TERT gene is not yet fully 
resolved, it is clear that cellular modifications especially in DNA methylation and 
histone modifications affect the TERT promoter region, which lead in part to 
regulation of this important gene in cellular aging (Tollefsbol, 2010). Therefore, 
chemical or natural compounds that increase telomerase activity, for instance by 
affecting epigenetic modifications, are promising therapeutics against premature 
aging. However, telomere length, telomerase activity, and epigenetic mechanisms 
are not only essential for cellular aging. They also play an important role in cancer. In 
general, tumour cells have shorter telomeres than the surrounding tissue due to their 
faster proliferation. Early tumour cells lack telomerase activity and replicate fast, 
resulting in fast telomere shortening and increased apoptosis within the tumour 
(Blasco, 2005). In 90 % of all types of human tumour, telomerase is reactivated, 
potentially due to age-related changes in DNA methylation and histone modifications 
resulting in rescue of short telomeres and maintenance of cells with potential 
chromosomal instability (Blasco, 2005). The fact that cancer cells have generally 
shorter telomeres than normal cells, together with the fact that cancer growth seems 
to depend on telomerase reactivation, indicates that therapeutics inhibiting 
telomerase activity will preferentially kill tumour cells and have no toxicity in normal 
cells. 
Importantly, telomere length and telomerase activity have a different effect on 
aging in S. cerevisiae. It has been shown that there is an inverse correlation between 
lifespan and telomere length in budding yeast (Austriaco & Guarente, 1997). 
Overexpression of truncated TLC1 leads to a shorter steady-state telomere length 
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and RLS extension. In contrast, RLS is decreased in yeast strains with longer 
telomeres (Austriaco & Guarente, 1997). It appears that telomeres regulate lifespan 
by modulating genomic silencing. It has been suggested that shortening of telomeres 
results in less recruitment of the SIR silencing machinery to the telomeres and a 
concomitant redistribution of this machinery to non-telomeric sites, like subtelomeric 
regions and the rDNA locus, that causes a delay in aging (Austriaco & Guarente, 
1997; Kozak et al., 2010). Conversely, telomere lengthening decreases lifespan and 
this decrease is due, at least in part, to greater recruitment of the Sir complex by the 
long telomeres (Austriaco & Guarente, 1997). This assumption is supported by 
findings of Tgs1, a snRNA and snoRNA methyltransferase, which is responsible for 
the m3G cap formation of the telomerase RNA moiety TLC1 in budding yeast. The 
absence of Tgs1 leads to elongated telomeres, enhanced telomeric silencing, and 
decreased RLS (Franke et al., 2008). Notably, the three heterochromatic regions in 
S. cerevisiae compete for the limited amount of Sir proteins, especially Sir2. 
Increased telomeric and/or HM silencing results in reduced repression at the rDNA 
locus (Smith et al., 1998), and derepression at this locus leads to the formation of 
ERCs whose accumulation in the mother cell correlates with aging (Sinclair & 
Guarente, 1997) (see 1.7). 
 
1.7 Impact of sirtuins on aging 
Sirtuins regulate various normal and abnormal cellular and metabolic processes, 
including tumorigenesis, neurodegeneration, and processes associated with type 2 
diabetes and obesity. Several age-related diseases, such as Alzheimer’s disease, 
and longevity have also been linked to the functions of sirtuins (Aljada et al., 2010). 
Therefore, compounds affecting the activity of the sirtuins are potential therapeutics 
against these diseases. 
The silent information regulator 2 (Sir2) is a NAD+-dependent histone deacetylase 
(HDAC) in S. cerevisiae and it is the founding member of the family of sirtuins. It is 
the catalytic subunit of the SIR complex and is involved in several cellular functions 
such as formation of heterochromatin at the HM loci, the telomeres, and the rDNA 
locus (see 1.10). Sir2 also takes part in the maintenance of genome stability via the 
repair of double-strand DNA breaks (Tsukamoto et al., 1997). This HDAC primarily 
affects replicative lifespan (RLS) not through telomeric repression or telomere length, 
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but through rDNA silencing (Kaeberlein et al., 1999). Due to their repetitive nature, 
rDNA arrays tend to undergo unequal recombination, which is suppressed by Sir2 
(Gottlieb & Esposito, 1989). In S. cerevisiae, deletion of SIR2 results in shortened 
RLS due to the formation of extrachromosomal rDNA circles (ERCs) (Kaeberlein et 
al., 1999; Steinkraus et al., 2008), which segregate asymmetrically during cell 
division. Their accumulation in the mother cell correlates with senescence (Figure 3). 
In agreement with this finding, overexpression of SIR2 increases RLS by suppressing 
rDNA recombination and decreasing ERC formation (Kaeberlein et al., 1999; 
Steinkraus et al., 2008). Notably, Sir2 abundance decreases with age (Dang et al., 
2009). Furthermore, there is some debate about the exact role of sirtuins in yeast 
caloric restriction (CR). Kaeberlein and colleagues reported that Sir2 and CR 
increase lifespan through independent pathways (Kaeberlein et al., 2004). However, 
a recent study indicates that there is a correlation between Sir2 and TOR signalling, 
because inhibition of TOR signalling by treatment with rapamycin leads to enhanced 
association of Sir2 with rDNA, resulting in decreased formation of ERCs and thus in 
extended RLS in S. cerevisiae (Ha & Huh, 2011). On the other hand, it has been 
reported that improved RLS is caused by increased rDNA stability and not through 
reduced formation of ERCs (Ganley et al., 2009; Unal et al., 2011). In line with this, 
sirtuins have been shown to play a conserved anti-aging role in higher eukaryotes 
(Haigis & Sinclair, 2010) although the accumulation of excised rDNA rings has not 
been detected in other species. Nevertheless, there is a recent publication that stated 
that overexpression of SIR2 homologs did not affect the lifespan of C. elegans and 
D. melanogaster and that previously described longevity might be effects of the 
genetic background (Burnett et al., 2011). 
 
 
Figure 3 rDNA recombination results in cellular senescence  
In S. cerevisiae, Sir2 represses the homologous recombination at the rDNA locus. Derepression 
results in the formation of extrachromosomal rDNA circles (ERCs), which segregate asymmetrically. 
Their accumulation in the mother cell finally leads to cell death. Picture based on (Grunstein & Gasser, 
2007). 
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In mammals, there are seven sirtuins (SirT1 - 7), which are characterized by their 
highly conserved central NAD+-binding and catalytic domain (Haigis & Sinclair, 
2010). They are strongly inhibited by nicotinamide (NAM, Figure 4) (Bitterman et al., 
2002; Sauve & Schramm, 2003; Sauve et al., 2006). The inhibition by NAM requires 
that NAM enters a highly conserved C-pocket, which is adjacent to the NAD+-binding 
site, thereby blocking NAD+ hydrolysis. In yeast, worms, and flies, NAM is recycled 
back to NAD+ in four steps, among others by the nicotinamidase Pnc1, which 
produces nicotinic acid in the first step (Haigis & Sinclair, 2010). 
The best studied mammalian sirtuin is SirT1. So far, most studies support the 
model that SirT1 mediates several beneficial effects of CR (Haigis & Sinclair, 2010), 
such as an increase in physical activity (Chen et al., 2005). However, the exact 
mechanism is still unclear. SirT1-deficient mice have a shorter lifespan, and CR does 
not increase the lifespan of these animals (Li et al., 2008). Therefore, SIRT1 may be 
required for lifespan extension by CR in mammals. However, upregulation of SirT1 
expression by CR seems to be induced in a tissue-specific manner (Chen et al., 
2008; Cohen et al., 2004). It is known that Sir2 is recruited to telomeres in yeast, and 
that the SIR complex spreads into subtelomeric regions via histone deacetylation, 
thereby forming heterochromatin. In contrast, potential functions of SirT1 at 
telomeres are less clear. A recent study showed that SirT1 is a positive regulator of 
telomere length in vivo and attenuates telomere shortening with aging, an effect that 
dependents on telomerase activity (Palacios et al., 2010). 
Sirtuins do not only modify histones, but also other substrates. For instance, 
mammalian SirT1 deacetylates among others the transcription factors FOXO and 
p53 in response to stress and DNA damage (Grunstein & Gasser, 2007; Haigis & 
Sinclair, 2010). This constitutes an additional possibility of SirT1-mediated lifespan 
extension, because acetylation of the tumour suppressor p53 promotes apoptosis 
(Luo et al., 2001; Vaziri et al., 2001). However, preventing apoptosis of cells with 
DNA damages may lead to cancer. Therefore, SirT1 is a possible cancer-related 
factor and compounds inhibiting SirT1, such as splitomicin (Figure 4), sirtinol, and 
EX-527, are potential anti-cancer therapeutics. Sirtuin activity can also be affected by 
modifications. SirT1 has at least 13 residues that are phosphorylated in vivo, and 
removal of these phosphates decreases its catalytic activity (Haigis & Sinclair, 2010). 
Additionally, the SIRT1 gene is controlled by numerous transcription factors and 
microRNAs (Haigis & Sinclair, 2010). 
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Figure 4 Chemical structures of nicotinamide, splitomicin, and resveratrol 
Nicotinamide and splitomicin are thought to inhibit sirtuin activity, while resveratrol is a potential sirtuin 
activator. The chemical structures were created by using the software MarvinSketch. 
 
Work on sirtuins and the mechanisms of nutrient restriction have given hope to the 
synthesis of future drugs to increase human lifespan by simulating the effects of DR. 
There are already compounds that have been proposed to activate SirT1 including 
resveratrol (Figure 4), quercetin, butein, SRT1720, and SRT2183 (Haigis & Sinclair, 
2010). They are thought to work by lowering the Michaelis constant for the substrate 
and for NAD+ and, to a lesser extent, by increasing enzyme velocity (Vmax) (Haigis & 
Sinclair, 2010). In contrast, analogues of NAM appear to activate sirtuins by 
occluding the C-pocket, thereby interfering with NAM inhibition (Sauve et al., 2006). 
Among these potential sirtuin-activating compounds, the best known is resveratrol, a 
natural compound found in several plants including red grapes. It is thought to mimic 
some of the effects of CR in a wide variety of organisms from yeast to mice, possibly 
by the activation of Sir2/SirT1. A recent study concludes that SRT1720 and 
resveratrol are not direct activators of SirT1, but can only activate the HDAC activity 
of SirT1 in vitro using one particular substrate (Beher et al., 2009). Another 
hypothesis is that resveratrol inhibits mTOR in mammals (Zhou et al., 2010). 
However, it remains controversial whether resveratrol actually extends lifespan, since 
many laboratories have not been able to reproduce the original observation in yeast 
(Bass et al., 2007; Howitz et al., 2003; Kaeberlein et al., 2005a; Wood et al., 2004). 
Mice on a high-fat diet treated with resveratrol display reduced mortality or protection 
against morbidity, possibly by activating a set of genes affected by nutrient restriction 
(Baur et al., 2006). However, mice and flies fed standard diet do not show increased 
survival (Fontana et al., 2010; Pearson et al., 2008). However, the resveratrol 
formulation SRT501 has already been tested on humans, but the clinical trial was 
suspended because several patients developed kidney failure. 
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1.8 Compounds known to extend lifespan 
So far, several compounds have been identified that are thought to extend the 
lifespan of at least one model organism. In this paragraph the most prominent 
candidates and their potential mode of action are summarized. 
Altering the nutrient signalling pathways displays the best known and so far the 
most effective way to extend lifespan (see 1.3). Apart from CR/DR, the deletion of 
components of these pathways or their inhibition by compounds also results in an 
increase in lifespan. For instance, rapamycin extends lifespan of D. melanogster 
(Bjedov et al., 2010; Moskalev & Shaposhnikov, 2010) and mice (Harrison et al., 
2009) as well as CLS and RLS in yeast (Medvedik et al., 2007; Wanke et al., 2008) 
by inhibiting the TOR-containing complex TORC1. This in turn, leads to longevity-
promoting effects, like enhanced stress resistance, which have also been reported 
for this compound (Medvedik et al., 2007). Furthermore, methionine sulfoxime (MSX) 
is known to increase CLS in yeast by inhibiting the glutamine synthetase and 
reducing both intracellular glutamine level and TOR signalling (Crespo et al., 2002). 
Additional compounds that have been reported to promote longevity by direct or 
indirect inhibition of the TOR signalling pathway, are caffeine (yeast, CLS) (Wanke et 
al., 2008), metformin (C. elegans and mice) (Anisimov et al., 2008; Onken & Driscoll, 
2010), wortmannin (D. melanogaster) (Moskalev & Shaposhnikov, 2010), and 
curcumin (D. melanogaster, mammals) (Beevers et al., 2009; Chen et al., 2011; Yu 
et al., 2008) as well as LY294002 and U0126 (human fibrosarcoma cells, RLS) 
(Demidenko et al., 2009). In contrast, valproic acid may increase lifespan of 
C. elegans by promoting nuclear localization of DAF-16, thereby reducing the activity 
of the insulin/IGF-1 signalling pathway (Evason et al., 2008). 
Another mechanism that is thought to result in lifespan extension is the activation 
of Sir2 and SirT1. In this context, the most prominent compound is resveratrol. 
However, as mentioned above, the longevity-promoting effect of this polyphenol is 
controversial. Some labs report that resveratrol extends the lifespan for instance of 
S. cerevisiae, C. elegans, and D. melanogaster (Gruber et al., 2007; Howitz et al., 
2003; Wood et al., 2004), but other labs failed to reproduce these results (Bass et al., 
2007). Apparently, resveratrol increases the life of mice only if they were fed a high-
calorie diet, but not a standard diet (Baur et al., 2006; Pearson et al., 2008). Actually, 
there are doubts whether resveratrol is a direct activator of SirT1 (Zarse et al., 2010) 
or rather an inhibitor of TOR signalling (Zhou et al., 2010). Other SirT1 activators that 
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are thought to increase lifespan are quercetin (Pietsch et al., 2011) and fisetin (Chen 
et al., 2011). Notably, resveratrol and quercetin have antioxidant properties 
(Cherniack, 2010) and according to Harman’s free-radical theory of aging (Harman, 
1956), antioxidants like lipoic acid may increase lifespan by detoxifying free radicals 
and/or enhancing resistance to age-related oxidative stress (Bauer et al., 2004; 
Benedetti et al., 2008). 
Furthermore, compounds affecting the epigenetic state of the chromatin are 
thought to influence lifespan. For instance, it has been reported that lithium extends 
the lifespan of C. elegans by altering the transcription of genes involved in histone 
methylation, nucleosome composition, and chromatin structure, thereby modulating 
longevity-related processes (McColl et al., 2008). HDAC inhibitors such as 
trichostatin A (TSA) and sodium butyrate promote longevity in D. melanogaster by 
hyperacetylation of the canonical histone H3 and increased expression of heat shock 
proteins (Zhao et al., 2005). Another compound that has been shown to extend 
lifespan by affecting PTMs is spermidine. Treatment of aging yeast cells with this 
HAT inhibitor results in hypoacetylation of histone H3 as well as in reduced ROS 
levels and suppression of necrosis (Eisenberg et al., 2009). Notably, the altered 
acetylation status of the chromatin led to significant upregulation of various 
autophagy-related transcripts, triggering autophagy in yeast, worms, flies, and human 
cells, where enhanced autophagy is crucial for polyamine-induced suppression of 
necrosis and improved longevity (Eisenberg et al., 2009). 
Compounds that promote longevity in model organisms and/or human cell lines 
are not only thought to extend human lifespan, but primarily to be potential 
therapeutics against premature aging syndromes and age-related diseases. One 
example is metformin, which is already used for the treatment of type 2 diabetes 
(Goldberg et al., 2010). However, it is known that some compounds have side 
effects. For instance, rapamycin strongly suppresses the immune system. As a 
consequence, the life-extending effect of those compounds can not be studied in 
humans. Therefore, the identification of novel longevity-promoting compounds is of 
continued interest. 
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1.9 Eukaryotic chromatin and epigenetic marks 
Since chromatin structure and epigenetic marks play an important role in aging (see 
1.4, 1.6, 1.7), they are explained in more detail in this and the following paragraph. 
The human genome consists of a total of about 3 x 109 base pairs (bp), which are 
organized into 23 chromosome pairs, and contains approximately 23,000 protein-
coding genes, far fewer than had been expected before its sequencing (Consortium, 
2004). In fact, only about 1.5 % of the genome codes for proteins, while the rest 
consists of non-coding RNA (ncRNA) genes, regulatory sequences, introns, and non-
coding DNA (ncDNA) (Consortium, 2001). 
In other organisms, the size and complexity of the genome differ as revealed by 
sequencing whole genomes of many eukaryotic organisms. The first eukaryotic 
organism whose genome was completely sequenced is the unicellular budding yeast 
S. cerevisiae (Goffeau et al., 1996). This genome contains about 6,000 genes on 
16 chromosomes and is more compact than the human genome meaning that the 
majority of the DNA sequence consists of open reading frames (ORFs) (Dujon, 
1996). 
For the development of higher eukaryotes, not only the nucleotide sequence or the 
number of genes are important, but also the precise control of gene expression. 
There are regulatory options that change gene transcription through modulation of 
chromatin without affecting the actual sequence of DNA nucleotides. Examples are 
replacement of canonical histones by histone variants, chromatin remodelling, 
posttranslational modifications (PTMs) of histone tails, and DNA methylation. These 
epigenetic marks appear to be inherited through all cell divisions, providing cellular 
“memory” that may extend the heritable information of the genetic (DNA) code. They 
are not only important for regulating gene expression, but also for genome replication 
and other cellular processes (Allis et al., 2007; Bernstein et al., 2007; Misteli, 2007). 
In eukaryotic cells, DNA is packed into a nucleoprotein structure called chromatin 
that contains nucleosomes as the basic unit. The nucleosome consists of 147 bp 
DNA wrapped around one histone octamer, which is formed by two copies of each of 
the canonical histones – H2A, H2B, H3, and H4 (Kornberg, 1974; Luger et al., 1997a; 
Luger et al., 1997b). Several amino acids of the highly conserved histones have been 
found to be a target of PTMs – primarily at the N-terminal tails of histones, but also in 
the globular histone domains (Xu et al., 2005). For instance, lysines can be 
acetylated (ac), methylated (me) or ubiquitinated (ub). These residues can not only 
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be (mono-) methylated but also di- and tri-methylated. Arginines can be methylated 
and serines or threonines can be phosphorylated (ph) (Figure 5). Additionally, there 
are isomerisation of prolines, SUMOylation, ADP-ribosylation, and deimination 
(Kouzarides, 2007). This diversity of modifications displays some kind of a “histone 
code” and increases the amount of information beyond the DNA sequence (Jenuwein 
& Allis, 2001). 
 
 
Figure 5 Sites of histone tail modifications 
The majority of histone modifications are illustrated. They primarily occur at the N-terminal histone 
tails, which are given in the single amino acid code but also in the globular domain (boxed). The blue, 
red, yellow, and green flags represent acetyl, methyl, phosphate, and ubiquitine groups. Picture based 
on (Allis et al., 2007). 
 
Most modifications are dynamic and reversible (Kouzarides, 2007). For instance, 
the action of histone acetyltransferases (HATs), which acetylate specific lysine 
residues in histone substrates (Marmorstein & Roth, 2001), is reversed by histone 
deacetylases (HDACs) (Grozinger & Schreiber, 2002). The modifications do not 
occur in isolation but rather in combination (H3K9me and H3S10ph or H4S1ph, 
H4R3me and H4K4ac). In addition to this, they affect each other. For instance, the 
phosphorylation of H3S10 by Snf1 kinase promotes the acetylation of H3K14 by 
Gcn5 (Cheung et al., 2000; Lo et al., 2000). 
An important effect of histone modifications is their impact on the chromatin status 
(Figure 6). The chromatin of eukaryotic cells is not uniform in structure but organized 
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in a highly condensed chromatin fiber known as heterochromatin and a less 
compacted type called euchromatin. The “open” euchromatin consists largely of 
coding sequences comprising the ubiquitously expressed housekeeping genes but 
also genes that are developmentally regulated or stress-induced in response to 
environmental cues. One epigenetic mark that is associated with euchromatin is the 
acetylation of lysine residues that neutralizes the positive charge of the amino acid, 
leading to reduced interaction with the negatively charged DNA. As a consequence, 
the chromatin structure is less condensed. Additionally, nucleosome-remodelling 
machines are recruited through the induction of the activating histone modifications 
and facilitate the engagement of the transcription machinery. So the euchromatin is 
transcriptionally active. This in turn alters the interaction of histones with regulatory 
proteins or other histones (Grant & Berger, 1999; Roth, 1995). Furthermore, the 
replacement of canonical histones by histone variants, is associated with active 
chromatin (Ahmad & Henikoff, 2002; Allis et al., 2007).  
In general, euchromatic genes that are not transcribed are transferred into more 
compact heterochromatin to protect the genes while they are not in use. Notably, 
inactivation of gene expression in heterochromatin is not restricted to specific genes 
but to their chromosomal location. Heterochromatin can spread and repress nearby 
genes. Thus, the expression status of a gene can be changed by its insertion 
adjacent to heterochromatic regions. This phenomenon is called position-effect 
variegation (PEV) (Muller, 1930). The time- and region-dependent regulation of gene 
expression by inactivating chromosomal domains is referred to as silencing (Rusche 
et al., 2003) and leads to a chromatin state known as facultative heterochromatin. In 
contrast, constitutive heterochromatin describes chromatin that is silent in all cell 
types. It may by default be induced at non-coding and highly repetitive regions like 
the telomeres. Modifications resulting in repressed chromatin are deacetylation and 
the phosphorylation of certain histone residues. Notably, the effect of histone 
methylation depends on the localization. It is associated with active (H3K4, H3K36, 
H3K79) or silenced chromatin (H3K9, H3K27, H4K20) (Kouzarides, 2007).  
However, not all sites are equally modified (Smith et al., 2003). Many of the 
modifying enzymes are recruited to special promoters (e.g. HDAC Hst1) (Robert et 
al., 2004), but there are also HDACs like Rpd3 and HATs that globally regulate 
transcription independently of sequence-specific transcription factors (Kurdistani et 
al., 2002).  
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Figure 6 Schematic illustration of euchromatin and heterochromatin  
In loosely packed euchromatin (left), transcription is active, whereas in tightly packed heterochromatin 
transcription is inactive (right). Green lines of DNA wrap around grey cylinders representing histone 
proteins. Black histone tails are modified where the blue, red, and yellow flags represent acetyl, 
methyl, and phosphate groups. Picture modified from (Jenuwein & Allis, 2001). 
 
An additional recruiting factor for chromatin-modifying activities is DNA 
methylation. This epigenetic mark is linked to methylation of H3K9 and repression 
(Bird, 2002) (see Figure 6). Abnormalities in the DNA methylation imprint cause 
several diseases, e.g. Prader-Willi-syndrome in humans (Driscoll et al., 1992) (see 
also 1.4). Furthermore, the RNA interference (RNAi) machinery has been linked to 
the formation of silent heterochromatic regions in S. pombe by inducing repressive 
histone marks (Hall et al., 2002; Volpe et al., 2002). Other examples for RNA-
facilitated repression are non-coding RNAs (ncRNAs). They are involved in 
mammalian rDNA silencing (Mayer et al., 2006) and dosage compensation. In female 
mammals, one of the two X-chromosomes is inactivated by the binding of the Xist 
RNA, resulting in heterochromatin formation along the entire chromosome, and 
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therefore the dosage of sex chromosome-linked gene expression is equalized 
between males and females (Avner & Heard, 2001). Notably, DNA methylation and 
RNAi do not occur in S. cerevisiae.  
Heterochromatic regions are located at the nuclear periphery (Andrulis et al., 
1998; Oki & Kamakaka, 2002). However, until today it is not clear if this localisation is 
a cause or consequence of heterochromatin formation. Nevertheless, there appears 
to be a highly conserved pathway leading to a heterochromatic state. It involves 
recruitment of heterochromatin-associated proteins like heterochromatic protein 1 
(HP1) and establishment of DNA methylation as well as repressive histone 
modifications like histone tail deacetylation and methylation of specific lysine 
residues (e.g. H3K9). Due to these epigenetic marks, silencing is inherited during 
DNA replication and multiple cell divisions (Ehrenhofer-Murray, 2004).  
In summary, epigenetic marks like histone modifications, DNA methylation, and 
histone variants influence diverse biological processes. This includes the regulation 
of gene expression by providing binding sites for transcription factors and silencing 
by heterochromatin formation (Berger, 2002) as well as replication (Vogelauer et al., 
2002), DNA damage repair (Dinant et al., 2008), and apoptosis (Ahn et al., 2005). 
 
1.10 Heterochromatic regions in S. cerevisiae 
In S. cerevisiae, there are three distinct heterochromatic regions – the silent 
mating-type loci HML and HMR, the telomeres, and the rDNA locus (Stone & Pillus, 
1998). The key component for silencing is Sir2, which belongs to the Class III of 
HDACs that are NAD+-dependent (Fukuda et al., 2006; Imai et al., 2000a; Imai et al., 
2000b; Moazed, 2001) and is conserved from bacteria to humans. For instance, its 
homolog in S. pombe is also required for heterochromatin formation 
(Shankaranarayana et al., 2003). Enzymes of the Sir2 family do not only modify 
histones, but also other substrates like the mammalian SirT1, which deacetylates the 
transcription factors FOXO and p53 in response to stress and DNA damage 
(Grunstein & Gasser, 2007) (see 1.7).  
In S. cerevisiae, Sir2 is the only factor present at all three heterochromatic loci, 
indicating that there are different mechanisms of silencing, which are explained in the 
next paragraphs (1.10.1 - 1.10.3). Apart from this, spreading of heterochromatin into 
euchromatic regions is prevented by boundary mechanisms like hyperacetylation, 
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H3K79me (van Leeuwen et al., 2002), the presence of the histone variant H2A.Z, 
Bdf1 (Meneghini et al., 2003), and tethering of DNA to nuclear pores (Ishii et al., 
2002). 
 
1.10.1 Silencing at the HM loci 
The budding yeast S. cerevisiae exists in both a haploid and a diploid state. Haploid 
yeast cells can either be of a or α mating-type. The mating of two cells (a and α) with 
opposing mating types results in diploid cells, which in turn can undergo meiosis to 
form haploid cells. There are three mating-type loci determining the mating-type of 
haploid yeast cells. All of them are located on chromosome III. The mating type 
(MAT) locus is actively transcribed and determines mating type by either the 
expression of the MATa1 gene, resulting in the MATa mating type or the expression 
of the MATα1 and MATα2 genes, which give rise to α cells (Herskowitz et al., 1977). 
Yeast cells carry an additional copy of the a and α genes at the HM loci, which are 
permanently repressed. Derepression leads to a concomitant expression of a and α 
genes. Therefore, it results in pseudodiploid cells that display cell-type characteristics 
of diploid cells and thus are in a non-mating, sterile state (Perrod & Gasser, 2003). 
For that reason, silencing of the HM loci is essential for maintaining the mating 
potential of the cells. Repression is mediated by two silencer DNA elements, called E 
(for essential) and I (for important) that flank the silent genes (Loo & Rine, 1994). 
They provide binding sites for the repressor activator protein (Rap1), the ARS binding 
factor (Abf1), and the origin recognition complex (ORC). Additional proteins that are 
involved in HM silencing are the Sir proteins (Sir1 - 4). 
Abf1, Rap1, and ORC act not only in HM silencing, but also in transcriptional 
regulation (Abf1 and Rap1) or replication initiation (ORC). They are recruiting factors 
for Sir proteins at the silencers (Lustig, 1998), where they function in a redundant 
manner. Rap1 recruits Sir4, Abf1 interacts with Sir3 and ORC has high affinity for 
Sir1. They all result in recruitment of Sir4 and in turn to binding of the SIR complex, 
which consists of Sir2/3/4 (Rusche et al., 2003). The formation of heterochromatin 
occurs in a stepwise manner. First, ORC binds Sir1. Sir4 is then recruited via its 
interaction with Sir1 and Rap1, leading to the binding of Sir2 and Sir3 (Rusche et al., 
2003). Nearby nucleosomes are deacetylated by the HDAC Sir2, providing new 
binding sites for the SIR complex (Hecht et al., 1995; Imai et al., 2000a). The 
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resulting positive feedback loop leads to the formation of heterochromatin across the 
HM loci. Notably, Sir1 is involved primarily in the establishment rather than the 
maintenance of heterochromatic repression (Pillus & Rine, 1989) and does not 
spread with the SIR complex beyond the silencers (Rusche et al., 2003).  
In addition to the mating-type loci, genes important for growth are located on 
chromosome III. Therefore, it is critical to restrict the repression to the HM loci. This is 
ensured by several boundary factors that prevent the multidirectional spreading of 
heterochromatin. For instance, the SAS-I complex globally acetylates H4K16, 
thereby antagonizing Sir2 activity (Kimura et al., 2002; Suka et al., 2002). 
Additionally, the binding of Bdf1 is thought to protect H4K16ac against deacetylation 
by Sir2 (Ladurner et al., 2003). The methylation of H3K79 by Dot1 also has boundary 
function (Ng et al., 2002; van Leeuwen et al., 2002) and heterochromatin spreading 
toward the telomere from HMR is prevented by a tRNA gene (Donze & Kamakaka, 
2001). 
 
1.10.2 Telomeric silencing 
Telomeres represent the protective ends of linear chromosomes with short, single-
stranded DNA overhangs. In S. cerevisiae, they consist of C1-3A/TG1-3 repeats with a 
total length of 300 - 350 bp. This nucleosome-free region (NFR) contains 16 - 20 
Rap1 binding sites (Gilson et al., 1993; Wright et al., 1992). Telomeres shield the 
chromosome ends from degradation, end-to-end fusions or homologous 
recombination (Smogorzewska & de Lange, 2004). This is due to the formation of 
subtelomeric heterochromatin.  
At the telomeres of S. cerevisiae, the SIR complex (Sir2/3/4), Rap1, and the Ku 
heterodimer consisting of yKu70 and yKu80 are involved in silencing. Ku helps Rap1 
to recruit Sir4 (Martin et al., 1999), leading to the binding of Sir2 and deacetylation of 
nucleosomes next to the NFR. This in turn provides new binding sites for the SIR 
complex. The spreading of heterochromatin from telomere ends towards the 
centromere into subtelomeric regions is restricted by boundary mechanisms. It is 
controlled, at least in part, by the opposing activities of Sir2 and Sas2 on H4K16 in 
some kind of competition zone (Kimura et al., 2002; Suka et al., 2002). The deletion 
of SIR2 results in hyperacetylation at telomere-proximal regions as well as at the HM 
and rDNA loci (Robyr et al., 2002). Sir2 is further discussed in lifespan extension as 
well as in the establishment of cancer (Blander & Guarente, 2004) (see 1.7).  
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Figure 7 Organization and silencing patterns of S. cerevisiae telomeres  
S. cerevisiae contains so called X and Y’ elements in the subtelomeric region of native telomeres. The 
Y’ element includes subtelomeric anti-silencing regions (STARs) with binding sites for transcriptional 
regulators that reduce the spreading of silent chromatin. In the X element, there are also binding sites 
for factors that have the opposing effect. This leads to a discontinuous silencing pattern. There is a 
gradient of repression at artificial telomeres, when a reporter gene is inserted instead of the X and 
Y’ elements. Picture based on (Grunstein & Gasser, 2007). 
 
In general, the silencing mechanism at the telomeres is similar to HM silencing – 
except for the absence of Sir1. However, native telomeres often contain an 
X element and mostly also an Y’ element in their subtelomeric region (Figure 7), 
which make the situation more complex. Both elements include binding sites for the 
transcriptional regulators Tbf1 and Reb1, which reduce spreading of silent chromatin 
(Fourel et al., 1999). X elements also contain binding sites for ORC and Abf1, which 
have the opposite effect. Consequently, subtelomeric repression is increased or 
decreased in a position-dependent manner (Pryde & Louis, 1999). This 
discontinuous silencing pattern cannot be observed at artificially truncated telomeres, 
where a reporter gene like URA3 is inserted instead of the X and/or Y’ element 
(Gottschling et al., 1990) (Figure 7 bottom). In this case, there is a gradient of 
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repression due to the levels of Sir2 and Sir4, which decrease with increasing 
distance from the telomere (Strahl-Bolsinger et al., 1997). 
Based on a current model, chromosome ends stabilize subtelomeric silencing by 
forming a loop back to the X element (Pryde & Louis, 1999). Another model implies 
stabilization of silencing through localization of heterochromatic regions at the 
nuclear periphery (Andrulis et al., 1998; Oki & Kamakaka, 2002), where they might 
interact with the nuclear pore complex (Galy et al., 2000). Up to now, it is unclear 
whether silencing is a cause or a consequence for the localization.  
 
1.10.3 rDNA silencing 
The S. cerevisiae ribosomal DNA (rDNA) locus contains 100 - 200 repeats of a 9.1 kb 
DNA sequence that includes the gene encoding 35S rDNA, which is a precursor for 
25S, 18S, and 5.8S rRNA (Petes & Botstein, 1977). Only approximately 50 % of the 
rDNA genes are transcribed at a given time, while the majority is silenced by the 
action of Sir2 (Smith & Boeke, 1997). Repression at the rDNA locus differs from HM 
and telomeric silencing, as it does not require Sir1 or Sir3 and Sir4 (Smith & Boeke, 
1997) and Sir2 at the rDNA locus is part of the regulator of nucleolar silencing and 
telophase (RENT) complex (Straight et al., 1999). It is known that heterochromatin 
formation at the rDNA locus prevents recombination and formation of ERCs (Sinclair 
& Guarente, 1997) (see 1.7), but the mechanistic aspects are still unclear. 
 
1.11 Outline of this thesis 
Several factors and pathways have been linked to the regulation of the complex 
aging process. So far, the best known and most effective way to extend lifespan is 
caloric restriction, in other words the alteration of the evolutionarily conserved 
nutrient signalling pathways. In addition, various compounds have been identified to 
promote longevity of at least one model organism. As some of these compounds 
display side effects, like suppression of the immune system, only a few are of 
potential use in humans. Therefore, it is of continued interest to identify novel 
longevity-promoting compounds. The aim of this study was to expand our knowledge 
of the molecular mechanisms of aging and to identify compounds that affect aging 
and lifespan. 
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To gain new insights into the process of chronological aging, a new high-
throughput method that enables the CLS measurement of many 
Schizosaccharomyces pombe cultures in parallel was established. Using this assay, 
we screened a small compound library, and the compounds that showed the 
strongest effect in lifespan extension were further characterized. To determine the 
potential mode of action of these compounds and to identify their potential target/s, 
their impact on the stress response was investigated, and epistasis analyses were 
performed in order to relate their effect to known aging pathways. 
In order to identify novel genetic factors that are involved in the regulation of aging 
and lifespan, we used the new CLS assay to screen a S. pombe deletion library for 
gene deletions that extend the CLS of fission yeast. However, in subsequent 
experiments, we found that the increase of CLS was caused by an unknown factor in 
the strain background of the deletion library rather than by the indicated gene 
deletions. 
In another approach, we used telomeric silencing, which has been associated with 
RLS, to identify compounds that affect this type of aging in Saccharomyces 
cerevisiae. A high-throughput method was used to screen approximately 19,000 
compounds for their impact on telomeric silencing of budding yeast. To identify the 
potential target/s of the compounds found to affect telomeric silencing, their effect on 
HM and rDNA silencing was also investigated and was put in the context of known 
silencing and aging pathways. 
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2 Material and Methods 
2.1 Escherichia coli strains 
TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC) ϕ80lacZΔM15 ΔlacX74 recA1 
araΔ139Δ(ara-leu)7697 galU galK rpsL (StrR) endA1 nupG (Invitrogen) 
DH5α F- ϕ80dlacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17 (rk-, mk+) 
phoA supE44 thi-1 gyrA96 relA1 λ- (Invitrogen) 
BL21 (DE3) F- ompT hsdSB(rB-, mB-) dcm+ Tetr gal λ(DE3) endA Hte [argU ileY leuW 
CamR] 
Rosetta (DE3) F- ompT hsdSB(rB- mB-) gal dcm pRARE (CamR) (Merck) 
 
2.2 Media and growth conditions 
2.2.1 E. coli growth conditions 
E. coli strains used for plasmid amplification were cultured according to standard 
procedures (Sambrook et al., 1989) at 37 °C in Luria-Bertani (LB) medium (5 g/l 
yeast extract, 10 g/l tryptone, 5 g/l NaCl) supplemented with 100 µg/ml ampicillin, 
50 µg/ml kanamycin or 34 µg/ml chloramphenicol. 
 
2.2.2 Saccharomyces cerevisiae media and growth conditions 
Media were as described previously (Sherman, 1991). Unless indicated otherwise, 
S. cerevisiae strains were grown on full medium (YPD: 10 g/l yeast extract, 20 g/l 
peptone, 2 g/l glucose). Marker selection was performed using selective minimal 
medium (YM: 6,7 g/l yeast nitrogen base w/o amino acids) supplemented with 2 % 
glucose and as required with 20 µg/ml for adenine, uracil, tryptophan, methionine, 
and histidine or 30 µg/ml leucine and lysine. YM + 5-FOA (5-fluoroorotic acid) 
medium contained 1 mg/ml 5-FOA, 20 µg/ml uracil and 2 % glucose. This medium 
was used to select against Ura3, since the URA3 protein converts 5-FOA to 
5-fluorouracil (5-FU), which is an inhibitor of DNA synthesis that causes cell death 
(Sherman, 1991). YM + αAA (α-amino-adipic acid) contained 2 g/l αAA and was 
used as LYS2-counterselective medium (Sherman, 1991). In contrast, YM medium 
containing 1 mg/ml 5-fluoroanthranilic acid (5-FAA) was used for counter selection of 
the tryptophan pathway represented by the expression of TRP1 (Toyn et al., 2000). 
For the analysis of MET15 expression, lead indicator plates containing 1 mg/ml lead 
nitrate were used. All S. cerevisiae strains were grown at 30 °C. 
 
2.2.3 Schizosaccharomyces pombe media and growth conditions 
Media were as described previously (Moreno et al., 1991). Unless indicated 
otherwise, S. pombe strains were grown on full medium (YES = yeast extract with 
supplements). Marker selection was performed using EMM (Edinburgh minimal 
medium) as selective minimal medium supplemented with 2 % glucose and as 
required with 225 mg/l for adenine, uracil, histidine, and leucine. 
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S. pombe strains were also grown in YM medium, which is usually used for 
S. cerevisiae. For S. pombe, this medium was supplemented with 3 % glucose and 
as required with 150 mg/l for adenine, uracil, histidine, and leucine. For overnutrition 
or dietary restriction 5 % and 1 % or 0.5 % glucose were used. Unless indicated 
otherwise, all S. pombe strains were grown at 30 °C. 
 
2.3 S. cerevisiae strain construction 
S. cerevisiae strains used in this study are listed in Table 1. They were generated by 
transformation with plasmids (Klebe et al., 1983), direct gene disruption, genomic 
integration, genetic crosses or originated from the laboratory strain collection. 
 
 
Table 1 S. cerevisiae strains used in this study 
Straina Genotype Sourceb 
AEY1 MATα ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 can1-100 
(= W303-1B) 
 
AEY2 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 can1-100 
(= W303-1A) 
 
AEY3 AEY1, but ADE2 lys2Δ  
AEY4 AEY2, but ADE2 lys2Δ  
AEY12 AEY1 ss-ΔI sir1Δ::URA3  
AEY21 AEY3 sir4Δ::LEU2  
AEY160 MATα his3Δ200 leu2Δ1 ura3-167 trp1Δ-6B3 met15Δ1 
RDN::Ty1::MET15 
J. Boeke 
AEY264 MATa his4  
AEY265 MATα his4  
AEY266 AEY2 sas2Δ::TRP1  
AEY269 AEY1 sas2Δ::TRP1  
AEY270 AEY1 + pRS316 (URA3)  
AEY303 JRY5078 = MATa hmrΔ::URA3 ade2-1 his3-11 trp1-1 leu2-3,112 
ura3-1 
 
AEY325 mataΔp hmlαΔp HMRssα trp1-1 ade2 leu2-3,112 ura3, his-  
AEY403 MATα HMRa-e**  
AEY474 MATα HMRa-e** sas2Δ::TRP1  
AEY565* MATa ura3-52 lys2-801 ade2-101 trp1-Δ1 his3-Δ200 leu2-Δ1 
ppr1Δ::HIS3 
O. Aparicio / D. 
Gottschling 
AEY567 MATa ΔA hmr::TRP1 rap1-12 (LEU2)  
AEY581 MATα ΔA hmr::TRP1  
AEY630 AEY1 + pRS414 (CEN-TRP1)  
AEY743 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 orc1Δ::TRP1 
can1-100 ade2Δ::his4  HIS3::HMR-URADE2-E + plasmid (URA3, 
ORC1) 
S. Bell 
AEY1017 AEY1 TEL VII-L::URA3 J. Berman  
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AEY1018 AEY2 sir1Δ::HIS3  sir3Δ::TRP1 TEL VII-L::URA3  
AEY1195 AEY160 sas2Δ::TRP1  
AEY1269 AEY1 ppr1Δ::HIS3  
AEY1499 AEY2 hst1Δ::KanMX  
AEY1676 MATα HMR::ADE2  
AEY1778 MATα his3Δ200 leu2Δ1 ura3-167 RDN1::Ty1-mURA (S2) J. Boeke 
AEY1779 MATα his3Δ200 leu2Δ1 ura3-167 RDN1::Ty1-mURA (S6) J. Boeke 
AEY2156* FEP 100-5 TEL IX-L position 1::URA3c, d E. Louis 
AEY2159* FEP 100-10 TEL XI-L position 1::URA3c, d E. Louis 
AEY2162* FEP 179 TEL XII-R position 2::URA3c, d E. Louis 
AEY2165* FEP 180 TEL XI-L position 2::URA3c, d E. Louis 
AEY2741 AEY1 + StuI-cut pRS406   
AEY3087 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0  
AEY3590 MATa rap1-12 TEL VII-L::ADE2::URA3  
AEY3595 AEY1 TEL VII-L::ADE2::URA3  
AEY3903 AEY2 rap1-17 HIS3 ura3 ADE2 – TEL VII-L D. Shore 
AEY3908 AEY1 adh4::URA3-(C1-3 A)n  L. Pillus 
AEY3909 AEY1 adh4::URA3-UASGal-(C1-3 A)n L. Pillus 
AEY4017 AEY3909 sir2::KanMX  
AEY4019 AEY3909 sir3::KanMX  
AEY4064 AEY1 + pAE1232 (pLEU2-SIR3)  
AEY4162* FEP100-5 TEL IX-L position 1::URA3c E. Louis 
AEY4163* FEP100-10 TEL XI-L position 1::URA3c E. Louis 
AEY4164* FEP179 TEL XII-R position 2::URA3c E. Louis 
AEY4165* FEP180 TEL XI-L position 2::URA3c E. Louis 
AEY4166* FEP184 TEL XI-L position 3::URA3c E. Louis 
AEY4167* FEP230-32 TEL XV-R position 9::URA3c  E. Louis 
AEY4168* FEP239-7 TEL IX-L position 7::URA3c E. Louis 
AEY4185 AEY2 hmr-ss::URA3 ΔI  
AEY4195 a   hmr-ss::3ARUΔI    sir2Δ  
α      HMR-ssΔI a       SIR2 
 
AEY4580 AEY4168, but TEL IX-L position 7::LYS2  
AEY4583 AEY4580 sir2Δ::KanMX   
a Strains were isogenic to W303 (AEY1, AEY2) except those marked with an asterisk. 
b Unless indicated otherwise, strains were designed during this study or were from the laboratory 
strain collection. 
c The exact genotypes of these strains are unknown. Positions of URA3 gene are described in (Pryde 
& Louis, 1999).  
d Notably, it turned out in later experiments that the indicated genotype of this strain is not correct, and 
thus, the precise site of URA3 integration is not known. 
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2.3.1 Crossing, sporulation, and tetrad dissection of S. cerevisiae strains 
Parental S. cerevisiae strains of opposite mating types were mixed in a drop of YPD 
medium and grown for 8 hours at 30 °C on a YPD plate. Cells were streaked YM 
plates supplemented with amino acids selecting for diploids. 
To induce sporulation, diploids were plated on sporulation medium (19 g/l KAc, 
0.675 mM ZnAc, 20 g/l agar) and incubated at 30 °C for at least three days. For asci 
digestion, a loop of sporulated cells was suspended in zymolyase buffer (1 M 
Sorbitol, 0.1 M NaCitrate, 60 mM EDTA pH 8.0, 5 mg/ml zymolyase) and incubated 
for 5 minutes at RT. The reaction was stopped by adding 100 µl H2O. Subsequently, 
tetrads were dissected on YPD plates using a micromanipulator (Narishige) 
connected to a Zeiss Axioscope FS microscope. The ascospores were incubated for 
2 - 3 days at 30 °C. Marker analysis was achieved by replicating the cells with the 
help of sterile velvet cloth on different selection plates. 
 
2.3.2 DNA techniques in S. cerevisiae  
Gene deletions with KanMX were performed as described (Wach et al., 1994). 
Double mutants were generated by crosses, subsequent tetrad dissection and the 
analysis of marker segregation. 
 For the replacement of the telomeric URA3 marker gene by LYS2, the LYS2 gene 
(pAE896) was amplified by PCR, and the PCR products were integrated at different 
chromosomal locations in the appropriate S. cerevisiae strains by homologous 
recombination. 
 
2.4 S. pombe strain construction 
S. pombe strains used in this study are listed in Table 2. The majority of these strains 
originated from the S. pombe Haploid Deletion Mutant Set ver 1.0 (Bioneer). The 
corresponding auxotrophic wild-type strain is ED666 (AEP57). All gene deletions of 
strains from the deletion library that showed an effect in further experiments were 
verified by PCR. Double mutants were constructed by tetrad dissection using ED665 
(AEP64) for changing the mating type. 
The remaining strains were generated by transformation with plasmids (Moreno et 
al., 1991), direct gene disruption, crossing of haploid h+ and h- cells, or they were 
derived from the laboratory strain collection. 
 
 
Table 2 S. pombe strains used in this study 
Strain Genotype Sourcea 
AEP1 h- leu1-32 ura4-D18 his3-D3  
AEP14 h- leu1-32 ade6-210 ura4-D18 mat1_m-cyhS, smt0, rpl42::cyhR 
(sP56Q) 
N. Krogan 
AEP55 h- msh2::his3 his3-D1 O. Fleck 
AEP56 h- msh6::arg3 arg3-D4 O. Fleck 
AEP57 ED666 = h+ ade6-M210 leu1-32 ura4-D18 Bioneer 
AEP58 ED668 = h+ ade6-M216 leu1-32 ura4-D18 Bioneer 
AEP59 h- ade6-M216 ura4-D18 leu1-32 his7-366 K. Runge 
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AEP60 AEP59 sck1::LEU2 K. Runge 
AEP61 AEP59 leu1::LEU2 K. Runge 
AEP62 AEP59 sck2::LEU2 K. Runge 
AEP64 ED665 = h- ade6-M210 leu1-32 ura4-D18 Bioneer 
AEP65 h90 ura4-D18 swi10::ura4+ H. Schmidt 
AEP66 h90 ura4-D18 swi9::ura4+ H. Schmidt 
AEP67 h- ura4-C109T leu1-32 K. Takegawa 
AEP68 AEP67 vma1::URA4 K. Takegawa 
AEP69 AEP67 vma3::URA4 K. Takegawa 
AEP70 msh6::KanMX mlh1::KanMX #14  
AEP71 msh6::KanMX mlh1::KanMX #16  
AEP72 msh6::KanMX rad2::KanMX #4  
AEP73 msh6::KanMX rad2::KanMX #8  
AEP74 rad2::KanMX mlh1::KanMX #12  
AEP75 rad2::KanMX mlh1::KanMX #14  
AEP76 rad2::KanMX rhp23::KanMX #1  
AEP77 rad2::KanMX rhp23::KanMX #7  
AEP78 rhp23::KanMX mlh1::KanMX #5  
AEP79 msh6::KanMX rhp23::KanMX #2  
AEP80 msh6::KanMX rhp23::KanMX #4  
AEP81 AEP57 rad2::NatMX #4  
AEP82 AEP57 rad2::NatMX #5  
AEP83 AEP1 rad2::NatMX #10  
AEP84 AEP1 rad2::NatMX #11  
AEP85 AEP57 rad13::NatMX #12  
AEP86 AEP57 rad13::NatMX #37  
AEP87 AEP1 rad13::NatMX #6  
AEP88 AEP1 rad13::NatMX #13  
AEP89 AEP57 msh6::NatMX #8  
AEP90 AEP57 msh6::NatMX #9  
AEP91 AEP1 msh6::NatMX #15  
AEP92 AEP1 msh6::NatMX #16  
AEP93 AEP57 ppk4::NatMX #5  
AEP94 AEP57 ppk4::NatMX #9  
AEP95 AEP1 ppk4::NatMX #4  
AEP96 AEP1 ppk4::NatMX #12  
a Unless indicated otherwise, strains were designed during this study or were from the laboratory 
strain collection or the S. pombe Haploid Deletion Mutant Set ver 1.0 (Bioneer). 
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2.4.1 Crossing, sporulation, and tetrad dissection of S. pombe strains 
Parental S. pombe strains of opposite mating types were mixed in a drop of YES 
medium and grown for 2 days at 23 °C on sporulation medium (SPAS). The mating 
cells will form transient diploids (zygotes) and then proceed directly into meiosis. 
The sporulated cells were placed on YES plates, where zygotic asci were 
separated based on their characteristic zig-zag or banana shape using a 
micromanipulator (Narishige) connected to a Zeiss Axioscope FS microscope. After 
the fission yeast asci fell apart spontaneously (4 – 5 hours at 37 °C), the ascospores 
were separated and incubated for 2 - 3 days at 30 °C. Marker analysis was achieved 
by replicating the cells with the help of sterile velvet cloth on different selection 
plates. Double mutants arising from crosses were verified by PCR. 
 
2.4.2 Gene disruption in S. pombe 
For the gene knockouts in S. pombe, the PCR sewing technique, also called 
megaprime PCR, was used. With this technique, DNA sequences complementary to 
about 500 bp downstream or upstream the ORF of the target gene were generated in 
a first step. Next, the NatMX cassette was amplified by PCR. In a last step, all three 
PCR products were sewed together. All gene disruptions and sequence insertions 
were verified by PCR analysis. 
 
2.5 Molecular cloning 
Plasmids were generated according to standard cloning techniques (Sambrook et al., 
1989). Kits for plasmid isolation and gel elution were purchased from Qiagen. 
Enzymes and respective buffers were used from NEB and Promega. Plasmids and 
oligonucleotides used for molecular cloning, overexpression or gene knockouts are 
listed in Table 3 and Table 4.  
 
Table 3 Plasmids used in this study 
Plasmida Description Sourceb 
pAE192  pJR304 = JDB Sir2 = multicopy sir2  
pAE231 pRS315-SIR2  
pAE232 pRS315-SIR3  
pAE255 pRS306 (Sikorski & 
Hieter, 1989) 
pAE264 pRS414 (Sikorski & 
Hieter, 1989) 
pAE269 pRS425 (Sikorski & 
Hieter, 1989) 
pAE478 pFA KanMX4  (Wach et al., 
1994) 
pAE712 pRS305-SIR2  
pAE896 pRS317  
pAE916 pCT300  
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pAE929 pFA6a – HIS3 MX6 (Wach et al., 
1994) 
pAE1003 pAG25 (Wach et al., 
1994) 
pAE1232 pRS425-SIR3  
pAE1325 pET15b   
pAE1373  2µ URA3 HOP1/lacZ – URS1H  A. Vershon 
pAE1394 pET24a(+) Sir2-His6x  
pAE1395 pAE1373 + NDT80 (-78) MSES A. Vershon 
pAE1429 REP4X = as REP3X (ATG-less derivate of REP3 with LEU2 
marker, nmt1 promoter and ars1), with ura4+ marker  
 
a Plasmids were generated according to standard cloning techniques.  
b Unless indicated otherwise, plasmids were constructed during this study or originated from the 
laboratory plasmid collection. 
 
 
Table 4 Oligonucleotides used for molecular cloning, knockout or replacement of telomeric 
URA3 by LYS2 
Oligonucleotide Oligonucleotide sequence (in 5’ to 3’ direction)a 
Integration LYS2 S1 (FOR) ATG TCG AAA GCT ACA TAT AAG GAA CGT GCT GCT ACT CAT 
CCT AGT CCT GTt ggc tta act atg cgg cat cag agc 
Integration LYS2 S2 (FOR) TTA GTT TTG CTG GCC GCA TCT TCT CAA ATA TGC TTC CCA 
GCC TGC TTT TCt ctc ctt acg cat ctg tgc ggt at 
Integration LYS2 S1 (REV) TTA GTT TTG CTG GCC GCA TCT TCT CAA ATA TGC TTC CCA 
GCC TGC TTT TCt ggc tta act atg cgg cat cag agc 
Integration LYS2 S2 (REV) ATG TCG AAA GCT ACA TAT AAG GAA CGT GCT GCT ACT CAT 
CCT AGT CCT GTt ctc ctt acg cat ctg tgc ggt at 
Sir2-S1 ATG ACC ATC CCA CAT ATG AAA TAC GCC GTA TCA AAG ACT 
AGC GAA AAT AAG GCG 
Sir2-S2 TTA GAG GGT TTT GGG ATG TTC ATC TGA TGT AAC GAC ATA 
CAC GCC CTT ATC CAT 
KanMX K2 GCC CCT GAG CTG CGC ACG TC 
KanMX K3 CCC AGA TGC GAA GTT AAG TGC GC 
Sir2_A1_500up GAA AGA AAT GAT TAT TAG CAG 
Sir2_A4_3200dwn CAA ATG CCT TTC AAC CGT G 
SIR2-A1 GGC ACC ACG AGC GGT TTA TTT GG 
SIR2-A4 CCT ACT GAA CCG TTC TTC GG 
NatMX K2 GTC CCC GGT GGC GGT GAC GCG G 
NatMX K3 GGT CGC CCC GGA GCA CCG GG 
CPN1 CGT CTG TGA GGG GAG CGT TT 
Rad2_ctrl_Sp.fw GCT AGT TTT GGA GAA AGC GTT GTT CGG G 
Rad13_ctrl_Sp.fw GGC TTG CTT TAA TCA CAT TTC TTC GTA TAA TAA TC 
Ppk4_ctrl_Sp.fw CTG TTT ACC TAC TAC CTA CTT CAA ATG TAT CGT C 
Msh6_ctrl_Sp.fw GCT CTC ATG TTA GCT TTG TTT ACT ATT AGA ATG C 
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Irc6_ctrl_Sp.fw CCA CCA AAA ACT TGT TTA ATA TTC TAC AGA ACT G 
Pms1_ctrl_Sp.fw GTA CAT CAA GGT CCA AAA AAT TCG C 
Nth1_ctrl_Sp.fw GCG CTC ACC TGC GTT GTT TCT TGG 
Spd1_ctrl_Sp.fw CGT CAC AAA GCC GAG TAG CAA ACG C 
Dss1_ctrl_Sp.fw GTG TAA CTC AGT AGA CAT CGT TAC CAG TG 
SPBC216.01c_ctrl_Sp.fw CGT CTT CAC TTT TGA AAA TTT GGT GAC GAA CG 
Rhp23_ctrl_Sp.fw GCT ACC TTG ACA ATT ATT CTC TGA TGC AAC G 
Msh1_ctrl_Sp.fw GAC AAT GAT GCA TTC ATT GTC GCT TAT AGT AAC 
Msh3_ctrl_Sp.fw CCG CCT ATA TTC ATT TAG AAA CTA TAA ATG CG 
Mlh1_ctrl_Sp.fw CGG TAC TTG TAC ATT CTG CGC TAT G 
KanB CTG CAG CGA GGA GCC GTA AT 
Rad27_ctrl_Sc.fw (A) GCT GGT AAG TTA TGA TAG AAA GCC A 
Rad2_ctrl_Sc.fw (A) AAT ACC ACA TTT TGT TGC TGT TTT T 
Ire1_ctrl_Sc.fw (A) AAT AGG TTT TCG CTA TTT TAT TGC C 
Rad2_NatMX_Sp.fw GCG TTG TTC GGG ATC TCG TAA TAT ACA TAA ATA AGT ATA 
TTT GCT AAA CGA TGc cag ctg aag ctt cgt acg c 
Rad2_NatMX_Sp.rev GCT TTT TTT AAG TTT TTT TTT TAG ATT AAT AAC AAT TAC 
ATG ACT TCG TTT TCA gca tag gcc act agt gga tct g 
Rad2_PCR1_Sp.fw CGG TAA AGT TCC AAT GTA CTT TTC  
Rad2_PCR1_Sp.rev CTT ATT TAT GTA TAT TAC GAG ATC CCG  
Rad2_PCR2_Sp.fw GTC ATG TAA TTG TTA TTA ATC TAA AAA AAA AAC  
Rad2_PCR2_Sp.rev CCC TTC TTT CAA ACT GTG AAC  
Rad13_NatMX_Sp.fw CAA AAA TAA AGT CGT CTA CAA CGA AAC TTC TTG ACA TCG 
CAT ATA ATA TTT TGC AAT Gcc agc tga agc ttc gta cgc  
Rad13_NatMX_Sp.rev CTT TTA TAG GAA CAA CCA GTT AAG TAA ACA AAT AAA TAA 
ATA ATT TAT TAA ACT Tag cat agg cca cta gtg gat ctg  
Rad13_PCR1_Sp.fw GGG AGT GAA ATC CCA TGT TG 
Rad13_PCR1_Sp.rev GCG ATG TCA AGA AGT TTC GTT G 
Rad13_PCR2_Sp.fw ATT TGT TTA CTT AAC TGG TTG TTC C 
Rad13_PCR2_Sp.rev CCA TCA TAT TTT GCT CAA CTT ACG 
Ppk4_NatMX_Sp.fw TTA GTT AAG TTG CTC TTA AAA AAT ATT TTT GTT AAA AAC 
TTT TAC CAA TGc cag ctg aag ctt cgt acg c 
Ppk4_NatMX_Sp.rev GGA TTA AAT TAC ATA TAA AAT GAC TTT AAG AAT TTA GTA 
TGT AAA CGT CAg cat agg cca cta gtg gat ctg 
Ppk4_PCR1_Sp.fw GGT TAT GTC TTC TGA TAA TGC ATA C 
Ppk4_PCR1_Sp.rev GGT AAA AGT TTT TAA CAA AAA TAT TTT TTA AG 
Ppk4_PCR2_Sp.fw CAT ACT AAA TTC TTA AAG TCA TTT TAT ATG  
Ppk4_PCR2_Sp.rev CCT TCA GAC ATA ATT TTG AAT TAC 
Msh6_NatMX_Sp.fw GCT TTT TGT AAA TAA CTG AAC TTA GCC AAA ACC AAC ACT 
TGT TCC AGT ATG cca gct gaa gct tcg tac gc 
Msh6_NatMX_Sp.rev GAA AGA TAT TGC TTT GAA TAG TCA TAA AAC TGA TAG AGT 
GTT GAC AGT TAT Tag cat agg cca cta gtg gat ctg 
Msh6_PCR1_Sp.fw CCT AAA CTC TCC TTC TCT GAA GG 
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Msh6_PCR1_Sp.rev GGT TTT GGC TAA GTT CAG TTA TTT AC 
Msh6_PCR2_Sp.fw GTC AAC ACT CTA TCA GTT TTA TG 
Msh6_PCR2_Sp.rev CCA TGT TGT TAG ACC AAG AAG  
Rad13_ctrl_Sp.up CGT CTC GTT CAC CAA TGG TGG G 
Rad13_ctrl_Sp.down GGG TCT TTA AAC TCG GGG AAG G 
Rad2_ctrl_Sp.up GAT CCG CAC GAA ATA CGT CGG  
Rad2_ctrl_Sp.down GAG GGC AAA GGT TTC AGG GG 
Msh6_ctrl_Sp.up GGC CAA CTT AGG GGA CAA CTT C 
Msh6_ctrl_Sp.down GGA ACG GGA TGT GTC ATC CAT G 
Ppk4_ctrl_Sp.up GCC TAT GGA TGA CTA TAC CCA AAG C 
Ppk4_ctrl_Sp.down CGA TCC CAC AAG CGG CTG G 
Dnm1_ctrl_Sp.fw GCATTCCCATAATCCAAATTGTGCGTGT 
Git3_ctrl_Sp.fw CGTTCTGATATTGCTTTTCTTGTTTTTTACTTTCTCACC 
Pka1_ctrl_Sp.fw GCCTCGACCTCTTTTAACCTTATTCTTGTTTTCGGG 
Tim11_ctrl_Sp.fw CGTTGCACTATTCGTGTTAAGTGTTTAGAGTTCG 
Atp14_ctrl_Sp.fw CAGCGATTGTTTATTTGGGCATTTAAAACTTTAGC 
a Nucleotides complementary to the URA3 marker gene (in case of replacement of by LYS2) or the 
NatMX cassette are shown in lower case letters. 
 
2.6 Growth assays 
Unless indicated otherwise, the growth assays were documented using the Molecular 
Imager GelDocTM XR System (Bio-Rad) and the Quantity One® Software (Bio-Rad). 
 
During this study, I spent time at the University of Applied Sciences (HTW) in Berlin 
in the lab of Prof. Dr. Jacqueline Franke to establish the automation of the high-
throughput methods (2.6.1.1 and 2.6.3) by using the robotic workstation Freedom 
EVO® (Tecan) that is connected with the microplate reader Infinite® M200 (Tecan) 
and the Cytomat® Tower Shaker (Thermo Scientific). 
 
2.6.1 Chronological lifespan assays 
2.6.1.1 High-throughput method to measure chronological lifespan (CLS) 
For each CLS assay, cells were inoculated from fresh single S. pombe colonies into 
YES medium for overnight cultures. 2 µl of these cultures (or of the S. pombe Haploid 
Deletion Mutant Set, Bioneer) were used to inoculate 150 µl medium per well in 
96 well microplates (TPP). The medium for CLS assay was YM medium containing 
3 % glucose with 150 mg/l of adenine, uracil, and histidine or leucine (Chen & Runge, 
2009). For overnutrition or dietary restriction 5 % and 0.5 % or 1 % glucose were 
used. The microplates were coverd with SILVERsealTM films (Greiner Bio-One) to 
avoid mixing of the cultures while shaking with 900 rpm at 30 °C. Aliquots of the 
cultures were taken at regular intervals, spotted onto YES plates and grown for 
2 days at 30 °C. 
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The effect of compounds on CLS was analyzed by adding the compounds to the 
medium immediately before the yeast cells were added (final concentration as 
indicated in the text and figure legends). 
 
2.6.1.2 Colony forming unit (CFU) method 
Overnight cultures (inoculated as described in 2.6.1.1) were used to inoculate 75 ml 
medium (see above) to an initial optical density at 600nm (OD600) of 0.1. The OD600 
of the aging culture was measured several times to ensure that the yeast cells reach 
stationary phase. Aliquots of the cultures were taken at regular intervals, serially 
diluted in sterile milliQ water and multiple dilutions were plated on YES plates and 
grown at 30 °C for 3 - 5 days. Colonies were then counted and used to calculate the 
number of colony forming units per ml culture (CFU/ml). For each strain or 
compound, at least 3 biological replicates were used. 
 For the compound prostaglandin J2 and its controls, a modified approach was 
used. The aging cultures were inoculated as described above but in a smaller volume 
(3 - 5 ml medium). Aliquots taken at regular intervals were serially diluted in YES 
medium and spotted onto YES plates, which were incubated at 30 °C for 2 days. 
 
2.6.2 Stress resistance 
For testing stress resistance, S. pombe cells were cultured for 1 or 2 days at 30 °C in 
YM medium containing 3 % glucose, the required supplements and in some cases 
also compounds (final concentration as indicated in the text and figure legends). After 
washing with YM medium, the cell concentration was adjusted to OD600 of 0.5. Next, 
H2O2 (10 mM - 300 mM final concentration) or menadione sodium bisulfite (25 mM 
final concentration) were added and incubated at 30 °C. To analyze the resistance 
against DNA damage, MMS was added (0,2 % final concentration) and incubated for 
15 - 60 minutes at 30 °C. For heat treatment, equal amounts of cells (OD600 of 0.5) 
were heat shocked for 45 - 90 minutes at 48 °C. Serial dilutions were spotted onto 
YES plates and incubated for 2 days at 30 °C.  
In some cases, the addition of the compound slows down the growth rate of the 
cells. To avoid misinterpretations due to differences in stress response that depend 
on the time the cells are in stationary phase, cells treated with these compounds 
were compared with DMSO-treated cells that were cultured for only 1 day at 30 °C. 
 
2.6.3 Telomeric silencing assay 
S. cerevisiae strains, media, and positive controls used for the screens are listed in 
Table 5. Blank (DMSO) and positive control were always located on the same 
microplate with the samples. 
The high-throughput screening (2.6.3.2) was performed at the Leibniz-Institute for 
Molecular Pharmacology (FMP) in Berlin. 
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Table 5 Strains, media, and positive controls used for telomeric silencing assay 
Screen S. cerevisiae strain Medium  Positive control 
Increased telomeric 
silencing 
TEL IX-L pos 7::URA3 5-FOAa + pLEU2-SIR3  
(in 5-FOA -leuc) 
Decreased telomeric 
silencing 
TEL IX-L pos 1::URA3 + 
pLEU2-SIR3 
YM -ura-leub 10 µM splitomicin 
a 5-FOA medium supplemented with adenine, histidine, lysine, tryptophan, and leucine. 
b YM medium supplemented with adenine, histidine, lysine, and tryptophan, but lacking uracil and 
leucine. 
c 5-FOA medium supplemented with adenine, histidine, lysine, and tryptophan, but lacking leucine. 
 
2.6.3.1 Screening of small compound libraries for effects on telomeric 
silencing 
S. cerevisiae strains were grown in YES medium over night at 30 °C. The medium 
used for the screen was inoculated with these cells to a final OD600 of 0.2 (5-FOA) or 
0.05 (YM). Into each well of 96 well plates (TPP) or 384 well plates (Corning, #3701), 
100 µl respectively 50 µl of this mixture were pipetted. DMSO or compounds from the 
Natural Products Library (Biomol; final concentration: 4 µg/ml or 20 µg/ml) or single 
compounds from Evonik were added (final concentration: 100 µg/ml). The 
microplates were incubated at 30 °C with constant shaking (300 rpm). At distinct time 
points, the microplates were removed from the incubator and the optical density at 
595 nm (OD595) was determined using the GENios ProTM microplate reader (Tecan) 
and the XFluor4GENiosPro Software (Tecan).  
Each primary candidate was validated several times. 
 
2.6.3.2 High-throughput screening of large compound libraries for effects on 
telomeric silencing 
Yeast cultures were inoculated as described above (see 2.6.3.1). 50 µl of the mixture 
were pipetted with the MicroFloTM Select Dispenser (BioTek) into each well of 
384 well plates (Corning, #3702) with sterile lids. For technical reasons, yeast cells 
and the corresponding medium used as control had to be manually added to the 
miroplates. The Sciclone ALH3000 Workstation (Caliper Life Science) was used to 
add 0.2 µl DMSO or 10 mM compounds from the ChemBioNet or the LOPAC 
compound library (final concentration: 40 µM). The microplates were incubated at 
30 °C. At distinct time points, the microplates were removed from the incubator and 
the yeast cells were shaked for 5 minutes with 1500 rpm using the MixMate 
(Eppendorf). Subsequently, the optical density at 595 nm (OD595) was determined 
using the Safire2TM microplate reader (Tecan) and the Magellan Software (Tecan).  
For validation, each primary candidate was tested 3 times in 3 concentrations 
(20 µM, 50 µM, 100 µM). 
 
2.6.3.3 Analysis of high-throughput screening data 
In both screens, the OD600 was first measured after the addition of the compounds. 
This blank value was subtracted from the following values to subtract out the 
absorption of the compounds. 
The cut-off was set to the 1.5-fold of the blank (DMSO). 
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2.6.4 Spot filter assay of compounds for effects on telomeric silencing 
S. cerevisiae cells (0.1 or 0.5 OD600) were plated on YM or 5-FOA plates. Whatman 
paper was used to make small, sterile filters, which were placed on the prepared 
plates. To test telomeric silencing, 1.25 µl, 2.5 µl, and 10 µl of 10 mM resveratrol, 
7.5 mM TSA, 10 mM splitomicin, or 623 mM nicotine were spotted onto these filters. 
 
2.6.5 Spot filter assay for effects on HM silencing 
To analyze the effect of compounds on HM silencing, 0.5 OD600 of MATa his4 
(AEY264) and hmlaΔp mataΔp HMRssα (AEY325) were mixed and plated onto YM 
plates without supplements. Small, sterile filters made out of Whatman paper were 
placed on the prepared YM plates. 1.25 µl, 2.5 µl, and 10 µl of 10 mM splitomicin 
(and DMSO) were spotted onto these filters to select for diploids by disturbing the 
HMR silencing.  
In another approach, 0.5 OD600 of MATa his4 (AEY264) and MATα HMRa-e** 
(AEY403) were mixed and plated onto YM plates without supplements. Different 
volumes of 623 mM nicotine were spotted onto small, sterile filters made of Whatman 
paper, which were placed on the YM plates. 
 
2.6.6 Patch mating assay 
HM silencing of S. cerevisiae was measured by determining the mating ability of a 
strain with a mating tester strain in a patch-mating assay. For this purpose, the 
candidate strains were streaked in 1 cm2 patches on a YPD plate (master plate) and 
grown over night at 30 °C. Next, 2.5 OD600 of a tester strain, MATa his4 (AEY264) or 
MATα his4 (AEY265), were plated on a YM plate. The master plate was then 
replicated onto the tester strain plate and incubated for 2 days at 30 °C. 
 
2.7 Protein expression and purification in E. coli  
For overproduction of His6x-tagged Sir2 protein, Rosetta cells harboring the plasmid 
pAE1394 were grown in LB medium supplemented with 50 µg/ml kanamycin and 
34 µg/ml chloramphenicol. 1.5 l medium were inoculated with a fresh overnight 
culture and incubated at 37 °C until an OD600 of 0.5 was reached. Protein expression 
was then induced by adding isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final 
concentration of 1 mM and the incubation was extended for additional 5 hours at 
30 °C. To harvest the cells, they were centrifugated with 6000 rpm for 20 minutes at 
4 °C. Next, they were resuspended in lysis buffer (50 mM NaH2PO4, 500 mM NaCl, 
20 mM imidazole) with 1 mg/ml lysozyme. To lyse the cells, they were dipped into 
liquid nitrogen 3 times and stored on ice in between for 10 minutes. Subsequently, 
they were sonicated for 5 minutes with 10 second intervals of ultrasonic and rest and 
finally, they were drawn through needles (19 G and 23 G) several times. The cell 
extract was centrifugated with 10000 rpm for 20 minutes at 4 °C. The supernatant 
was mixed with Ni-NTA beads (Qiagen) for 1.5 hours at 4 °C and then applied onto a 
Ni-NTA sepharose column (Qiagen) equlibrated with lysis buffer. Chelate affinity 
chromatography was performed under native conditions according to the standard 
procedures recommended by the manufacturer (Qiagen). 
Purification of the Sir2 protein was verified on SDS-PAGE by Coomassie Brilliant 
Blue R250 staining. 
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2.8 SDS-PAGE and Western Blotting 
Purified proteins were separated by SDS-PAGE (10 %) in Tris-glycine buffer 
according to standard methods (Laemmli, 1970). Then, they were transferred to a 
nitrocellulose membrane (Amersham Hybond ECL, GE Healthcare) by blotting with 
the Bio-Rad Tank Transfer System with 5,5 mA x h/cm2 in transfer buffer (25 mM 
Tris; 52 mM glycine; 10 % methanol). Subsequently, the nitrocellulose membrane 
was blocked in TBS-T + 5 % milk (50 mM Tris HCl pH 7.5; 150 mM NaCl; 0.1 % 
Tween20; 5 % milk powder) for 1 hour at RT. The blot was then incubated with the 
primary antibody (mouse α-His, Sigma, 1:3000) over night at 4 °C in TBS-T + 5 % 
milk and washed 2 times for 5 minutes with TBS-T. Next, the blot was incubated with 
the appropriate secondary antibody conjugated to horseradish peroxidase (sheep α-
mouse, Sigma, 1:1000) in TBS-T + 5 % milk for 1 hour at RT. After washing 4 times 
for 5 minutes with TBS-T and TBS the Western blot signals were visualized on 
Amersham HyperfilmTM ECL chemiluminescence films (GE healthcare) by using the 
Amersham ECLTM Western Blotting Analysis System (GE healthcare). 
 
2.9 Fluorescence-based in vitro HDAC assay 
To measure Sir2 deacetylase activity, a simple fluorescence-based assay (Heltweg 
et al., 2003; Heltweg & Jung, 2003) was used. In two consecutive reactions, 
deacetylation of the substrate MAL generates a fluorophore that is excited at 360 nm. 
The emitted light at 460 nm was detected using the GENios ProTM microplate reader 
(Tecan). This experiment was performed by Gesine Hoffmann. 
 
2.10 Telomeric restriction fragment (TRF) analysis 
S. cerevisiae strains were grown over night in minimal medium. In some cases, 
10 µM splitomicin or resveratrol were added. Genomic DNA was isolated and then 
digested with XhoI. After separation by agarose gel electrophoresis, DNA was 
transferred onto Zeta Probe GT Membranes (Bio-Rad) as described (Sambrook et 
al., 1989). Next, Southern blotting was performed as described (Southern, 1975). 
The DNA was blotted onto a nitrocellulose membrane by capillary action. Afterwards, 
the membrane was baked at 80 °C for 1 - 2 hours. A C1-3A containing 280 bp EcoRI 
fragment of pCT300 (pAE916) labeled by random primer labeling with [α-32P]dCTP 
was used as a probe for hybridization of the Southern blot (Wellinger et al., 1993). 
Subsequently, the blot was exposed to a phosphorimager screen (Molecular 
Dynamics) for 12 hours. 
 
2.11 Fluorescence staining 
Fluorescence staining with phloxine B (Applichem), dihydrorhodamine123 (DHR123, 
Cayman) and FITC-VAD-fmk (CaspACE, Promega) was performed as described 
(Roux et al., 2006) and analyzed under the Zeiss Axio Imager.M1 fluorescence 
microscope using the AxioVision Software (Zeiss). Stained cells were counted by 
using ImageJ 1.39. 
 Vacuolar membranes were stained using SynaptoRed (Merck), which is also 
called FM4-64, as previously described (Iwaki et al., 2003). Based on the work of Liu 
and colleagues, staining of acidic compartments was performed using quinacrine 
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dihydrochloride (Sigma Aldrich) (Liu et al., 1997). At variance with this protocol, 
quinacrine was dissolved in YES medium instead of YPD medium. 
 
2.12 Measurement of the pH-value 
The pH-value of yeast cultures was determined by spotting aliquots on pH indicator 
sticks (pH 2.0 - 9.0, Merck), which detect changes of the pH-value in 0.5 steps. 
 
2.13 Compounds 
The compound libraries used in this study are listed in Table 6. Secondary 
candidates were purchased from Biomol, Cayman, ChemDiv, ChromaDex, Enzo, 
Fluka, Latoxan, LKT, Roth, Sigma, and TimTec. 
 
 
Table 6 Compound libraries used in this study 
Library Sourcea Number of compounds Concentration 
Natural Products Library (v5.0) Biomol 502 1 mg/ml in DMSO 
Natural Products Evonik 20 5 mg/ml in DMSO or H2O 
ChemBioNet FMP (ChemDiv) 16,896 10 mM in DMSO 
LOPAC FMP (Sigma) 1,267 10 mM in DMSO 
a FMP = Leibniz-Institute for Molecular Pharmacology, Screening Unit, Berlin 
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3 Results 
3.1 Compounds and gene deletions affecting chronological aging 
of S. pombe 
So far, the mechanisms that lead to chronological aging are less well characterized 
for S. pombe than for S. cerevisiae. CR, defined as reduced intake of glucose and 
amino acids, extends CLS of fission yeast by the downregulation of the two nutrient 
sensing pathways, namely the TOR signalling pathway, including Sck2, and the 
Git3/PKA pathway (Roux et al., 2010). However, there are differences between these 
two pathways. A decrease in TOR signalling is proposed to increase mitochondrial 
activity, while a reduction of the Git3/PKA pathway is thought to additionally activate 
the Wis4/Wis1/Sty1 MAP kinase cascade thereby leading to enhanced stress 
resistance (Roux et al., 2010). In contrast to S. cerevisiae (Burtner et al., 2009), no 
study has reported an effect of ethanol and acetic acid on S. pombe lifespan so far. 
 
3.1.1 Establishment of methods to measure the CLS of S. pombe 
The chronological lifespan of S. cerevisiae and S. pombe is usually measured by 
plating serial dilutions of stationary phase aging cultures and determining the ability 
of individual yeast cells to form a colony. This so called CFU method is illustrated in 
Figure 1 (see 1.2). Since only a few yeast cultures can be analyzed in parallel by 
using this traditional method, it was necessary to develop a new high-throughput 
method that enables the CLS measurement of many yeast cultures simultaneously.  
Different media can be used for S. pombe growth. Therefore in a first step, the 
yeast medium most suitable for measuring the CLS under our conditions had to be 
determined. To this end, S. pombe wild-type cells were grown in EMM and YM 
medium, each containing the standard glucose concentration (2 % for EMM, 3 % for 
YM), and the CLS was measured by using the CFU method. In both approaches, 
overnutrition was achieved by using a high glucose concentration of 5 %, while 0.5 % 
glucose modelled DR. In agreement with earlier results (Chen & Runge, 2009), 
lifespan was increased in YM medium containing a low glucose concentration of 
0.5 % as compared to the standard concentration, and it was decreased by 
overnutrition (Figure 8A). In contrast, yeast cells grown in EMM medium containing 
5 % glucose displayed a longer lifespan than cells grown under standard conditions 
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(Figure 8B), indicating that a higher glucose concentration in EMM medium had the 
opposite effect than in YM medium. This has already been observed and discussed 
by other groups (Chen & Runge, 2009; Roux et al., 2010) and suggests that nutrients 
are limited in EMM medium to an extent that they cause lifespan shortening with 3 % 
glucose. Since lifespan-extension by CR and the shortening of CLS by overnutrition 
are evolutionarily conserved (see 1.3), we decided to use YM medium here for the 
analyses of chronological aging. Notably, the maximum lifespan is significantly 
shorter in standard YM medium compared to standard EMM medium (Figure 8) 
(Chen & Runge, 2009). 
 
 
Figure 8 High glucose concentration shortened CLS of S. pombe in YM medium and extended 
lifespan in EMM medium 
Wild-type cells (AEP57) were grown in 50 ml cultures at 30 °C. When reaching the stationary phase 
(day 0), samples were taken at the indicated time points, serially diluted in sterile water and then 
plated onto full medium plates. After incubating these plates at 30 °C for five days, the arising colonies 
were counted and the survival rate was calculated by defining the colony forming units (CFUs) per ml 
culture on day 0 as 100 %. Cells were grown under standard (2 % or 3 % glucose) as well as under 
CR (0.5 % glucose) and overnutrition conditions (5 % glucose) in either YM medium (A) or EMM 
medium (B). 
 
Next, we sought to develop a high-throughput method to measure the CLS of 
many yeast cultures in parallel. For this purpose, small aging cultures were grown in 
96 well microplates and spotted onto full medium plates at regular intervals to 
determine the viability of the culture. In the initial experiment, all wells were 
inoculated with the same wild-type strain, and six wells in a row contained medium 
with the same glucose concentration. In YM medium containing 5 % glucose, most 
yeast cells had lost viability on day five, whereas cells cultured in 3 % glucose were 
still viable (Figure 9). This indicated that this assay recapitulated the lifespan-
shortening of high glucose concentrations. Similarly, lifespan was extended in YM 
medium containing 0.5 % glucose, thus modelling CR (Figure 9), showing that the 
assay reproduced the lifespan-shortening and -extending effects observed in 
Figure 8A, indicating that this method was a viable approach for large-scale studies.  
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Notably, both the CFU method and the new spotting method did only work using 
fission yeast, but not with budding yeast. As soon as the first S. cerevisiae cells died, 
re-growth of the remaining cells was observed (data not shown). This effect did not 
occur in S. pombe aging assays for unknown reasons. 
 
 
Figure 9 High-throughput method for the measurement of CLS of S. pombe 
S. pombe wild-type cells (AEP57) were grown in 96 well microplates. Each row consisting of six wells 
contained YM medium with a different glucose concentration (top to bottom: 0.5 %, 3 %, 5 %). At the 
indicated time points, the aging cultures were spotted onto YES plates and incubated at 30 °C for two 
days. Each spot represents one well. Decreased growth implied a reduction in the ability to re-enter 
the cell cycle and therefore a shortening of the CLS. 
 
3.1.2 Identification of lifespan-extending compounds 
3.1.2.1 Screen for compounds that affect the CLS of S. pombe 
After the establishment of a high-throughput measurement of CLS, it was used to 
analyze a small compound library (Biomol) consisting of 502 natural products for their 
effect on the CLS of wild-type S. pombe cells. Each compound was tested in a final 
concentration of 4 µg/ml as a biological duplicate in YM medium containing 3 % 
glucose, as first experiments using a final concentration of 20 µg/ml of some 
compounds led to increased rate of non-growing yeast cells (data not shown), 
indicating toxic effects. To determine the impact of the compounds on the lifespan 
and to correct for potential variations between individual microplates, each group of 
6 x 8 wells contained as a control wild-type cells with the solvent DMSO and cultured 
in YM medium containing 0.5 %, 3 %, and 5 % glucose. An example of a screening 
plate is shown in Figure 10.  
In this screen, we identified 48 primary candidates that showed an impact on the 
CLS of S. pombe (Table 7, Table 8) or delayed growth (Table 9). In the case of the 
latter, the yeast cells treated with these compounds reached stationary phase to a 
later time point than the control cells. Therefore, a potential lifespan-extension was 
hard to detect and thus, the corresponding compounds were analyzed a second time. 
For validation, all primary candidates were re-tested in two different concentrations 
(2 µg/ml and 4 µg/ml) in biological triplicates. In this experiment, 20 compounds 
extended lifespan (Table 10). Notably, rapamycin is also contained in the compound 
library, but did not show an effect at the tested concentrations of 2 µg/ml and 4 µg/ml, 
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which correspond to 2.19 µM and 4.38 µM for this compound (data not shown). 
However, there was a slight increase of CLS when 100 nM rapamycin was used 
(data not shown), indicating that the inability to identify rapamycin as a lifespan 
extending compound in our screen was due to the fact that the concentration tested 
here was too high. 
 
 
Figure 10 Example of the screen for compounds altering CLS 
All wells of 96 well microplates were inoculated with a S. pombe wild-type strain (AEP57). The 
compounds indicated as their original position in the library (e.g. 1-H3 = microplate 1, row H, 
column 3) were tested in YM medium containing 3 % glucose. As controls, DMSO-treated cells were 
grown in standard YM medium (3 % glucose) as well as under CR and overnutrition conditions (0.5 % 
and 5 % glucose). At the indicated time points, the cells were spotted onto full medium plates and 
incubated at 30 °C for two days. Green: primary candidates that increased CLS, red: primary 
candidates that resulted in a shortened lifespan. 
 
 
Table 7 Primary candidates of compounds that decreased CLS 
CAS No. compound CAS No. compound 
42228-92-2 Acivicina 13220-57-0 Tryptanthrinb 
88495-63-0 Artesunatea 481-42-5 Plumbagina 
 C2 Phytoceramidea 596-85-0 Manoola 
124753-97-5 C6 Ceramidea 126-19-2 Sarsasapogenina 
7059-24-7 Chromomycin A3a 512-64-1 Echinomycina 
59865-13-3 Cyclosporin Aa 515-03-7 Sclareola 
76808-15-6 Ebelactone Ba 51-56-9 Homatropine HBra 
116355-84-1 Fumonisin B2a 63968-64-9 Artemisinina 
83807-40-3 Geranylgeranoic Acida 495-02-3 Auraptenea 
500-64-1 Kavain (+/-)a 13190-97-1 Solanesola 
18378-89-7 Mithramycin Aa 7184-60-3 Borrelidina 
35891-70-4 Myriocina  Luffariellolidec 
554-62-1 Phytosphingosineb  Phytosphingosine Nicotinic Acidc 
13292-46-1 Rifampicinb  Salicyloyl-Phytosphingosinec 
a final concentration of 4 µg/ml 
b final concentration of 20 µg/ml 
c final concentration of 100 µg/ml 
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Table 8 Primary candidates of compounds that increased CLS 
CAS No. compound 
22373-78-0 Monensin Sodiuma 
24280-93-1 Mycophenolic Acida 
16561-29-8 Phorbol 12-myristate 13-acetateb 
60203-57-8 Prostaglandin J2b 
83-79-4 Rotenonea 
19545-26-7 Wortmannina 
54-11-5 (-)- Nicotinea 
38970-49-9 Tschimganinea 
77029-83-5 Hypocrellin Aa 
518-17-2 Evodiaminea 
548-83-4 Galanginea 
1968-05-4 3,3’-Diindolylmethanea 
a final concentration of 4 µg/ml 
b final concentration of 20 µg/ml 
 
Table 9 Primary candidates of compounds that delayed growth 
CAS No. compound 
52665-69-7 Antibiotic A-23187a 
28380-24-7 Nigericin Sodiuma 
2001-95-8 Valinomycina 
19545-26-7 Wortmanninb 
54-11-5 (-)- Nicotineb 
481-42-5 Plumbagina 
484-12-8 Ostholea 
1397-89-3 Amphotericin Ba 
 Mangosteenc 
 Turmeric Oilc 
a final concentration of 4 µg/ml 
b final concentration of 20 µg/ml 
c final concentration of 100 µg/ml 
 
Notably, compounds that decreased lifespan in the validation experiment were not 
further evaluated, as cytotoxic effects could not be excluded. 
Among the secondary candidates that extended lifespan, we identified nicotine 
and wortmannin (Table 10). The effect of nicotine on CLS was further investigated 
and is described in paragraph 3.2.4.6. Since wortmannin is an immunosuppressive 
drug that is already known to inhibit phosphatidylinositol 3-kinases (PI3Ks) and 
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mTOR (Feldman & Shokat, 2010) and thereby to promote longevity (Moskalev & 
Shaposhnikov, 2010), this compound was not further analyzed. 
 
Table 10 Secondary candidates of compounds that improved CLS 
Strength of CLS 
extensiona CAS No. compound 
2 µg/ml 4 µg/ml 
42228-92-2 Acivicin2 +++ +++ 
83807-40-3 Geranylgeranoic Acid2 O (+) 
22373-78-0 Monensin Sodium O + 
24280-93-1 Mycophenolic Acid ++ ++ 
28380-24-7 Nigericin Sodium2 (+) ++ 
60203-57-8 Prostaglandin J2 +++b +++c 
83-79-4 Rotenone (+) + 
2001-95-8 Valinomycin (+) O 
19545-26-7 Wortmannin +++ +++ 
54-11-5 (-)- Nicotine (+) ++ 
38970-49-9 Tschimganine O + 
481-42-5 Plumbagin2 (+) + 
512-64-1 Echinomycin2 ++ O 
515-03-7 Sclareol2 O (+) 
495-02-3 Auraptene2 O (+) 
77029-83-5 Hypocrellin A (+) (+) 
518-17-2 Evodiamine (+) (+) 
548-83-4 Galangine O (+) 
1968-05-4 3,3’-Diindolylmethane (+) + 
 Mangosteen2 +++d (+)e 
a (+) slight increase, + moderate increase, ++ strong increase, +++ very strong increase of CLS,  
O no change 
b final concentration of 10 µg/ml 
c final concentration of 20 µg/ml 
d final concentration of 50 µg/ml 
e final concentration of 100 µg/ml 
 
The secondary candidates that showed the strongest effects in the validation 
experiment were re-ordered from different companies for further analyses. Four 
different concentrations of the compounds originating from the library and of the 
                                            
2 The compound showed a different effect in the primary screen. However, the effect in the validation 
experiment was the reproducible result. 
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re-ordered compounds were tested in parallel to ensure that the observed lifespan-
extension was truly caused by the indicated compound and was not due to 
degradation products or contaminations. Additionally, the effect of the re-ordered 
compounds on the CLS of another S. pombe wild-type strain (AEP1) was 
investigated to confirm that it did not depend on the background of the strain. As an 
example, the results of mycophenolic acid (MPA) are shown in Figure 11. This 
compound extended the CLS of both wild-type strains at a final concentration of 
20 µg/ml. 
 
 
Figure 11 Example of a lifespan-extending compound 
96 well microplates with YM medium containing 3 % glucose were inoculated with S. pombe wild-type 
cells (AEP57 and AEP1). The indicated concentrations of the compound originating from the library 
(here: well 1 -H4) and of the re-ordered compound (here: mycophenolic acid, MPA) were added 
(day 0). At the indicated time points, the aging cultures were spotted onto full medium plates that were 
incubated at 30 °C for two days. DMSO-treated cells served as control. 
 
Finally, eight secondary candidates could be shown to promote longevity. In 
addition to MPA, the remaining candidates were acivicin, 3,3’-diindolylmethane 
(DIM), mangosteen, monensin, nigericin, prostaglandin J2 (PGJ2), and tschimganine 
(Figure 12). Based on these initial tests, the concentration of the compounds that led 
to the strongest effect was used for the following experiments. 
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Figure 12 Final candidates of longevity-promoting compounds 
S. pombe wild-type cells (AEP57) were grown in 96 well microplates in YM medium containing 3 % 
glucose and the indicated compounds. DMSO served as control. 
 
In contrast to the other candidates, mangosteen is not a single compound but 
rather a compound mixture. The effect of its main constituents α-mangostin, 
β-mangostin, gartanin, and 8-desoxygartanin on CLS was also analyzed with the new 
method. However, none of the several tested concentrations extended lifespan of 
S. pombe wild-type cells (AEP57) (data not shown), indicating that it is probably the 
interplay of the single compounds or another unidentified component that leads to 
increased CLS. 
So far, the effect of the compounds had only been measured by using the new 
microplate CLS method. To further verify their life-extending effect, seven of the eight 
secondary candidates were subsequently tested with the traditional CFU method. In 
the case of the eighth candidate, PGJ2, for economic reasons only small amounts of 
the compound were at our disposal, which were not sufficient for the CFU method. 
For the CFU experiment, the concentration that led to the strongest lifespan-
extension in the previous experiments was chosen. The analysis was performed at 
least twice to ensure the reproducibility and indeed, all results were similar to those 
shown in Figure 13, thereby confirming the impact of the compounds on CLS.  
PGJ2 was tested using a modified approach, in which cultures of wild-type cells 
(AEP57) were grown in test tubes in the presence of PGJ2 or DMSO. At regular 
intervals, aliquots were taken, serially diluted and subsequently spotted on 
fullmedium plates. The viability of the cells treated with the compound was increased 
ten-fold compared to the control on day seven and also on day 12 (Figure 14), 
thereby verifying its lifespan-extending effect. 
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Figure 13 Lifespan-extension could be confirmed by using the CFU method 
For this experiment, S. pombe wild-type cells (AEP57) were grown in YM medium containing 3 % 
glucose. The indicated compounds (grey) were tested at least one time in biological duplicate or 
triplicate and the corresponding averages are shown in the graphs. The black bars represent the 
standard deviation. DMSO-treated cells served as control (black). 
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Figure 14 CLS of S. pombe was increased by PGJ2 
Cultures of S. pombe wild-type cells (AEP57) in YM medium containing 3 % glucose and 20 µg/ml 
prostaglandin J2 (PGJ2) were grown in test tubes. Aliquots taken at the indicated time points were ten-
fold serially diluted in YES medium and spotted onto full medium plates that were incubated at 30 °C 
for two days. DMSO-treated cells served as control. 
 
In another approach, the effect of the compounds on the viability of fission yeast 
was further verified by fluorescence staining. For this purpose, wild-type cells 
(AEP57) treated with the compounds were stained using FITC-VAD-fmk (CaspACE) 
or phloxine B to detect apoptotic and dead cells respectively. All stainings were 
performed with exponentially grown cells as well as with cells that were in stationary 
phase for approximately three days. To quantify the impact of the compounds, the 
amount of stained cells compared to the total cell number was calculated. Since 
apoptosis is the process of programmed cell death, staining apoptotic and dead cells 
is nearly the same. Therefore, it was not surprising that the results of these two 
experiments were similar (Figure 15, Figure 16). Four compounds, namely DIM, 
mangosteen, PGJ2, and tschimganine, led to a reduction of apoptotic and dead cells 
in stationary phase compared to the control treated with DMSO (Figure 15, 
Figure 16), thereby confirming their longevity-promoting effect again. MPA treatment 
resulted only in a reduction of dead cells (Figure 16). In contrast, an increase of 
apoptotic and dead cells was observed in stationary phase of acivicin-, monensin-, 
and nigericin-treated cells (Figure 15, Figure 16). The reasons are unknown. 
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Figure 15 Fluorescence staining of apoptotic cells 
S. pombe wild-type cells (AEP57) were grown in YM medium containing 3 % glucose and the 
indicated compounds (grey bars) or DMSO as control (black bars). During exponential (exp.) phase 
and stationary (stat.) phase, aliquots of the cultures were taken and stained with 10 µM FITC-VAD-fmk 
(CaspACE). Subsequently, the samples were analyzed using a fluorescence microscope. Stained 
cells were counted and their amount compared to the total cell number was calculated. Total numbers 
of counted cells are given above the bars. 
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Figure 16 Fluorescence staining of dead cells 
S. pombe wild-type cells (AEP57) were grown in YM medium containing 3 % glucose and the 
indicated compounds (grey bars) or DMSO as control (black bars). During exponential (exp.) phase 
and stationary (stat.) phase, aliquots of the cultures were taken and stained with 5 mg/ml phloxine B. 
Subsequently, the samples were analyzed using a fluorescence microscope. Stained cells were 
counted and their amount compared to the total cell number was calculated. Total numbers of counted 
cells are given above the bars. 
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3.1.2.2 Impact of CLS-extending compounds on stress response 
In general, lifespan extension through CR has been linked to increased stress 
resistance. In S. pombe, this is true for pka1Δ cells, but not for sck2Δ cells (Roux et 
al., 2006), indicating that there are differences between the two nutrient signalling 
pathways in fission yeast. Here, we therefore sought to determine whether the 
identified compounds might act by affecting the stress resistance of S. pombe wild-
type cells (AEP57). For this purpose, the cells were grown in medium containing the 
compounds or DMSO as a control. Subsequently, they were exposed to heat or 
treated with the DNA-damaging agent methyl methanesulfonate (MMS) or with 
hydrogen peroxide (H2O2), which causes oxidative stress. Surprisingly, variations in 
the stress response could be observed for DMSO-treated cells as a function of the 
duration the cells spent in stationary phase before they were exposed to the different 
kinds of stress. Notably, stationary phase was reached after less than one day at 
30 °C. Cells that were grown for two days were more sensitive to DNA damage 
(MMS) than cells that were grown for only one day. Conversely, they were 
significantly more resistant against oxidative stress (Figure 17). The reason for these 
differences is not known. 
 
 
Figure 17 Stress resistance was altered by the duration in stationary phase 
S. pombe wild-type cells (AEP57) were treated with DMSO and grown in YM medium containing 3 % 
glucose for one or two days. The cultures were adjusted to an OD600 of 0.5. Aliquots were treated with 
150 mM or 200 mM hydrogen peroxide (H2O2) for one hour at 30°C or with 0.2 % methyl 
methanesulfonate (MMS) for 30 minutes or 45 minutes at 30 °C. Another sample was incubated for 
one hour at 48 °C (HS). Subsequently, the cells were six-fold serially diluted and spotted onto full 
medium plates that were incubated at 30 °C for two days. 
 
This was an important observation, since some of the analyzed compounds 
slowed down the growth rate of cultures that were grown in test tubes and thereby 
led to a delay in reaching stationary phase. Therefore, three compounds that delayed 
growth were compared to DMSO-treated cells that were grown for two days 
(Figure 18A), while the remaining five compounds that did not delay growth were 
compared to control cells that were grown for one day (Figure 18B).  
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Figure 18 Impact of compounds on stress resistance 
Analysis of stress resistance of S. pombe wild-type cells (AEP57) that were treated with compounds 
as described in Figure 17. DMSO-treated cells served as control. 
(A) Stress response of cells that were treated with DMSO, 2 µg/ml nigericin, 4 µg/ml monensin or 
4 µg/ml tschimganine for two days. 
(B) Analysis of stress resistance cells that that were treated with 50 µg/ml mangosteen, 20 µg/ml 3,3’-
diindolylmethane (DIM), 20 µg/ml prostaglandin J2 (PGJ2), 20 µg/ml mycophenolic acid (MPA) or 
20 µg/ml acivicin after one day. 
(C) Impact of two day-treatment with DMSO, 2 µg/ml nigericin, 4 µg/ml monensin or 4 µg/ml 
tschimganine on oxidative stress resistance. 
(D) Stress response to MMS of cells that were treated with DMSO, 50 µg/ml mangosteen, 20 µg/ml 
PGJ2 or 20 µg/ml DIM for one day. 
 
Due to the fact that the control cells treated with H2O2 in Figure 18A and those 
treated with MMS in Figure 18B already showed maximal growth, it was not possible 
to measure a potential increase of the stress resistance by the compounds. However, 
increased concentrations or a longer incubation time did not change the result (data 
not shown). Therefore, we tested the response to these particular stresses under 
conditions where the control cells were more sensitive. As a result, the impact of 
tschimganine, monensin, and nigericin on oxidative stress resistance after one day 
was analyzed. Nigericin treatment led to increased resistance, while the cells treated 
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with tschimganine or monensin showed a slightly increased sensitivity against 
oxidative stress (Figure 18C). Additionally, we tested the resistance against MMS of 
mangosteen-, DIM-, and PGJ2-treated cells after two days in stationary phase. The 
MMS resistance of the DMSO-treated cells was reduced under these conditions, and 
this was also the case for the compound-treated cells (Figure 18D), indicating that 
the compounds did not affect this particular stress response. All results concerning 
the impact of the compounds on stress resistance are summarized in Table 11. 
Based on their impact on stress resistance (Table 11), first hypotheses about the 
potential mode of action of the compounds could be made. Only DIM and 
mangosteen caused increased resistance against both heat and oxidative stress as 
has been reported for pka1Δ cells (Roux et al., 2006), indicating that these two 
compounds might affect the Git3/PKA pathway in S. pombe. In the case of acivicin, 
MPA, nigericin, and PGJ2, the cells treated with these compounds showed improved 
resistance against oxidative stress, which could be a possible explanation for their 
life-extending effect. Tschimganine enhanced the resistance against heat and DNA 
damage, which might be a reason for increased CLS. Monensin was the only 
compound that did not improve any of the tested stress responses, thereby giving no 
indications as to its potential mode of action.  
 
Table 11 Impact of compounds on stress resistance 
compound HS MMS H2O2 
20 µg/ml Acivicin ⎯ ⎯ + 
20 µg/ml DIM + O + 
50 µg/ml Mangosteen + O + 
4 µg/ml Monensin O O (⎯) 
20 µg/ml MPA ⎯ ⎯ + 
2 µg/ml Nigericin O O + 
20 µg/ml PGJ2 O O + 
20 µg/ml Tschimganine + + (⎯) 
O unchanged, (⎯) slightly decreased, ⎯ decreased, + increased stress resistance 
Abbrevations: HS = heat shock, MMS = methyl methanesulfonate,  
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Figure 19 Fluorescence staining of ROS 
S. pombe wild-type cells (AEP57) were grown in YM medium containing 3 % glucose and the 
indicated compounds (grey bars) or DMSO as control (black bars). During exponential (exp.) phase 
and stationary (stat.) phase, aliquots of the cultures were taken and stained with 30 µM 
dihydrorhodamine 123 (DHR123). Subsequently, the samples were analyzed using a fluorescence 
microscope. Stained cells were counted and their amount compared to the total cell number was 
calculated. Total numbers of counted cells are given above the bars. 
 
In general, an increased resistance against oxidative stress is thought to be 
associated with decreased ROS levels. To test this, fluorescence staining was 
performed using wild-type cells (AEP57) treated with the compounds. Exponentially 
grown cells as well as cells that were in stationary phase for approximately three 
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days were stained for ROS by using dihydrorhodamine 123 (DHR123). To quantify 
the impact of the compounds, the amount of stained cells compared to the total cell 
number was calculated (Figure 19).  
Contrary to our expectation, all compounds, except for tschimganine, showed 
increased amounts of ROS-labelled cells either during exponential growth or in 
stationary phase (Figure 19). In the case of acivicin, DIM, mangosteen, MPA, 
nigericin, and PGJ2, the increased number of DHR123-stained cells could be a hint 
that these compounds caused the previously found enhanced resistance against 
oxidative stress (Figure 18, Table 11) by increased ROS levels resulting in the 
expression and activation of proteins involved in this kind of stress response.  
 
3.1.2.3 General characterization of the CLS-extending compounds 
In a next step, we wanted to determine whether the identified compounds might act 
through pathways that are already known to extend lifespan (CR, Sir2). For this 
purpose, their effect was analyzed under different conditions by using the microplate 
CLS method (see 3.1.1). First, wild-type cells (AEP57) were treated with the 
compounds and grown in YM medium containing different glucose concentrations, 
whereby 3 % glucose represented the standard condition and 1 % glucose was used 
to model DR, while 5 % glucose constituted overnutrition. Notably, pka1Δ cells 
showed a stronger effect under overnutrition conditions (data not shown) (Zuin et al., 
2010). Second, we sought to determine whether the compounds altered CLS by 
affecting one of the known life-extending pathways. Therefore, their effect on sck2Δ 
(AEP62) and pka1Δ cells was investigated. Since rapamycin and wortmannin have 
previously been shown to extend the CLS by inhibiting TOR signalling, wild-type cells 
(AEP57) were simultaneously treated with the compounds and 100 nM rapamycin or 
2.5 µM wortmannin to test whether they might act synergistically. Furthermore, given 
that Sir2 is an important factor in regulating the lifespan of S. cerevisiae (see 1.7), 
S. pombe strains carrying deletions of the Sir2 homologs Sir2 and Hst2 were 
additionally tested for life-extending effects by the compounds. Except for the pka1Δ 
cells that were grown in YM medium containing 5 % glucose, the remaining deletion 
strains were grown under standard conditions. The results of these experiments, 
which were performed at least three times, are summarized in (Table 12).  
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Table 12 Summary of epistasis analyses 
glucose 
compound 
1 % 3 % 5 % 
pka1Δa sck2Δ  
100 nM 
Rapa-
mycin 
2.5 µM 
Wort-
mannin 
sir2Δ  hst2Δ  
20 µg/ml Acivicin + + + → + + → → → 
20 µg/ml DIM + + + + (+) (+) O + + 
50 µg/ml Mangosteen + + + + + + O → + 
4 µg/ml Monensin + + + O (+) + O O O 
20 µg/ml MPA + + + → + + → + + 
2 µg/ml Nigericin + + (+) + (+) + + (+) ⎯ 
20 µg/ml PGJ2 + + + O + + (+) (+) + 
20 µg/ml Tschimganine + + + + + + O + (+) 
a pka1Δ cells were grown in YM medium containing 5 % glucose. 
O no change, → delayed growth,  ⎯ decreased, (+) slightly increased or + increased CLS 
 
Notably, the conditions where the compounds did not increase CLS were of 
special interest because this can be interpreted as epistasis, meaning that a 
compound acts in the same pathway as another gene or treatment. In general, the 
lifespan-extending effect of the compounds seemed to be independent of the glucose 
concentration of the medium, as all of them increased CLS compared to the DMSO 
control (Table 12). Notably, the lifespan of wild-type yeast cells could be even further 
extended compared to cells grown in medium containing 1 % glucose by lower 
glucose concentrations, for instance 0.5 % (data not shown), indicating that there is 
still a potential way to increase CLS by the same pathways. As a conclusion, the 
lifespan extension by the compounds in medium containing 1 % glucose was no 
irrefutable proof that they did not act through to the CR pathways. Nevertheless, it 
could be suggested that the tested compounds act independently from the TOR 
signalling pathway because the compounds promoted longevity of sck2Δ cells and 
rapamycin-treated wild-type cells (Table 12).  
Strikingly, PGJ2 extended lifespan with only one exception. It did not improve the 
CLS of pka1Δ cells (Figure 20C), suggesting that its effect might be linked to the 
Git3/PKA signalling pathway. Monensin failed to extend the CLS of pka1Δ, sir2Δ, and 
hst2Δ cells (Figure 20). This indicated that monensin might promote longevity 
through the Git3/PKA signalling pathway, and that its action required the Sir2 
homologs or at least one of their targets. The latter might also be true for nigericin, 
since hst2Δ cells treated with this compound displayed a reduced lifespan 
(Figure 20B). On the other hand, MPA and acivicin delayed the growth of pka1Δ cells 
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(Figure 20C), which already have a slowed growth rate, and of wortmannin treated 
cells. Therefore, this could be an indication that MPA and acivicin affect a target that 
acts in a pathway parallel to the nutrient sensing pathways to extend lifespan. As 
acivicin also delayed the growth of sir2Δ and hst2Δ cells, this compound might 
additionally act parallel to these HDACs. 
 
 
Figure 20 Examples of epistasis analysis 
(A) pka1Δ, (B) sir2Δ, and (C) hst1Δ cells originating from the S. pombe deletion library (Bioneer) were 
grown in YM medium containing 5 % (B) or 3 % glucose (A, C) and the indicated compounds. DMSO-
treated deletion cells as well as wild-type cells (AEP57) treated with DMSO served as controls. The 
aging cultures were spotted on YES plates at the indicated time points. All plates were incubated at 
30 °C for two days. 
 
However, DIM, mangosteen, tschimganine, and monensin did not further increase 
the lifespan of wild-type cells that were additionally treated with wortmannin although 
they improved CLS of sck2Δ cells and rapamycin-treated wild-type cells (Table 12). 
Since the results of the wortmannin-treated cells showed comparatively strong 
variability (data not shown), the absence of a lifespan-extending effect might be due 
to effects of wortmannin as a PI3K inhibitor other than inhibiting TOR signalling. As 
mangosteen delayed the growth of cells carrying a deletion of SIR2 (Figure 20A), it 
might act in parallel to the HDAC coded by this gene. 
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3.1.2.4 Potential mechanisms of lifespan extension by the compounds 
In order to gain insight into the mode of action of the identified compounds, we 
searched the literature for information known about them. Based on this, we 
hypothesized what could be the potential target of the individual compound. As far as 
practicable, these hypotheses were investigated, and the corresponding results are 
presented in the following paragraphs. 
Notably, DIM, mangosteen, and tschimganine were tested in the experiments for 
monensin and nigericin, as we had no separate hypotheses how these three 
compounds may lead to increased lifespan. 
 
3.1.2.4.1 PGJ2 did not extend the CLS of dnm1Δ and git3Δ cells 
The group of prostaglandins is divided into three main classes based on their mode 
of synthesis. For instance, class 2 prostaglandins, like PGJ2, originate from 
arachidonic acid. To test whether the lifespan extension by PGJ2 is a general effect 
of prostaglandins or not, those contained in the small compound library (Biomol), 
namely PGA1, PGB1, PGE1, PGE2, and PGF2α, were re-tested in our lifespan assay. 
Wild-type cells (AEP57) were treated with four different concentrations of each of 
those prostaglandins, but none of them altered CLS (Figure 21). Since the re-tested 
prostaglandins belong to class 1 as well as class 2, this led to the conclusion that 
increased lifespan is specific for PGJ2 and not an effect of prostaglandins per se or 
members of a certain class of prostaglandins. 
A derivative of PGJ2 called 15-deoxy-Δ-12, 14-prostaglandine J2 (15d-PGJ2) has 
previously been shown to induce mitochondrial fusion by inactivating the dynamin-
related protein 1 (Drp1) (Mishra et al., 2010) whose homolog is called Dnm1 in 
fission yeast. In general, the activity of Drp1/Dnm1 leads to mitochondrial fission, 
while its counterpart, OPA1/Msp1, promotes the fusion of mitochondria. To test 
whether there is a relationship between the potential inactivation of Dnm1 and 
lifespan extension by PGJ2, the CLS of dnm1Δ and msp1Δ cells originating from the 
S. pombe deletion library (Bioneer) was analyzed. Notably, the CLS of dnm1Δ cells 
was comparable to that of wild-type cells (AEP57), while msp1Δ cells displayed a 
slightly reduced lifespan (Figure 22, DMSO). Treatment with PGJ2 resulted in 
increased lifespan of wild-type and msp1Δ cells, whereas the CLS of dnm1Δ cells 
was unchanged (Figure 22, PGJ2). These results indicate that lifespan extension by 
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PGJ2 requires Dnm1 and mitochondrial fission. However, as dnm1Δ cells did not 
display an increased CLS compared to wild-type cells, this might be not the (Fang et 
al.) reason for the lifespan-extending effect of this compound.  
 
 
 
Figure 21 Other tested prostaglandins did not extend CLS 
S. pombe wild-type cells (AEP57) were grown in YM medium containing 3 % glucose and 
0.4/2/4/20 µg/ml of the indicated prostglandins. At regular intervals, the cultures were spotted on YES 
plates that were then incubated at 30 °C for two days. 
 
 
 
Figure 22 CLS of dnm1Δ  cells was not increased by PGJ2 
dnm1Δ and msp1Δ cells originating from the S. pombe deletion library (Bioneer) as well as the 
corresponding wild-type cells (AEP57) were grown in YM medium containing 3 % glucose and 
20 µg/ml prostaglandin J2 (PGJ2) or DMSO. These cultures were spotted on YES plates at the 
indicated time points. The plates were incubated for two days at 30 °C. 
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Furthermore, it was known that human prostaglandins inhibit G-protein coupled 
receptors (Narumiya et al., 1999). Notably, the glucose receptor Git3, which is part of 
the nutrient sensing pathways in S. pombe, is such a transmembrane receptor. 
Therefore, we analyzed the CLS of strains carrying a deletion of G-protein coupled 
receptors or proteins involved in G-protein signalling. git3Δ cells were the only cells 
whose lifespan was increased compared to the wild-type cells (AEP57) (Figure 23, 
DMSO). On the other hand, these cells were also the only ones whose lifespan was 
not further improved by PGJ2-treatment (Figure 23, PGJ2). In summary these results 
suggest that PGJ2 extended the CLS of fission yeast by inhibiting Git3 and thus 
mimicking CR. 
 
 
Figure 23 PGJ2 did not enhance the CLS of git3Δ  cells 
The indicated strains originating from the S. pombe deletion library carry single deletions of genes 
encoding for G-protein coupled receptors and proteins involved in G-protein signalling. These cells as 
well as the corresponding wild-type cells (AEP57) were grown in YM medium containing 3 % glucose 
and 20 µg/ml prostaglandin J2 (PGJ2) or DMSO. At the indicated time points, all cultures were spotted 
on YES plats that were subsequently incubated at 30 °C for two days. 
 
3.1.2.4.2 CLS of strains carrying deletions of V-ATPase subunits was not 
increased by monensin and nigericin 
Monensin and nigericin are both naturally occurring polyethers that exhibit a similar 
structure (Figure 24A, B) and display a significant preference to form complexes with 
monovalent cations, for instance sodium. Furthermore, they have been described as 
Golgi-disturbing agents (Dinter & Berger, 1998). However, their precise mode of 
action at the level of Golgi membranes is still unknown. Nevertheless, if their impact 
on the Golgi apparatus leads to the lifespan extension, other Golgi-disturbing agents 
should have the same effect. To test this hypothesis, S. pombe wild-type cells 
   Results 
 81 
(AEP57) were treated with brefeldin A (Figure 24C), and the tested concentrations 
were identical to those used for monensin and nigericin. However, CLS was not 
affected by the brefeldin A-treatment (Figure 25), indicating that the life-extending 
effect of monensin and nigericin is probably not due to their Golgi-disturbing function. 
 
 
Figure 24 Chemical structures of monensin, nigericin, and brefeldin A 
The chemical structures were created by using the software MarvinSketch. 
 
 
Figure 25 Brefeldin A had no impact on CLS 
S. pombe wild-type cells (AEP57) were grown in YM medium containing 3 % glucose and the 
indicated concentrations of the Golgi-disturbing agent brefeldin A. DMSO served as control. At regular 
intervals, the cultures were spotted on YES plates that were subsequently incubated at 30 °C for two 
days. 
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It is known for S. cerevisae that this yeast produces acetic acid, which in turn has 
been reported to be the primary molecular factor limiting the lifespan of yeast cells 
under these standard conditions (Burtner et al., 2009). Since monensin and nigericin 
are both ionophores that are incorporated into biological membranes (Liu, 1982), it 
was possible that this function of the compounds is the cause not only for their known 
antibiotic properties but also for their effect on CLS. To test this theory, wild-type cells 
(AEP57) were grown in the presence of these compounds, and the pH-value of the 
medium was subsequently determined at regular intervals. Simultaneously, the OD of 
the culture was measured, and the resulting values were used for normalization in 
order to exclude the possibility that differences of the pH-value are caused by altered 
maximal growth. As shown in Figure 26 (right), the extracellular pH-value was not 
changed by monensin and nigericin, suggesting that they did not act as ionophores in 
the plasma membrane. This has already been reported for S. cerevisiae, where they 
selectively act on the mitochondrial inner membrane (Kovac et al., 1982). 
 
 
Figure 26 Compounds did not affect the extracellular pH-value 
S. pombe wild-type cells (AEP57) were grown in YM medium containing 3 % glucose and the 
indicated compounds. At regular interval, the pH-value was determined by spotting aliquots on pH 
indicator sticks that detect changes of the pH-value in 0.5 steps (left). In parallel, the optical density at 
600 nm (OD600) was measured (middle). The resulting pH-values were normalized by using the 
corresponding OD600 value (right). 
 
Significantly, while the pH-value of the medium dropped from 4.5 to 2.3 – 3 in the 
initial 20 hours for four of the five compounds, the pH-value of the medium of cells 
DIM-treated did not change during the initial 40 hours, but only decreased at a later 
time point (Figure 26 left). This was in line with the observation that the 
corresponding cells started growing after 40 hours (Figure 26 middle), confirming that 
the changes of the pH-value depend on the optical density of the culture. However, 
neither DIM nor mangosteen or tschimganine significantly slowed the acidification of 
the medium. 
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Figure 27 The analyzed compounds did not disrupt endocytosis 
S. pombe wild-type cells (AEP57) were grown in YM medium containing 3 % glucose and the 
indicated compounds. The cells were harvested during exponential growth and stained with 80 µM 
SynaptoRed. Wild-type cells treated with 150 mM hydrogen peroxide (H2O2) for one hour after the 
staining or with DMSO as well as vma1Δ cells (AEP68) served as control. All samples were analyzed 
using a fluorescence microscope.  
 
Monensin and nigericin are not only Ionophores, but also act as Na+/H+- 
respectively K+/H+-antiporters (Liu, 1982). As a consequence, they affect the 
   Results 
 84 
membrane potential and several processes that depend on the ionic gradient. One 
enzyme whose activity is linked to the ionic gradient is the vacuolar adenosine 
triphosphatase (V-ATPase), which consists of various subunits. The deletion of two 
of these subunits has previously been shown to affect the acidification of intracellular 
compartments and to disrupt endocytosis (Iwaki et al., 2004). To determine whether 
monensin and nigericin led to a similar effect, the vacuolar membranes of S. pombe 
wild-type cells treated with these two compounds as well as with DIM, tschimganine, 
and mangosteen were stained with SynaptoRed, a dye that becomes fluorescent 
when incorporated into the plasma membrane. The DMSO-treated control cells were 
filled with several small vacuoles, and the nucleus was “visible” as a non-fluorescent 
structure in the middle of the cell (Figure 27). In contrast, vma1Δ cells (AEP68) 
displayed an accumulation of the fluorescent dye at structures that are supposed to 
be pre-vacuolar compartments (Iwaki et al., 2004) (Figure 27). Notably, the cells 
treated with the compounds exhibited no defects in endocytosis as observed for 
vma1Δ cells but rather looked like the control cells (Figure 27). These results indicate 
that the compounds did affect lifespan by disrupting endocytosis. 
Nevertheless, the vacuoles of the cells treated with DIM appeared to be slightly 
enlarged compared to those of the cells treated with the other compounds 
(Figure 27). Another result that was previously shown to be distinct for DIM-treated 
cells, was the significantly increased ROS level during exponential growth (Figure 19. 
Notably, it was already known that (osmotic) stress results in vacuolar fusion, thereby 
leading to less but enlarged vacuoles in S. pombe (Takegawa et al., 2003). To 
determine whether there was a relationship between the slightly enlarged vacuoles 
and the increased ROS level, DMSO-treated cells were stained with SynaptoRed and 
subsequently treated with 150 mM H2O2 for one hour to induce the formation of ROS. 
As a result, the vacuoles of these cells were even more enlarged compared to those 
of DIM-treated cells (Figure 27 bottom), maybe due to higher amounts of ROS. This 
led to the suggestion that the increased ROS level during exponential growth by DIM 
treatment might be the cause for the slightly enlarged vacuoles of the DIM-treated 
cells. Furthermore, these results showed that treatment with the remaining 
compounds did not stress the cells. 
As the deletion of Vma1 and Vma3 has previously been shown to affect the 
acidification (Iwaki et al., 2004), the acidic compartments were analyzed in the next 
step. For this purpose, wild-type cells (AEP57) treated with the compounds were 
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harvested during the exponential growth phase and stained with quinacrine, which is 
a weakly basic dye that accumulates in acidic compartments in response to proton 
gradients. In general, acidic compartments display a special kind of vacuoles, the 
equivalent to mammalian lysosomes. At first glance, no reduction of the staining, like 
it was the case for vma3Δ, was observed (Figure 28A). In all samples, there are a 
few cells that were completely stained, probably representing dead cells.  
 
 
Figure 28 Impact on the acidification of intracellular compartments 
S. pombe wild-type cells (AEP57) were grown in YM medium containing 3 % glucose and the 
indicated compounds. vma3Δ cells (AEP69) served as control. The cells were harvested during 
exponential growth and stained with 200 µM quinacrine. Subsequently, the samples were analyzed 
using a fluorescence microscope.  
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However, at higher magnification, it became obvious that cells treated with DIM 
differed from the other compound-treated cells. Instead of a few (mostly two) distinct 
compartments, several smaller compartments were visible (Figure 28B). To 
determine whether this effect was also a consequence of the increased ROS level in 
the exponential growth phase of DIM-treated cells, this experiment was repeated. 
This time, an aliquot of the DMSO-treated wild-type cells was incubated with 150 mM 
H2O2 for one hour before the staining. For unknown reasons, the DMSO- and DIM-
treated cells look different in comparison with Figure 28, even if the general tendency 
meaning more and smaller compartments in the DIM-treated cells was similar 
(Figure 29). However, those cells that were additionally incubated with H2O2 were 
uniformly stained. As the treatment with H2O2 led to an enhanced effect compared to 
DIM in the endocytosis experiment (Figure 27), this might also be the case for the 
acidic compartments. As a consequence, the whole-cell-staining could be due to a 
strong fragmentation of the acidic compartments leading to tiny, undistinguishable 
structures. This could be tested by repeating this experiment with lower H2O2 
concentrations that should lead to a weaker phenotype. 
 
 
Figure 29 Effect of DIM on intracellular compartments did not depend on increased ROS levels 
S. pombe wild-type cells (AEP57) were grown in YM medium containing 3 % glucose and 20 µg/ml 
DIM or DMSO The cells were harvested during exponential growth and stained with 200 µM 
quinacrine. An aliquot of the DMSO-treated cells was incubated for one hour at 30 °C with 150 mM 
hydrogen peroxide (H2O2) before the staining. Subsequently, the samples were analyzed using a 
fluorescence microscope 
 
In summary, the results of the fluorescence stainings suggested that none of the 
tested compounds inhibited the V-ATPase. Furthermore, altered endocytosis by 
treatment with DIM seemed to be an effect of increased ROS levels while the reason 
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for the fragmentation of the acidic compartments in DIM-treated cells remained 
unclear. Notably, there seemed to be no direct relationship between the acidic 
compartments and the vacuoles as their size and number per size differed 
(Figure 27 - 29) (Iwaki et al., 2004). 
We next hypothesized that the potential disturbance of the ionic gradient by 
monensin and nigericin might activate the V-ATPase and right thereby lead to 
lifespan extension. Therefore, we analyzed the CLS of vma1Δ (AEP68) and vma3Δ 
cells (AEP69). When only treated with DMSO, these cells displayed a reduced 
lifespan (Figure 30). Furthermore, treatment with monensin or nigericin did not 
increase their lifespan (Figure 30), suggesting that monensin or nigericin might 
extend lifespan by an activation of the V-ATPase. 
 
 
Figure 30 Deletion of V-ATPase subunits led to a reduced lifespan, which could not be 
extended by monensin or nigericin 
S. pombe wild-type cells (AEP57) as well as vma1Δ (AEP68) and vma3Δ cells (AEP69) were grown in 
YM medium containing 3 % glucose and 4 µg/ml monensin or 2 µg/ml nigericin. DMSO served as 
control. At the indicated time points, the aging cultures were spotted on YES plates that were 
incubated at 30 °C for two days. 
 
3.1.2.4.3 The lifespan-extending effect of mycophenolic acid and acivicin was 
not affected by guanine or glutamine  
MPA and acivicin are known to inhibit the inosine monophosphate (IMP) 
dehydrogenase (Ransom, 1995) and the guanosine monophosphate (GMP) 
synthetase (Nakamura et al., 1995) respectively, the two enzymes involved in the 
conversion of IMP to GMP and thereby in the de novo biosynthesis of guanine 
nucleotides. Based on this, we hypothesised that these two compounds extended 
CLS by depleting nucleotide levels. Notably, an agent that is known to inhibit the 
same enzyme as MPA is 6-azauracil (6-AU) (Exinger & Lacroute, 1992). Thus, 6-AU 
might be expected to increase lifespan. To test this, we used the same 
concentrations of 6-AU as for the initial experiments with MPA and acivicin 
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(0.4/2/4/20 µg/ml) as well as concentrations that were used in other studies 
(75/100/150 µg/ml). We analyzed its impact on normal wild-type cells (AEP57) and 
also on wild-type cells carrying an ura4+-marked plasmid (AEP57 + pAE1429) in YM 
medium containing 1 %, 3 % or 5 % glucose. However, the CLS was not altered 
under any of the tested conditions (Figure 31, data not shown), suggesting that MPA 
and acivicin might act different from 6-AU to extend lifespan. 
 
 
Figure 31 CLS was not altered by 6-AU 
S. pombe wild-type cells (AEP57) were grown in YM medium containing 3 % glucose and the 
indicated concentrations of 6-azauracil (6-AU). DMSO served as control. At regular intervals the 
cultures were spotted on YES plates that were subsequently incubated at 30 °C for two days. 
 
The next logical step would be to determine the CLS of cells where the IMP 
dehydrogenase is deleted. In fission yeast, this enzyme is predicted to be encoded 
by the gene gua1+ whose deletion is lethal and therefore could not be analyzed here. 
 
 
Figure 32 Guanine did not affect lifespan of S. pombe 
The indicated concentrations of guanine were added to YM medium containing 3 % glucose and 
20 µg/ml mycophenolic acid (MPA) or acivicin. As a solvent control for guanine, NaOH was added, 
while DMSO served as control for MPA and acivicin. All the resulting media were used for cultures of 
S. pombe wild-type cells (AEP57). At the indicated time points, these cultures were spotted onto YES 
plates that were incubated at 30 °C for two days. 
 
According to our hypothesis, the addition of guanine to the growth medium should 
increase the guanidine level, and as this is the opposite effect of MPA and acivicin, it 
should result in reduced CLS and abolish the lifespan-extension caused by MPA or 
acivicin. To test this, the effect of six guanine concentrations ranging from 75 µg/ml 
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up to 300 µg/ml was analyzed. None of them changed the lifespan of wild-type cells 
(AEP57) treated either with DMSO (control), MPA or acivicin (Figure 32, data not 
shown). Both MPA and acivicin still increased lifespan under these circumstances. 
The GMP synthetase, which is inhibited by acivicin, catalyzes the amination of the 
intermediate xanthosine monophosphate (XMP) to GMP. This ATP-dependent 
reaction also requires glutamine, which is converted to glutamate. This led to the 
suggestion that low amounts of glutamine should extend lifespan, while higher 
concentrations should have the opposite effect. Based on this hypothesis, S. pombe 
wild-type cells (AEP57) were grown in YM medium containing 3 % glucose and 
3.75 g/l or 1 g/l glutamine. Notably, the lower concentration did not change the CLS 
compared to medium without glutamine, while the higher concentration increased 
lifespan (Figure 33). This result was not only contrary to our hypothesis above, but 
also to previous studies that reported that reduced levels of glutamine as an activator 
of the TOR signalling pathway extended both CLS and RLS in S. cerevisiae 
(Kaeberlein et al., 2005b; Powers et al., 2006). Nevertheless, MPA and acivicin 
increased lifespan compared to DMSO in medium containing no, low or high 
amounts of glutamine (Figure 33). In summary, these results indicate that the life-
extending effect of MPA and acivicin was independent of the GMP biosynthesis. 
 
 
Figure 33 MPA and acivicin increased CLS independently of the glutamine concentration 
S. pombe wild-type cells (AEP57) were grown in YM medium containing 3 % glucose, the indicated 
concentrations of glutamine and 20 µg/ml mycophenolic acid (MPA) or acivicin. DMSO served as 
control. At the indicated time points, the cultures were spotted onto YES plates that were incubated at 
30 °C for two days. 
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3.1.3 Identification of genes that affect the lifespan of S. pombe 
3.1.3.1 Screen for gene deletions that increase the CLS of S. pombe 
The fission yeast genome contains about 5,000 protein-coding genes, which is the 
smallest number among the commonly used eukaryotic model organisms (Wood et 
al., 2002). Comparative genomic analysis showed that around 500 fission yeast 
genes have no homologs in budding yeast, but are conserved in other eukaryotic 
species, including human, apparently due to lineage-specific gene losses that 
happened during the evolution of S. cerevisiae (Wood, 2006). However, compared to 
S. cerevisiae, less is known about the mechanisms that alter lifespan of S. pombe. 
Since it is known that lifespan is regulated by many evolutionarily conserved factors 
in a complex manner, the identification of novel genetic factors that affect the CLS of 
fission yeast might help as to understand lifespan regulation not only in fission yeast, 
but also in higher eukaryotes.  
In this approach, we sought to identify novel genetic factors whose deletion 
extended the CLS of S. pombe. For this purpose, we screened a S. pombe deletion 
library (Bioneer) that contains 3,004 haploid strains carrying single deletions of non-
essential genes by using the new microplate CLS method (see 3.1.1) for strains with 
increased CLS. This experiment was performed as previously described for the 
compounds in 3.1.2.1.  
From this screen, we obtained 291 primary candidates that extended lifespan 
(Table 13). 
 
Table 13 Primary candidates of gene deletions that increased CLS 
Systematic Name Systematic Name Systematic Name Systematic Name Systematic Name 
SPAC1002.05c SPAC23G3.03 SPAC824.02 SPBC19F8.03c SPBC947.08c 
SPAC1002.07c SPAC23G3.12c SPAC869.11 SPBC19G7.17 SPBC947.15c 
SPAC105.03c SPAC23H3.15c SPAC890.05 SPBC1A4.04 SPBP16F5.03c 
SPAC1071.11 SPAC24B11.09 SPAC926.02 SPBC20F10.07 SPBP16F5.07 
SPAC11D3.16c SPAC24B11.12c SPAC926.03 SPBC211.06 SPBP35G2.07 
SPAC11E3.01c SPAC24C9.12c SPAC977.17 SPBC215.05 SPBP35G2.13c 
SPAC11E3.05 SPAC25H1.07 SPAC9G1.02 SPBC215.06c SPBP8B7.28c 
SPAC11E3.08c SPAC26A3.16 SPAC9G1.04 SPBC215.13 SPBPB2B2.11 
SPAC12B10.13 SPAC26F1.05 SPACUNK4.16c SPBC216.01c SPBPB2B2.14c 
SPAC12B10.16c SPAC27D7.06 SPAP27G11.10c SPBC21B10.03c SPCC1020.11c 
SPAC139.06 SPAC27F1.05c SPAP7G5.04c SPBC21B10.10 SPCC1235.09 
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SPAC13C5.04 SPAC29A4.19c SPAPB1E7.02c SPBC23E6.08 SPCC1235.11 
SPAC144.06 SPAC29B12.03 SPAPB24D3.09c SPBC24C6.05 SPCC1235.15 
SPAC14C4.07 SPAC29B12.04 SPAPB2B4.07 SPBC25B2.03 SPCC1259.03 
SPAC14C4.09 SPAC2E1P3.01 SPAPJ695.01c SPBC25D12.06 SPCC1259.10 
SPAC14C4.11 SPAC2F3.11 SPAPYUG7.03c SPBC25H2.16c SPCC126.08c 
SPAC1556.04c SPAC2F3.16 SPBC106.17c SPBC27B12.11c SPCC126.13c 
SPAC1565.07c SPAC2F7.17 SPBC1105.02c SPBC29A3.07c SPCC1322.16 
SPAC15F9.01c SPAC30D11.07 SPBC1105.13c SPBC29A3.14c SPCC1393.13 
SPAC16.04 SPAC323.01c SPBC119.05c SPBC2D10.12 SPCC13B11.02c 
SPAC1610.01 SPAC32A11.02c SPBC1198.06c SPBC2G2.05 SPCC1442.05c 
SPAC167.01 SPAC343.16 SPBC1198.08 SPBC2G2.07c SPCC162.01c 
SPAC1687.23c SPAC3A11.03 SPBC1198.12 SPBC2G2.08 SPCC1620.02 
SPAC16C9.02c SPAC3A11.03 SPBC11B10.07c SPBC2G5.02c SPCC1682.15 
SPAC16E8.05c SPAC3A12.13c SPBC1271.10c SPBC30D10.03c SPCC1682.16 
SPAC16E8.18 SPAC3C7.06c SPBC1271.15c SPBC30D10.04 SPCC16A11.07 
SPAC1782.11 SPAC3F10.04 SPBC146.06c SPBC32F12.02 SPCC16C4.04 
SPAC1783.01 SPAC3G6.01 SPBC146.10 SPBC336.10c SPCC16C4.10 
SPAC1783.02c SPAC3G6.02 SPBC14C8.15 SPBC342.01c SPCC16C4.11 
SPAC1783.07c SPAC3G6.06c SPBC14F5.07 SPBC359.06 SPCC1739.06c 
SPAC17A5.16 SPAC3G9.07c SPBC1539.06 SPBC365.16 SPCC1739.15 
SPAC17C9.02c SPAC3G9.08 SPBC15C4.01c SPBC36B7.03 SPCC18.15 
SPAC17G8.11c SPAC3H8.08c SPBC15C4.04c SPBC3B8.03 SPCC1840.05c 
SPAC17H9.04c SPAC4A8.09c SPBC15D4.02 SPBC3B8.04c SPCC1884.02 
SPAC17H9.06c SPAC4F10.14c SPBC1685.01 SPBC3B8.06 SPCC18B5.01c 
SPAC17H9.08 SPAC4F10.18 SPBC1685.06 SPBC3E7.08c SPCC24B10.08c 
SPAC17H9.13c SPAC4F10.20 SPBC1685.10 SPBC3E7.10 SPCC24B10.22 
SPAC1851.03 SPAC4G8.10 SPBC1685.13 SPBC3E7.12c SPCC285.16c 
SPAC18B11.04 SPAC4G9.09c SPBC16D10.08c SPBC3H7.14 SPCC297.05 
SPAC1952.17c SPAC4G9.10 SPBC16G5.15c SPBC409.07c SPCC364.03 
SPAC19A8.03 SPAC4G9.14 SPBC16H5.04 SPBC4C3.08 SPCC4F11.03c 
SPAC19A8.11c SPAC4H3.07c SPBC1709.05 SPBC4F6.08c SPCC4G3.04c 
SPAC19G12.02c SPAC513.03 SPBC1709.06 SPBC4F6.11c SPCC553.01c 
SPAC1A6.01c SPAC589.02c SPBC1711.03 SPBC557.05 SPCC622.08c 
SPAC1B1.02c SPAC5H10.06c SPBC1711.15c SPBC577.06c SPCC622.12c 
SPAC1B3.04c SPAC631.02 SPBC1718.02 SPBC609.04 SPCC622.14 
SPAC1B3.17 SPAC637.09 SPBC1718.07c SPBC660.05 SPCC70.06 
SPAC1D4.05c SPAC644.08 SPBC1734.06 SPBC660.11 SPCC74.05 
SPAC1F7.08 SPAC644.09 SPBC1773.01 SPBC725.01 SPCC74.06 
SPAC20G8.02 SPAC664.03 SPBC1773.12 SPBC725.14 SPCC757.09c 
SPAC20G8.04c SPAC6B12.16 SPBC1778.02 SPBC776.11 SPCC777.07 
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SPAC21E11.03c SPAC6C3.07 SPBC17A3.08 SPBC800.02 SPCC777.10c 
SPAC21E11.05c SPAC6F12.06 SPBC17D1.02 SPBC800.03 SPCC790.03 
SPAC227.11c SPAC6F12.10c SPBC17D11.01 SPBC839.04 SPCC794.02 
SPAC227.15 SPAC6F12.12 SPBC17D11.03c SPBC887.04c SPCC794.07 
SPAC22A12.16 SPAC6F6.09 SPBC17G9.10 SPBC887.11 SPCC794.15 
SPAC22E12.18 SPAC6G10.02c SPBC18E5.10 SPBC887.15c SPCC965.08c 
SPAC22F3.09c SPAC821.03c SPBC19C7.01 SPBC902.04 SPCC970.05 
SPAC23D3.13c     
 
For validation, the primary candidates were re-tested in biological triplicates. The 
screening results could be reproduced for 87 gene deletions. To obtain an overview 
about the processes that were affected by these deletions and thus might play a role 
in the regulation of CLS, the secondary candidates were grouped based on their 
potential function, and the resulting groups were sorted depending on the average 
strength of their effect in the validation experiment (Table 14).  
 
Table 14 Secondary candidates of gene deletion strains that exhibited increased CLS grouped 
based on the potential function of the coded protein 
group systematic name gene name strength of effecta 
SPCC16C4.11 pef1 + 
SPBC106.10 pka1 +++ 
SPAC4G9.09c arg11 ++++ 
SPBC725.14 arg6 ++++ 
SPAC343.16 lys2 ++++ 
SPBC4F6.11c   ++++ 
SPCC622.12c gdh1 ++++ 
SPAP7G5.04c lys1 ++++ 
SPAC24C9.12c   +++ 
SPBC1105.02c lys4 ++++ 
SPAC4G9.10 arg3 ++++ 
SPAC17C9.02c lys7 ++++ 
nutrition 
SPAC23G3.03 sib2 +++ 
SPAC3G6.02 dss1 +++ 
SPBC14F5.07 ssm4 +++ 
SPAC824.02   ++++ 
SPBC23E6.08 sat1 ++++ 
SPBC4C3.08 mug136 ++ 
ER, Golgi 
SPAC4G8.10 gos1 ++ 
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SPAC24B11.12c   ++++ 
SPBC11B10.07c ivn1 +++ 
SPBC1198.06c   +++ 
SPBC342.01c alg6 +++ 
ER, Golgi 
SPCC126.08c   +++ 
SPAC19A8.11c irc1 +++ 
SPCC285.16c msh6 ++ 
SPAC19G12.02c pms1 +++ 
SPBC3E7.08c rad13 +++ 
SPAC3G6.06c rad2 +++ 
SPAC30D11.07 nth1 ++++ 
DNA repair 
SPBC216.01c   ++ 
SPAC167.01 ppk4 / ire1 ++++ 
SPAC25H1.07   + 
SPCC1020.11c   + 
SPBC1711.03   ++ 
SPBC15C4.01c oca3 +++ 
UPRER  
SPBC16D10.08c hsp104 ++++ 
SPBC20F10.07   +++ 
apoptosis 
SPBC660.05   ++ 
SPCC297.05   +++ 
SPBC359.06 mug14 +++ 
SPCC74.06 mak3 ++ 
SPAC977.17   + 
SPAP27G11.10c nup184 +++ 
SPBC3E7.12c chr1 + 
SPCC553.01c   +++ 
SPBC211.06 gfh1 +++ 
SPAC6F12.06   ++ 
SPBC609.04 caf5 ++++ 
SPAC18B11.04 ncs1 +++ 
SPBPB2B2.14c   ++ 
SPBC1105.13c   +++ 
SPAC6C3.07 mug68 ++ 
SPAC513.03 mfm2 + 
SPAC6B12.16 meu26 ++ 
mixed, unkown 
SPAC644.08   +++ 
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SPAC1F7.08 fio1 +++ 
SPCC1884.02 nic1 ++ iron homeostasis 
SPBC1718.07c zfs1 ++ 
SPAC4G9.14   +++ 
SPBC947.15c   ++ 
SPAC17H9.08   ++++ 
SPCC794.07 lat1 + 
mitochondria 
SPAC4F10.20 grx1 + 
SPAC6F6.09 eaf6 + 
SPBP16F5.03c tra1 ++ 
SPAC139.06 hat1 +++ 
SPAC3G9.07c hos2 ++ 
SPCC622.08c hta1 + 
SPBC947.08c   ++ 
SPAC631.02   +++ 
SPBC1773.12   + 
SPAC1A6.01c   +++ 
SPBC25B2.03   ++ 
transcription 
SPAC29B12.03 spd1 +++ 
SPBC2G2.05 rpl1603 ++ 
SPBC21B10.10 rps402 + 
SPBC839.04 rpl803 + 
SPCC70.06   ++ 
ribosome 
SPBC660.11 tcg1 ++++ 
SPAC1783.02c vps66 ++ 
vacuole 
SPAC144.06 apl5 ++ 
SPBC336.10c tif512 + 
SPAC3A12.13c   +++ 
SPBC21B10.03c   + 
SPBC1685.06 cid11 +++ 
RNA, translation 
SPBC19C7.01   + 
a + slight increase, ++ moderate increase, +++ strong increase, ++++ very strong increase of CLS 
 
In agreement with previous work, we found 13 strains with deletions in genes 
altering nutrient uptake and sensing to extend lifespan (Table 14), which was 
consistent with the notion that these mutants impart some kind of CR upon the cells. 
Furthermore, several strains carrying deletions of genes that code for ribosomal 
proteins or proteins involved in transcription or translation also displayed an 
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increased lifespan. This might be a secondary effect, as these deletions probably 
affect the expression of various genes, which in turn could also have an impact on 
lifespan. Significantly, strains with deletions of genes encoding for proteins that are 
involved in the repair of single-stranded DNA damage also improved CLS (Table 14). 
These results were surprising, because one might expect that defects in DNA repair 
would result in premature aging rather than in lifespan extension. To uncover how 
these gene deletions promote longevity, we decided to further analyze the effects of 
this group. Notably, later experiments showed that the lifespan extension of the 
analyzed deletion strains is rather an effect of the strain background than of the gene 
deletions themselves (see 3.1.3.6). As a consequence, other groups of genes 
affecting CLS (Table 14) were not pursued. 
However, we wanted to verify the improvement of CLS at first. For this purpose, 
the secondary candidates of the DNA repair group were tested several times by 
using the new method. Another gene deletion (rhp23Δ), which displayed a strong 
effect in the primary screen but failed to increase lifespan in the validation screen, 
was additionally analyzed. An example of these experiments is shown in Figure 34. 
Six gene deletion strains, namely rad2Δ, nth1Δ, rad13Δ, rhp23Δ, msh6Δ, and pms1Δ, 
showed a reproducible lifespan extension compared to the corresponding wild-type 
cells (AEP57).  
 
 
Figure 34 DNA repair mutants exhibited extended CLS 
Deletion strains from the S. pombe deletion library (Bioneer) and the corresponding wild-type cells 
(AEP57) were grown in YM medium containing the indicated glucose concentrations and spotted onto 
YES plates at regular intervals. The plates were incubated for two days at 30 °C. 
 
Furthermore, the CLS of four of these strains was investigated by using the 
traditional CFU method. To date, CR or the deletion of genes that encode for proteins 
involved in the nutrient sensing pathways are the most powerful tools known to 
promote longevity. In order to evaluate the potential lifespan-extending effect of the 
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candidates, sck2Δ cells (AEP62) and the corresponding wild-type cells (AEP61) were 
used for comparison because it was already published that this particular deletion 
strain had an increased CLS (Chen & Runge, 2009). All tested gene deletion strains 
extended lifespan at least as strong as the sck2Δ control (Figure 35), thereby 
verifying that they have a strong impact on the CLS of fission yeast. 
 
 
Figure 35 The tested gene deletion strains displayed an extended lifespan comparable to the 
sck2Δ  cells 
CLS of S. pombe strains from the deletion library (Bioneer) carrying single deletions of DNA repair 
genes (grey) and the corresponding wild-type cells (AEP57, black) were determined by using the CFU 
method. sck2Δ cells (AEP62, grey) and the corresponding wild-type strain (AEP61, black) served as 
positive control. All cells were tested at least one time in biological duplicate and the corresponding 
averages are shown in the graphs. The black bars represent the standard deviation. 
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3.1.3.2 General characterization of the CLS-extending DNA repair mutants 
The DNA repair mutant strains found to increase lifespan in the screen affect 
different types of single-stranded DNA repair. Rad2 and Nth1 are part of base 
excision repair (BER), while Rad13 and Rhp23 belong to nucleotide excision repair 
(NER) (Kanamitsu & Ikeda, 2010; Wood, 1996). The third pair, Msh6 and Pms1, 
takes part in mismatch repair (MMR) (Marti et al., 2002). Just like for the compounds, 
we sought to determine whether there is a correlation between the lifespan-extending 
effect of the identified strains and CR. Thereby, it would be interesting if there were 
any differences between the mutants of the three repair pathways.  
We investigated the CLS of the respective strains compared to wild-type cells 
(AEP57) in YM medium containing the standard glucose concentration (3 %) as well 
as under CR and overnutrition conditions (0.5 % or 5 % glucose). Importantly, while 
lifespan was extended under CR conditions as expected, it was even further 
increased in the DNA repair deletion strains. Additionally, CLS was improved in 
medium containing higher glucose concentrations (5 %) in all six deletion strains 
(Table 15). These results suggested that the life-extending effect of the DNA repair 
mutant strains was independent of CR and that it was not mediated by the TOR or 
the Git3/PKA pathways. 
 
Table 15 Summary of CLS improvement depending on glucose concentration 
glucose concentration 
pathway deletion 
0.5 % 3 % 5 % 
rad2Δ + ++ (+) 
BER 
nth1Δ ++ +++ + 
rad13Δ +++ +++ ++ 
NER 
rhp23Δ ++ ++ ++ 
msh6Δ +++ +(+) (+) 
MMR 
pms1Δ + +++ (+) 
(+) Minimal, + slight, +(+) moderate, ++ strong or +++ very strong increase of CLS 
 
Next, we analyzed how the deletion of the DNA repair genes affected stress 
response. For this purpose, the resistance of these strains against heat, MMS-
induced DNA damage and oxidative stress caused by menadione sodium bisulfite 
(MD) and H2O2 was tested at different concentrations (MD, H2O2) with diverse 
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incubation times (heat shock, MMS) and under changed conditions (one or two days 
in stationary phase). All results showed the same tendency in that the deletion strains 
are rather sensitive than resistant (Figure 36, data not shown). Especially rhp23Δ 
cells were highly sensitive to the analyzed stresses. rad13Δ, rhp23Δ, rad2Δ, and 
nth1Δ cells displayed improved sensitivity to MMS-induced DNA damage, indicating 
that MMS causes a type of DNA damage whose repair requires intact BER and NER 
pathways. In case of nth1Δ cells, it has already been shown that they are 
hypersensitive to MMS but not to H2O2 and menadione (Osman et al., 2003).  
 
 
Figure 36 Analysis of stress resistance of DNA repair mutants 
S. pombe wild-type cells (AEP57) and the indicated deletion strains were grown in YM medium 
containing 3 % glucose for one day. The cultures were adjusted to an OD600 of 0.5. Aliquots were 
treated with 25 mM menadione sodium bisulfite (MD) and 150 mM hydrogen peroxide (H2O2) for one 
hour at 30°C or with 0.2 % methyl methanesulfonate (MMS) for 30 minutes at 30 °C. Another sample 
was incubated for one hour at 48 °C (HS). Subsequently, the cells were six-fold serially diluted and 
spotted onto full medium plates that were incubated at 30 °C for two days. 
 
3.1.3.3 Lifespan-extension was not due to altered auxotrophies or hormetic 
doses of DNA damage 
Defects in DNA repair result in an elevated rate of spontaneous mutations (Fleck et 
al., 1999; Li, 2008; Wood, 1996). It was therefore possible that the increased CLS of 
strains with deletions in DNA repair genes was due to mutations arising in genes 
involved in nutrient uptake and sensing. To test this hypothesis, we investigated 121 
old yeast cells taken from the CFU experiments shown in Figure 35 for additional 
acquired auxotrophies. None of them exhibited altered auxotrophies (Figure 37), 
arguing that increased CLS was not due to secondary mutations in nutritional genes 
related to CR. This conclusion was supported by the fact that not all deletions 
causing increased mutation rates resulted in lifespan extension (see below). 
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Figure 37 Auxotrophies were not altered in old DNA repair mutant cells 
Old cells of the S. pombe strains carrying deletions of DNA repair genes were taken at the end of the 
CFU experiments (Figure 35) and streaked on YM plates supplemented with uracil, adenine, and 
leucine and on YES plates. The plates were incubated at 30 °C for two days. 
 
In general, defects in DNA repair have been associated with premature aging (see 
1.5). Therefore, finding DNA repair deletion strains to exhibit extended CLS seemed 
to be a paradox. However, one possible explanation is that lifespan extension in the 
absence of selected DNA repair proteins might be due to a hormetic effect. The term 
hormesis describes the phenomenon that low doses of harmful or toxic compounds 
may have a positive effect, whereas they inhibit at moderate and kill at high 
concentrations (Mattson, 2008; Schumacher et al., 2008; Schumacher, 2009). It is 
assumed that low doses of toxins, or in this case low levels of DNA damage, might 
activate repair mechanisms and thus cause increased resistance. To test this, we 
used the DNA-alkylating agent MMS to determine whether lifespan was increased 
due to a hormetic effect. MMS causes a wide variety of DNA base damage whose 
repair o requires intact BER and NER pathways (see 3.1.3.2). We tested the 
influence of 14 different MMS concentrations between 0.0025 % and 0.00001 % on 
the CLS of wild-type cells (AEP57). Notably, these concentrations were only a 
fraction of the MMS concentration used for the analysis of the stress response 
(Figure 36). None of them altered lifespan (Figure 38) thus arguing that the increased 
CLS of the identified DNA repair deletion strains was not because of a hormetic 
effect of low level DNA damage. 
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Figure 38 Hormetic doses of MMS did not alter CLS 
S. pombe wild-type cells (AEP57) were cultured in YM medium containing 3 % glucose and different 
concentrations of the DNA damaging agent methyl methanesulfonate (MMS). At the indicated time 
points, the cells were spotted onto YES plates and incubated at 30 °C for two days to determine their 
viability. 
 
3.1.3.4 Selected DNA repair mutants displayed extended CLS 
The proteins encoded by the genes that were deleted in the CLS-extending strains 
identified here are not only involved in three different DNA repair pathways but also 
take part at diverse steps of DNA repair. The proteins affected by the identified 
deletions are involved in DNA damage recognition (Rhp23, Msh6, Pms1) (Buermeyer 
et al., 1999; Fukumoto et al., 2002; Marti et al., 2002; Sugasawa et al., 1998), 
damage excision (Rad2, Rad13) (Kanamitsu & Ikeda, 2010; Wood, 1996) or both 
(Nth1) (Kanamitsu & Ikeda, 2010). This raised the question whether there are more 
DNA repair deletion strains that might extend lifespan but failed to show an effect in 
the primary screen. To answer this question, we queried the deletion library for 
additional deletions that affect proteins involved in BER, NER or MMR and measured 
their CLS of the respective strains. An example is shown in Figure 39, and all results 
are summarized in Table 16. 
 
 
Figure 39 Not all DNA repair mutants showed increased lifespan 
S. pombe strains from the deletion library (Bioneer) carrying single deletions of genes encoding for 
MMR (A) and NER (B) factors and the corresponding wild-type cells (AEP57) were grown in YM 
medium containing the indicated glucose concentrations. The aging cultures were spotted on YES 
plates that were incubated at 30 °C for two days. 
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Table 16 Summary of screening for DNA repair mutants with extended lifespan 
pathway deletion S. pombe protein human homolog function CLSa 
rad2Δ FEN-1 endonuclease  FEN-1 removal of 5’ 
 dRP end 
++ 
nth1Δ DNA endonuclease III, 
DNA N-glycosylase, 
AP lyase 
NTH1 binding, 
recognition, 
excision 
+++ 
mag1Δ DNA-3-methyladenine 
glycosylase 
AAG/MPG binding, 
recognition, 
excision 
⎯ 
mag2Δ DNA-3-methyladenine 
glycosylase 
AAG/MPG binding, 
recognition, 
excision 
⎯ 
thp1Δ uracil DNA N-glycosylase  binding, 
recognition, 
excision 
⎯ 
myh1Δ adenine DNA glycosylase  binding, 
recognition, 
excision 
(+) 
ung1Δ uracil DNA N-glycosylase UNG1 binding, 
recognition, 
excision 
(+) 
apn1Δ AP endonuclease HAP1/APE excision ⎯ 
apn2Δ AP endonuclease HAP1/APE excision ⎯ 
BER/ 
UVER 
uve1Δ endonuclease  excision ⎯ 
rad13Δ DNA endonuclease XPG excision +++ 
rhp23Δ  HR23B (GGR) recognition ++ 
rhp14Δ  XPA damage 
verification 
(+) 
rhp26Δ  CSB (TCR) recognition (+) 
rhp7Δ homolog of Rad7 
(S.cerevisiae) 
 binding of UV-
damaged DNA 
(+) 
rhp41Δ  XPC (TCR) recognition (+) 
NER 
 
rhp42Δ  XPC (GGR) recognition +(+) 
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msh6Δ MutS hMsh6 (MutSα) recognition +(+) 
msh2Δ MutS hMsh2 (MutSα/β) recognition +++ 
pms1Δ MutL hPms2 (MutL) recognition +++ 
mlh1Δ MutL hMlh1(MutL) recognition +(+) 
msh1Δ   mt MMR ⎯ 
msh3Δ  hMsh3 (MutSβ)  ⎯ 
MMR 
exo1Δ exonuclease I  excision (+) 
a ⎯ No, (+) minimal, + slight, +(+) moderate, ++ strong or +++ very strong lifespan-extension 
compared to wild-type cells (AEP57). 
Abbrevations: BER = base excision repair, UVER = UV-damaged DNA endonuclease-dependent 
excision repair, NER = nucleotided excision repair, MMR = mismatch repair, GGR = global genomic 
repair, TCR = transcription-coupled repair, mt = mitochondrial. 
 
Importantly, our results did not disagree with previous publications reporting that 
defects in DNA repair result in premature aging in S. cerevisiae and in mice (de Boer 
et al., 2002; Maclean et al., 2003). The deletions analyzed in those studies have no 
or a functionally different homolog in S. pombe or did not show a significant life-
extending effect in our assay. For instance, the homologs of Nth1 in budding yeast 
and mice, Ntg1/NTH1, act in both the nucleus and in mitochondria, while S. pombe 
Nth1 was not observed in mitochondria (Kanamitsu & Ikeda, 2010). 
Mispaired but undamaged nucleotides are removed by the MMR pathway. In 
S. pombe, DNA mismatches are recognized by a complex, which is build by two 
heterodimers called MutS and MutL. So far, strains with deletions of msh6+ and 
pms1+ were shown here to exhibit an extended lifespan. The proteins encoded by 
these genes are each one part of the MutS and MutL heterodimer. Notably, the 
strains carrying single deletions of their counterparts (msh2+ and mlh1+) also 
displayed increased CLS. In fission yeast, there is only one MutS heterodimer 
consisting of Msh6 and Msh2 and one MutL heterodimer (Pms1/Mlh1), while other 
organisms have two MutS homologs, like MutSα and MutSβ in S. cerevisiae, and up 
to four MutL homologos that recognize different kinds of DNA mismatches (Marti et 
al., 2002). One of these homologos that is involved in MMR in budding yeast and in 
humans is Msh3 (Marti et al., 2002). However, the CLS of the tested msh3Δ cells 
was not affected in our assay (Table 16). The same was true for cells carrying a 
deletion of msh1+, which codes for a protein that is part of the mitochondrial MMR. 
This result indicated that the life-extending effect was limited to the nuclear MMR.  
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NER recognizes bulky, helix-distorting lesions such as UV-induced pyrimidine 
dimers. There are two subpathways called TCR and GGR (Schumacher et al., 2008) 
(see 1.5). Rhp23 is involved in the GGR. There exist homologs of Rhp23 in budding 
yeast (Rad23) and humans (HR23A/HR23B), and they form a complex with Rad4 
respectively XPC, which was found to be involved in DNA damage recognition as 
well as in the assembly and disassembly of NER complexes (Prakash & Prakash, 
2000). One homolog of Rad4 in S. pombe is Rhp42, which is also termed Rhp4b 
(Fukumoto et al., 2002). Strains carrying single deletions of both rhp42+ and rhp23+ 
exhibited a moderate to strong increase of CLS (Table 16). The DNA endonuclease 
Rad13 is the homolog of the human XPG protein and makes the 3’ incision in NER 
(Wood, 1996), and the CLS of rad3Δ cells was also increased (Table 16). These 
results indicated an important role for the Rhp23-Rhp42 complex in affecting lifespan. 
In the BER pathway, single bases that are damaged by oxidation, alkylation, 
hydrolysis, or deamination are recognized and removed by lesion-specific DNA 
glycosylases. Notably, we identified only one DNA glycosylase whose deletion 
extended CLS significantly (Table 16). This enzyme is called Nth1 and possesses 
also an apurinic/apyrimidinic (AP) lyase activity that removes oxidized bases in the 
early steps of the BER pathway. Additionally, a large portion of the AP sites 
generated by the action of the monofunctional DNA glycosylases is incised by Nth1 
in short-patch BER (Kanamitsu & Ikeda, 2010). The second protein whose deletion 
increased lifespan is Rad2. In contrast to Nth1, the flap endonuclease Rad2 is 
involved in long-patch BER where it incises the flap DNA containing the lesion after 
DNA synthesis. Together with the UV endonuclease Uve1, Rad2 also acts in the 
alternative excision repair pathway (UVER) that is similar to the long-patch BER 
pathway, but excises UV damages normally repaired by NER (McCready et al., 2000; 
Osman et al., 2003). However, the CLS of uve1Δ cells was not extended, indicating 
that it is probably the Rad2 function in BER rather than its function in UVER that 
contributes to lifespan-extension.  
 
3.1.3.5 Segregants from genetic crosses showed variability in CLS 
Several studies have shown that proteins involved in NER interact with BER and 
MMR components (Bertrand et al., 1998; Fleck et al., 1999; Kanamitsu & Ikeda, 
2010) and that these three DNA repair pathways display partially overlapping 
functions (Fleck et al., 1999; Kunz & Fleck, 2001; McCready et al., 2000; Yonemasu 
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et al., 1997; Yoon et al., 1999). Therefore, we reasoned that the function of the repair 
pathway that is impaired by the deletion might be undertaken by one of the other 
(two) repair pathways. The resulting activation of additional DNA repair mechanisms 
might then lead to improved lifespan. To test this hypothesis, we planned to perform 
epistasis analysis and to determine the CLS of double mutants. Since our deletion 
strains originated from the S. pombe deletion library (Bioneer), all strains displayed 
the same mating type (h+). To generate double mutants by genetic crosses, strains 
with the respective deletion but the opposite mating type had to be generated. For 
this initial experiment, a wild-type strain (AEP64) that was isogenic to the deletion 
library but had the opposite mating type (h-) was used. The segregants that arose 
from these crosses were tested for their mating type and the presence of the 
deletion. Only those cells that were h- and carried the deletion were used for further 
crosses. 
Here, we made an unexpected observation regarding the lifespan of deletion 
mutants originating from genetic crosses. The original single deletion strains 
extended lifespan as expected. However, when measuring the CLS of the final 
double mutants, we observed a strong variability in the lifespan of the tested strains 
(Figure 40A, data not shown), although they displayed the same genotype as 
determined by PCR. To determine the potential cause for this variability, the lifespan 
of the deletion cells arising from the initial crosses was also analyzed. And again, 
there were great differences in their CLS (Figure 40B, data not shown) even if they 
were smaller compared to the previous experiment (Figure 40A), suggesting that 
their CLS was determined by factors other than the genotype. The only known 
difference between the rad2Δ segregants shown in Figure 40B and the presented 
strains was that they originated from a genetic cross. These results indicated that the 
CLS was some how influenced by genetic crosses per se. To test this hypothesis, 
two wild-type strains (AEP57, AEP64) were crossed. As shown in Figure 40C, the 
lifespan of all four spores arising from these tetrads varied slightly, suggesting that it 
was an unknown, non-Mendelian factor that affected the CLS of fission yeast. 
Possible explanations could be differences in mitochondrial DNA and/or epigenetic 
modifications, like PTMs on histones.  
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Figure 40 Varying CLS of yeast cells arising from crossings 
(A) Measurement of the CLS of rad2Δ rhp23Δ double mutants arising from genetic crosses. S. pombe 
wild-type cells (AEP57) as well as rad2Δ and rhp23Δ cells originating from the deletion library 
(Bioneer) served as controls. 
(B) Measurement of the CLS of rad2Δ segregants that arose from a genetic cross of wild-type cells 
(AEP64) and rad2Δ cells originating from the S. pombe deletion library (Bioneer). The initial mating 
partners served as control. 
(C) Measurement of the CLS of four segragants (a-d) resulting from a single tetrad that arose from a 
genetic cross of two S. pombe wild-type strains (WT 1 = AEP64, WT 2 = AEP57). The initial mating 
partners served as control. 
All gene deletions were confirmed by PCR. 
 
3.1.3.6 Deletion of DNA repair genes did not extend CLS 
The previous results raised the question whether the improvement of lifespan of the 
analyzed deletion strains was truly caused by their respective gene deletions or by 
other non-genetic factors. To address this question, three DNA repair genes (rad2+, 
rad13+, msh6+) and one UPRER gene (ppk4+) were deleted by replacing their open 
reading frame (ORF) with the NatMX cassette in two different S. pombe wild-type 
strains (AEP1 and AEP57). After confirming the deletion by PCR, the CLS was 
measured. Examples are shown in Figure 41. The deletion strains originating from 
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the S. pombe deletion library (Bioneer), which were used as controls, extended 
lifespan as expected (Figure 41, data not shown). However, the cells where the DNA 
repair genes were deleted with NatMX did not exhibit changes in lifespan (Figure 41, 
data not shown). The same was true for the deletion of the UPRER gene ppk4+ (data 
not shown).  
 
 
Figure 41 Deletion of DNA repair genes in wild-type cells did not extend CLS 
rad2+ and rad13+ were deleted in S. pombe wild-type cells (here: AEP57) by replacing their open 
reading frame with a NatMX cassette. After confirming the knockout (KO) by PCR, the CLS of these 
cells was analyzed in YM medium containing 3 % glucose. The original wild-type cells (AEP57) as well 
as the indicated deletion strains originating from the S. pombe deletion library (Bioneer) were used as 
controls. 
 
In summary, these results indicated that the observed lifespan extension was 
probably not due to the indicated gene deletions. Since this was not only the case for 
the DNA repair genes but also for ppk4+, secondary effects like additional mutations 
caused by defects in DNA repair could be excluded. This result posed a serious 
challenge to our previous observations concerning the lifespan-extending effect of 
individual gene deletions originating from the S. pombe deletion library (Bioneer). As 
a consequence, other groups of genes affecting CLS (Table 14) were not pursued. 
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3.2 Compounds altering telomeric silencing of S. cerevisiae 
3.2.1 High-throughput in vivo screen for compounds affecting telomeric 
silencing 
The regulation of telomere length is tightly linked to cellular aging and tumour growth. 
Shortening of telomeres is associated with premature aging in mammals, while 
activation of telomerase and telomere lengthening are linked to cancer. Intriguingly, 
there is an inverse correlation between lifespan and telomere length in S. cerevisiae 
(Austriaco & Guarente, 1997). Austriaco and Guarente suggested that telomeres 
regulate lifespan by modulating genomic silencing in budding yeast. According to 
their hypothesis, short telomeres recruit less of the SIR silencing machinery to the 
telomeres. As a result, this machinery is redistributed to non-telomeric sites, causing 
a delay in aging – probably by enhanced rDNA silencing. Conversely, telomere 
lengthening reduces lifespan. This decrease is due, at least in part, to greater 
recruitment of the SIR complex by the long telomeres and might lead to increased 
telomeric silencing (Austriaco & Guarente, 1997). Therefore, the measurement of 
telomeric silencing can be taken as an indicator of the potential lifespan of 
S. cerevisiae, with improved silencing implying a decrease in lifespan and reduced 
silencing representing lifespan extension. Since telomeric silencing is technically 
easier to measure than lifespan, an approach was taken here to identify compounds 
that affect telomeric silencing, hoping that they would also affect the lifespan of yeast. 
 
3.2.2 Experimental set-up 
3.2.2.1 Identification of potential positive controls 
In a first step for setting up a high-throughput screen for compounds that affect 
telomeric silencing, an experimental strategy was required, in which increased or 
decreased telomeric silencing can be measured by a simple growth assay. To this 
end, different S. cerevisiae strains carrying an URA3 reporter gene in the 
subtelomeric region were used. Spreading of telomeric heterochromatin into 
centromere-proximal regions causes repression of the integrated URA3 gene, 
resulting in the ability to grow on URA3-counter-selective 5-FOA medium. 
Conversely, reduced silencing leads to URA3 expression and the inability to grow on 
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5-FOA. An SIR3 overexpression vector was constructed (pAE1232), as it was 
expected to improve the silencing at the telomeres by increased spreading of 
heterochromatin. Indeed, TEL XI-L position 2::URA3 cells (AEY2165)3 showed 
enhanced growth on 5-FOA plates when transformed with this plasmid compared to 
yeast cells carrying the empty vector (pAE269), indicating enhanced repression of 
the URA3 gene (Figure 42).  
 
 
Figure 42 Telomeric silencing was improved by SIR3 overexpression 
The strain TEL XI-L position 2::URA3 (AEY2165)3 carries an URA3 reporter gene at a (sub-) telomeric 
region. Six-fold serial dilution of these cells transformed with either a SIR3 overexpression plasmid 
(pAE1232) or the corresponding empty vector (pAE269) were spotted on YM medium lacking uracil 
and URA3-counter-selective 5-FOA plates and subsequently incubated at 30 °C for two days to 
determine telomeric silencing.  
 
Furthermore, the effect of resveratrol and splitomicin on telomeric silencing was 
tested. Resveratrol activated SirT1 in the fluorescence-based in vitro HDAC assay 
(unpublished data of Gesine Hoffmann) and may be an activator of sirtuins like yeast 
Sir2 (Haigis & Sinclair, 2010). Therefore, treatment with this compound should result 
in enhanced telomeric silencing in S. cerevisiae. However, resveratrol did not alter 
telomeric silencing, as the addition of this compound did not enhance the growth of 
TEL XV-R position 9::URA3 (AEY4167) and TEL IX-L position 7::URA3 (AEY4168) 
on 5-FOA (Figure 43A). Furthermore, the growth of TEL XI-L position 2::URA3 
(AEY2165)3 on 5-FOA was not changed by either resveratrol or trichostatin A (TSA), 
a known inhibitor of Class I and II HDACs that does not affect sirtuins (Rusche et al., 
2003; Vanhaecke et al., 2004) (Figure 43B). This led to the conclusion that 
resveratrol has no influence on telomeric silencing and does not activate Sir2, which 
is in line with observations of other groups that resveratrol does not affect aging in 
S. cerevisiae (Bass et al., 2007; Howitz et al., 2003; Kaeberlein et al., 2005a; Wood 
et al., 2004), and that its activation of sirtuins is highly dependent on the substrate 
(Beher et al., 2009).  
                                            
3 Notably, it turned out in later experiments that the indicated genotype of this strain is not correct, and 
thus, the precise site of URA3 integration is not known. 
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Figure 43 Resveratrol did not affect telomeric silencing 
(A) The telomeric silencing of two strains carrying an URA3 marker gene at distinct subtelomeric 
locations on different chromosome ends (AEY4167 and AEY4168) was analyzed. For this purpose, 
serial dilutions were spotted on 5-FOA plates with and without 10 µM resveratrol as well as on YM 
plates lacking uracil. 
(B) 0.1 OD of TEL XI-L position 2::URA3 (AEY2165)3 were plated on a 5-FOA plate. The indicated 
volumes of DMSO, 10 mM resveratrol and 7.5 mM trichostatin A (TSA) were spotted on sterile filters 
made of Whatman paper. 
All plates were incubated at 30 °C for two days. 
 
On the other hand, splitomicin, a known Sir2 inhibitor (Bedalov et al., 2001), 
inhibited Sir2 in the in vitro HDAC assay (Figure 44A) and was expected to disrupt at 
least the telomeric silencing in vivo. Indeed, splitomicin inhibited the growth of TEL 
XI-L position 2::URA3 (AEY2165)3 on 5-FOA (Figure 44B) as can be seen as a zone 
of growth inhibition around the filters, indicating reduced repression of the URA3 
marker gene. This concentration-dependent effect was not due to a general growth 
inhibition, since this compound increased the growth of TEL IX-L position 1::URA3 
cells (AEY4162) carrying the SIR3 overexpression vector (pAE1232) on medium 
lacking uracil (Figure 44C). Together, these results indicated that splitomicin, as 
expected, disrupts telomeric silencing. However, as an inhibitor of Sir2, splitomicin 
was expected to affect all three types of silencing in S. cerevisiae. Therefore, its 
effect on HM silencing was additionally tested by a spot filter assay, where MATa 
his4 cells (AEY264) were mixed with mataΔp hmlαΔp HMRssα cells (AEY325). 
These two yeast strains are only able to mate and form diploids if HMR silencing of 
the latter strain is disrupted. Indeed, the amount of diploid colonies around the filters 
increased with the concentration of splitomicin (Figure 44D), showing that this 
compound not only suppresses telomeric but also HM silencing – probably through 
the inhibition of Sir2. 
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Figure 44 Splitomicin inhibited Sir2 activity in vitro and improved telomeric and HM silencing in 
vivo 
(A) Sir2 deacetylase activity was measured by Gesine Hoffmann using a fluorescence-based assay. In 
two consecutive reactions, deacetylation of the substrate MAL generates a fluorophore that is excited 
at 360 nm and light at 460 nm was emitted. The blank (DMSO) was defined as 100 %. 
(B) To determine telomeric silencing, 0.5 OD of the strain TEL XI-L position 2::URA3 (AEY2165)3 were 
plated on URA3-counter-selective 5-FOA plates.  
(C) 0.1 OD of TEL IX-L position 1::URA3 (AEY4162) carrying an SIR3 overexpression vector 
(pAE1232) were plated on a YM plate lacking uracil and leucine to analyze the repression of the sub 
telomeric URA3 marker gene. 
(D) To examine HM silencing, 0.5 OD of each MATa his4 (AEY264) and mataΔp hmlαΔp HMRssα 
(AEY403) cells were mixed and plated on YM plates without supplements. 
The indicated volumes of DMSO and 10 mM splitomicin were spotted on sterile filters made of 
Whatman paper. All plates were incubated at 30 °C for two days. 
 
Based on the model of Austriaco and Guarente (Austriaco & Guarente, 1997) and 
the previous results, shortening of the telomeres was expected for SIR3 
overexpression, while splitomicin should lead to longer telomeres. Surprisingly, 
neither SIR3 overexpression nor treatment with 10 µM splitomicin or 10 µM 
resveratrol affected telomere length of the analyzed yeast strains (Figure 45).  
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Figure 45 SIR3 overexpression, resveratrol, and splitomicin did not affect telomere length 
The telomere length of the indicated strains was determined by telomeric restriction fragment (TRF) 
analysis using a [α-32P]dCTP-labelled probe for hybridization. Notably, it turned out in later 
experiments that the indicated genotype of these strains is not correct, and thus, the precise site of 
URA3 integration is not known. 
 
3.2.2.2 Yeast strains used in the in vivo screen for compounds affecting 
telomeric silencing 
For S. cerevisiae, a discontinuous telomeric silencing pattern has been described at 
native telomeres. The repression of a subtelomeric (marker) gene is affected in a 
position-dependent manner (Pryde & Louis, 1999) (see 1.10.2). A yeast strain 
harbouring a subtelomeric URA3 marker gene that is only slightly repressed could 
therefore be used to identify compounds that increase telomeric silencing. Therefore, 
such yeast cells are able to grow on minimal medium lacking uracil, but show only 
weak growth on the counter-selective 5-FOA medium. The addition of a compound 
that increases telomeric silencing should lead to URA3 repression and to less 
synthesis of uracil. As a consequence, there should be more growth on 5-FOA, while 
the growth on YM medium lacking uracil should be reduced. The previous results 
suggested that SIR3 overexpression represents an adequate positive control for this 
approach (see 3.2.1).  
For the identification of compounds that decrease telomeric silencing, a yeast 
strain showing strong telomeric repression was needed. In contrast to the first 
approach, the addition of a compound that reduces telomeric silencing should lead to 
URA3 expression resulting in less growth on 5-FOA and improved growth on minimal 
medium lacking uracil. The addition of 10 µM splitomicin was shown to mimick this 
effect (see 3.2.1). Therefore, it could be used as a positive control in the second 
approach.  
In order to find suitable yeast strains for the screens that showed the telomeric 
silencing patterns described above, we obtained seven S. cerevisiae strains, each 
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carrying an URA3 marker gene at a different subtelomeric region (Pryde & Louis, 
1999). To analyze the telomeric silencing and the strength of the effect of the positive 
controls, these strains were transformed with the SIR3 overexpression plasmid 
(pAE1232) and the corresponding empty vector (pAE269). Subsequently, serial 
dilutions were spotted on minimal medium lacking uracil and 5-FOA plates, each with 
and without 10 µM splitomicin (Figure 46). As a result, the strains could be clustered 
into two groups. The first group contains the strains with strong telomeric repression 
when carrying the SIR3 overexpression plasmid, as indicated by reduced growth on 
YM lacking uracil compared to the empty vector (TEL IX-L position 1, TEL XI-L 
position 1, TEL XI-L position 2). This difference was reversible by disrupting telomeric 
silencing through the addition of 10 µM splitomicin (Figure 46, lines 1, 2, 4). The 
strains, whose growth on 5-FOA was increased by the presence of the SIR3 
overexpression plasmid (TEL XII-R position 2, TEL XI-L position 3, TEL XV-R 
position 9, TEL IX-L position 7) (Figure 46, lines 3, 5 - 7), were clustered in the 
second group. These strains displayed weak to moderate telomeric silencing, when 
carrying the empty vector. 
Based on these results, TEL IX-L position 1::URA3 (AEY4162) carrying the SIR3 
overexpression plasmid (pAE1232) was selected to screen for compounds that 
decrease telomeric silencing. This strain exhibited a strong telomeric silencing when 
SIR3 was overexpressed (Figure 46, line 1). Compounds that disturb telomeric 
silencing cause an induction of cell growth on YM medium lacking uracil. Therefore, 
the addition of 10 µM splitomicin could be used as positive control. To identify 
compounds that increase telomeric silencing, TEL IX-L position 7::URA3 (AEY4168) 
was chosen. This strain showed moderate silencing under normal conditions causing 
weak growth on counter-selective 5-FOA medium (Figure 46, line 7). The growth 
could be improved by a stronger repression of the reporter gene, here mimicked by 
the induction of a SIR3 overexpression plasmid (pAE1232) that served as positive 
control in the screen. Importantly, both approaches exploit a positive growth selection 
that excludes the problem of achieving false-positive effects from compounds that 
are toxic to the cell and cause a decreased growth without affecting telomeric 
silencing. 
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Figure 46 SIR3 overexpression and splitomicin affected telomeric silencing of potential 
screening strains 
Cells with an URA3 marker gene inserted at distinct subtelomeric regions on different chromosome 
ends (top to bottom: AEY4162 - AEY4168; (Pryde & Louis, 1999) were transformed with a SIR3 
overexpression plasmid (pAE1232) and the corresponding empty vector (pAE269). To analyze their 
telomeric silencing, six-fold serial dilutions of the strains were spotted on YM plates lacking uracil and 
URA3-counter-selective 5-FOA plates, each with and without 10 µM splitomicin. All plates were 
incubated at 30 °C for two days. 
 
3.2.3 Results of the high-throughput in vivo screen 
To analyze the effect of several compounds on telomeric silencing at once, we 
established a novel high-throughput method. Small liquid cultures of the screening 
strains (see 3.2.2.2) were grown in 96-well or 384-well microtiter plates. Their growth 
was determined by measuring the optical density at distinct intervals using a 
microplate reader. Notably, the effects of the positive controls in liquid cultures were 
identical to those observed in the previous experiments where solid medium was 
used (see 3.2.2.2). Compounds that resulted in at least a 1.5 fold increase compared 
to DMSO-treated cells were scored as positive hits. 
Using this method, we screened approximately 19,000 compounds for their impact 
on the telomeric silencing of S. cerevisiae. In the first step, a small compound library 
(Biomol) as well as a few single compounds (Evonik) were tested using two different 
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compound concentrations. Eight of these 522 compounds showed an effect in the 
screen for increased telomeric silencing (Table 17), while four compounds resulted in 
reduced silencing (Table 18). Next, we cooperated with the Screening Unit of the 
Leibniz-Institute for Molecular Pharmacology (FMP) in Berlin to analyze the 
ChemBioNet library containing approximately 17,000 compounds and the LOPAC 
library (1,280 compounds). In the screen for enhanced telomeric repression, 127 
primary candidates were identified (Table 19). Additionally, 146 compounds were 
found in the screen for decreased telomeric silencing (Table 20). All primary 
candidates were re-tested as triplicates using at least three different compound 
concentrations. Finally, four compounds that increased telomeric silencing and two 
hits leading to reduced silencing could be validated (Table 21). Interestingly, these 
compounds showed only a weak or moderate effect in the initial screen (Tables 
17 - 20, marked in dark grey). 
 
Table 17 Primary candidates (Biomol and Evonik) that increased telomeric silencing 
fold changea 
well compound 
4 µg/ml 20 µg/ml 
1-A9 Betulinic acid 3,48 1,51 
1-B2 C6-Ceramide 7,29 2,86 
1-G12 Mezerein 2,14 1,02 
2-F8 Nicotine 4,46 0,57 
2-H1 Oxytetracycline, a -apo- 1,82 1,04 
3-D3 Chrysoeriol 2,06 1,24 
6-B6 3,3-Diindolylmethane 0,49 1,71 
6-E2 Phytosphingosine nicotinic acid 
(Evonik) 
1,82b --- 
a X-fold increase of optical density (OD600) caused by 4 µg/ml or 20 µg/ml compound compared to the 
blank (DMSO) 
b final concentration of 100 µg/ml 
light grey = below cut-off (< 1.5); dark grey = secondary candidate 
 
Table 18 Primary candidates (Biomol and Evonik) that decreased telomeric silencing 
fold changea 
well compound 
4 µg/ml 20 µg/ml 
1-B2 C6-Ceramide 1,21 1,69 
2-G2 Quercetin Dihydrat 0,98 1,60 
3-G8 Tamarexitin 0,92 1,79 
6-B4 Geraldol 0,85 1,70 
a X-fold increase of optical density (OD600) caused by 4 µg/ml or 20 µg/ml compound compared to the 
blank (DMSO) 
light grey = below cut-off (< 1.5) 
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Table 19 Primary candidates (ChemBioNet and LOPAC) that increased telomeric silencing 
Comp. IDa fold changeb Comp. ID
a fold changeb Comp. ID
a fold changeb Comp. ID
a fold changeb 
39509 2,39 36556 1,73 37936 1,62 39104 1,55 
36784 2,37 37253 1,73 38817 1,62 36976 1,55 
35234 2,35 37904 1,72 29510 1,62 39681 1,55 
37760 2,25 38480 1,72 32410 1,62 29862 1,55 
38638 2,25 38977 1,72 34669 1,62 37169 1,55 
26352 1,99 36206 1,71 37269 1,61 29511 1,55 
39713 1,95 33932 1,71 39717 1,61 36558 1,55 
37262 1,95 37585 1,71 37840 1,61 39745 1,55 
36901 1,94 32173 1,70 38320 1,61 38240 1,54 
36816 1,94 39873 1,70 27397 1,61 36550 1,54 
34438 1,93 37257 1,70 37968 1,60 26004 1,54 
31973 1,93 34438 1,93 37060 1,59 26689 1,54 
34475 1,91 31981 1,70 39931 1,59 38593 1,54 
39376 1,90 40064 1,69 27649 1,59 37267 1,53 
37297 1,88 37278 1,69 36124 1,59 27585 1,53 
38305 1,85 37256 1,69 41603 1,58 35840 1,53 
40048 1,84 41762 1,68 37357 1,58 39771 1,53 
31972 1,82 38672 1,68 35503 1,58 40080 1,53 
37824 1,81 37255 1,67 39120 1,57 35232 1,53 
38479 1,81 37664 1,67 39995 1,57 26069 1,53 
37032 1,81 38945 1,67 36960 1,57 36900 1,53 
37252 1,81 26317 1,67 37363 1,57 28405 1,53 
36559 1,81 30211 1,66 39456 1,56 36096 1,53 
36432 1,79 24889 1,66 37632 1,56 39728 1,52 
30224 1,79 37263 1,66 38336 1,56 30918 1,52 
37254 1,78 39729 1,66 27399 1,56 29163 1,52 
38311 1,77 39714 1,65 38288 1,56 29509 1,52 
36207 1,77 27393 1,65 39830 1,56 36479 1,51 
39719 1,77 36961 1,65 36555 1,56 26229 1,51 
31979 1,76 38128 1,65 27473 1,56 40909 1,51 
39808 1,75 35449 1,64 35168 1,55 40160 1,51 
35695 1,74 39601 1,64 27601 1,55   
a Compound IDs used at the Screening Unit of the Leibniz-Institute for Molecular Pharmacology (FMP) 
in Berlin. 
b X-fold increase of optical density (OD595) caused by 40 µM compound compared to the blank 
(DMSO). 
dark grey = secondary candidates 
 
Table 20 Primary candidates (ChemBioNet and LOPAC) that decreased telomeric silencing 
Comp. IDa fold changeb Comp. ID
a fold changeb Comp. ID
a fold changeb Comp. ID
a fold changeb 
100657 3,34 35637 1,88 30310 1,73 25185 1,63 
38258 2,77 31412 1,88 27852 1,73 26322 1,63 
38441 2,42 24020 1,87 31298 1,73 24580 1,62 
33446 2,41 35441 1,87 32676 1,72 28388 1,62 
28466 2,36 26226 1,86 41656 1,72 27012 1,61 
36993 2,34 33424 1,85 24161 1,71 31651 1,60 
24963 2,34 25271 1,85 27053 1,71 29908 1,60 
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100662 2,32 39625 1,85 27359 1,71 29618 1,60 
35077 2,31 25107 1,85 29156 1,71 40080 1,59 
100683 2,25 26673 1,84 31284 1,71 33064 1,59 
40868 2,24 27715 1,82 28630 1,70 31229 1,59 
28594 2,23 31588 1,81 25154 1,70 37980 1,59 
33719 2,19 28147 1,81 24232 1,70 25825 1,58 
27746 2,15 24883 1,81 26755 1,69 26882 1,58 
26433 2,13 26372 1,81 29873 1,69 37810 1,58 
39769 2,11 31379 1,80 27061 1,69 26397 1,57 
39564 2,10 31601 1,80 31571 1,69 30272 1,57 
27091 2,09 29857 1,80 28469 1,69 27697 1,57 
33583 2,03 25652 1,80 29944 1,69 36036 1,56 
35213 2,02 26497 1,79 30228 1,68 38579 1,56 
26902 2,00 39928 1,79 29155 1,68 27157 1,56 
39707 2,00 33164 1,78 25858 1,68 31474 1,55 
24851 1,99 39684 1,78 25955 1,67 25202 1,55 
27108 1,99 24244 1,78 32276 1,67 29842 1,54 
100087 1,98 31299 1,77 30449 1,66 32332 1,54 
29524 1,98 26347 1,77 28467 1,66 35183 1,53 
41726 1,96 27090 1,77 25068 1,66 36053 1,53 
26739 1,95 31364 1,76 37540 1,65 30135 1,53 
24932 1,95 100403 1,76 27057 1,64 24582 1,53 
36640 1,92 32721 1,75 27394 1,64 24916 1,52 
27307 1,92 29860 1,75 32019 1,64 24835 1,52 
32675 1,91 40086 1,75 28002 1,64 36004 1,52 
38026 1,91 32212 1,75 36560 1,64 26620 1,52 
25253 1,89 25637 1,75 27051 1,63 38468 1,51 
30180 1,89 28516 1,75 31509 1,63 36788 1,50 
27348 1,88 28454 1,74 26721 1,63 28403 1,50 
28523 1,88 39708 1,73     
a Compound IDs used at the Screening Unit of the Leibniz-Institute for Molecular Pharmacology (FMP) 
in Berlin. 
b X-fold increase of optical density (OD595) caused by 40 µM compound compared to the blank 
(DMSO). 
dark grey = secondary candidates 
 
 
Table 21 Secondary candidates of compounds that alter telomeric silencing 
Increased telomeric silencing Decreased telomeric silencing 
Comp. IDa Compoundb Comp. IDa Compoundb 
⎯ nicotine 24835 8011-0384 (ChemDiv) 
26004 8016-8224 (ChemDiv), 
ST4114419 (TimTec) 
29944 C274-8454 (ChemDiv) 
35168 K289-0473 (ChemDiv)   
35733 C593-0506 (ChemDiv)   
a Compound IDs used at the Screening Unit of the Leibniz-Institute for Molecular Pharmacology (FMP) 
in Berlin. 
b Compound names of the companies from which the compounds were reordered. 
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To further verify the effect of the identified secondary candidates on telomeric 
silencing and to analyze their potential mode of action, they were reordered from 
Roth (nicotine), TimTec, and ChemDiv. However, the screening results for the 
compounds K289-0473, 8011-0384, and C274-8454 could not be reproduced, 
indicating that their effect might result from degradation products within the library or 
that their identity is mistaken at the ChemDiv library. Three compounds (C593-0506, 
ST4114419, nicotine) could be re-validated – all of them enhanced telomeric 
silencing (Figure 47). They were also tested in medium without yeast cells. Under 
these conditions, the addition of C593-0506 and ST4114419 resulted in increased 
optical density (data not shown). Additional observations indicated that this increase 
was rather caused by the precipitation of the compound, possibly due to a reaction 
with components of the medium, than by improved cell growth. Therefore, these 
compounds were not investigated further. 
 
 
Figure 47 Three secondary candidates were re-validated for increased telomeric silencing 
After the initial screens and the first validation, the effect of the identified compounds on telomeric 
silencing was analyzed by determining the growth of TEL IX-L position 7::URA3 (AEY4168) in URA3-
counter-selective 5-FOA medium in 96-well microplates. For this purpose, the optical density of the 
miniaturized liquid cultures was measured at the indicated time points after inoculation. The results of 
the three validated secondary compounds that increase telomeric silencing are shown ((A) C593-
0506, (B) ST4114419, (C) nicotine). For each compound three different concentrations were tested as 
triplicates. 2-F8 represents the compound that originated from this well of the Natural Products Library 
(Biomol) that was indicated as 1 µg/µl nicotine.The SIR3 overexpression strain (+ pSIR3) served as 
positive control and the dashed line shows the cut-off corresponding to the 1.5-fold of the blank 
(DMSO). 
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In the case of nicotine, there was some confusion regarding its real concentration 
in the library (well 2-F8), because 125 µM of nicotine reordered from Roth, which 
should approximately be the concentration of nicotine in the library, did not affect 
telomeric repression (Figure 47C). Even if the concentration was increased ten-fold 
(= 1.25 mM), there was no effect (Figure 47C). However, 12.5 mM nicotine enhanced 
telomeric silencing – even stronger than the compound from the library (Figure 47C). 
To confirm that this increase is caused by improved cell growth, 1 µl of the analyzed 
cultures was plated on YM plates. Indeed, the growth of cells carrying the SIR3 
overexpression plasmid (+ pSIR3) was enhanced compared to the blank (DMSO). In 
the case of 12.5 mM nicotine and the undiluted compound originating from well 2-F8 
of the compound library, even more cells grew (data not shown) indicating that the 
increase in optical density was due to an increase in cell number and hence 
enhanced telomeric silencing. In summary, nicotine was the only secondary 
candidate that remained after these initial experiments. 
 
3.2.4 Effect of nicotine on silencing and lifespan 
3.2.4.1 The increase of telomeric silencing was caused by nicotine and was not 
due to degradation products 
Based on the suggestion that the effect on telomeric silencing of some secondary 
candidates identified in the screen might be caused by degradation products (see 
3.2.3), this had to be tested for nicotine. For this purpose, Werner Karow from the 
Faculty of Chemistry at the University of Duisburg-Essen performed mass 
spectrometry (MS) using the “original” nicotine from the Natural Products Library 
(Biomol) and the reordered compound (Roth). With this method, the mass-to-charge 
ratio of charged particles is measured (Sparkman, 2000) that can be used for 
determining the elemental composition of a sample. Additionally, high-performance 
liquid chromatography combined with mass spectrometry (HPLC-MS) was performed 
by Markus Kaiser at the Chemical Genomics Centre of the Max-Planck Society in 
Dortmund. By this means, the components of the sample are physically separated 
before being analyzed by MS. This technique is generally used for specific detection 
and potential identification of chemicals in the presence of other chemicals (in a 
complex mixture) (Gey, 2008). Both experiments showed that the majority of the 
analyzed sample consisted of nicotine. Furthermore, small quantities of oxidation 
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product nicotine-N-oxide were found (personal communication with Markus Kaiser, 
data not shown). To ensure that the effect on telomeric silencing was due to nicotine 
and not to nicotine-N-oxide, different concentrations of nicotine-N-oxide reaching 
from 10 nM to 100 µM were tested. None of them resulted in improved repression of 
the subtelomeric URA3 marker gene (Figure 48), indicating that the effect observed 
in the previous experiments was indeed caused by nicotine.  
 
 
Figure 48 Nicotine-N-oxide did not alter telomeric silencing 
The effect of several nicotine-N-oxide concentrations on telomeric silencing was analyzed by 
determining the growth of TEL IX-L position 7::URA3 (AEY4168) in 5-FOA medium. Therefore, the 
optical density (OD600) was measured at the indicated time points. The SIR3 overexpression strain 
(+ pSIR3) served as positive control and the dashed line shows the cut-off corresponding to the 
1.5-fold of the blank (DMSO). 
 
So far, 12.5 mM was the only tested concentration of the reordered nicotine that 
affected telomeric silencing. In order to find a lower concentration with a comparable 
effect, 13 different concentrations between 1 mM and 12.5 mM were tested 
(Figure 49). Concentrations of at least 4 mM nicotine significantly increased telomeric 
silencing. This concentration-dependent effect was stronger than the effect of the 
positive control (+ pSIR3). The maximum enhancement of growth in 5-FOA medium, 
meaning maximal telomeric repression, was reached by the addition of 8 mM 
nicotine. Based on these results a nicotine concentration of 6 mM was chosen for 
further experiments.  
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Figure 49 Nicotine increased telomeric silencing  
To analyze the effect of several nicotine concentrations on telomeric silencing, the growth of TEL IX-L 
position 7::URA3 (AEY4168) in 5-FOA medium was determined by measuring the optical density 
(OD600) at the indicated time points. The SIR3 overexpression strain (+ pSIR3) served as positive 
control and the dashed line shows the cut-off corresponding to the 1.5-fold of the blank (DMSO). 
 
3.2.4.2 The effect of nicotine neither depended on the type of the medium nor 
on the telomeric position or the nature of the reporter gene 
In the previous experiments, telomeric silencing was determined by measuring the 
optical density of small liquid cultures grown in 96-well or 384-well microplates, 
because it enabled the analysis of several cultures in parallel. In the following 
experiments, six-fold serial dilutions spotted on different plates were used to examine 
silencing in the following experiments. 
To determine whether the enhancement of telomeric repression by nicotine 
depends on the position of the URA3 marker gene within the telomere, the growth on 
5-FOA of two strains carrying the URA3 at distinct subtelomeric locations on different 
chromosome ends (AEY4167 and AEY4168) was analyzed. Under normal conditions 
both strains showed a weak to moderate silencing. The addition of 6 mM nicotine led 
to an increase of telomeric silencing, as measured by improved growth on 5-FOA 
(Figure 50A). This was confirmed in a spot filter assay, where growth on 5-FOA was 
increased around the filters with 0.5 µl and 1 µl undiluted nicotine, while 2.5 µl up to 
10 µl inhibited growth in a concentration-dependent radius (data not shown). In 
another approach, the subtelomeric URA3 gene was replaced by a LYS2 reporter 
gene in the yeast strains TEL XV-R position 9::URA3 (AEY4167) and TEL IX-L 
position 7::URA3 (AEY4168). The resulting strains exhibited a moderate growth on 
LYS2-counter-selective α-amino adipic acid (αAA) medium. The cell growth was 
increased by the addition of 6 mM nicotine (Figure 50B, data not shown), indicating 
improved repression of the telomeric LYS2. This was confirmed by the wild-type 
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LYS2 strain (AEY1), whose growth on αAA was not affected by adding 6 mM nicotine 
(Figure 50B).  
 
 
Figure 50 The effect of nicotine did not depend on the position within the telomere or the 
nature of the reporter gene 
(A) The yeast strains TEL XV-R position 9::URA3 (AEY4167) and TEL IX-L position 7::URA3 
(AEY4168) carry an URA3 reporter gene at distinct subtelomeric locations on different chromosome 
ends. URA3 repression was tested by spotting serial dilutions on counter-selective 5-FOA medium 
with and without 6 mM nicotine. All plates were incubated at 30 °C for two days. 
(B) The subtelomeric URA3 gene was replaced by a LYS2 reporter gene in the yeast strain TEL IX-L 
position 7::URA3 (AEY4168). Telomeric silencing of the resulting yeast strain (AEY4580) was 
analyzed like in (A) using αAA for LYS2-counter-selection. 
 
To test whether the effect on nicotine did depend on 5-FOA, for instance by 
preventing the intake of 5-FOA, the telomeric silencing of TEL XI-L position 1::URA3 
cells (AEY4163) carrying the SIR3 overexpression plasmid (pAE1232) or the 
corresponding empty vector (pAE269) was analyzed on YM medium. This strain 
displayed a weak silencing, as indicated by good growth on YM medium lacking 
uracil, which was only slightly reduced by the SIR3 overexpression. When 6 mM 
nicotine was added, telomeric silencing was increased, causing impaired growth on 
this medium (Figure 51). This effect was not due to a general growth inhibition by 
nicotine, because the growth on YM plates containing uracil was not affected by the 
compound (Figure 51). Again, the growth on 5-FOA was improved by adding 6 mM 
nicotine (data not shown).  
Together, these results suggested that the effect of nicotine neither depends on 
the type of the medium nor on the (sub-) telomeric position or the nature of the 
reporter gene. 
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Figure 51 Nicotine enhanced telmeric silencing independently of 5-FOA 
The strain TEL XI-L position 1::URA3 (AEY4163) carries an URA3 reporter gene at a subtelomeric 
region. Six-fold serial dilution of these cells transformed with either a SIR3 overexpression plasmid 
(pAE1232) or the corresponding empty vector (pAE269) were spotted on YM plates with and without 
uracil, each with and without 6 mM nicotine, to determine telomeric silencing. The plates were 
subsequently incubated at 30 °C for two days. 
 
3.2.4.3 Nicotine increased HM silencing in vivo, and its effect did not depend 
on Rap1 
So far, only telomeric silencing was analyzed for an effect by nicotine. However, it is 
known that there are several components of the telomeric silencing machinery that 
also take part in HM silencing (see 1.10). Nevertheless, there are also some 
differences between these two types of silencing in S. cerevisiae. To obtain insight 
into the way nicotine might act and to limit the number of its potential targets, the 
effect of this compound on HM silencing was investigated. A spot filter assay using 
the yeast strains MATa his4 (AEY264) and MATα HMRa-e** (AEY403) to test the 
impact of nicotine on HM silencing resulted in the same effects like in the telomeric 
spot filter assay (see 3.2.4.2). Increased growth could be observed around the filters 
with 0.5 µl and 1 µl undiluted nicotine, while higher volumes inhibited growth in a 
concentration-dependent manner (data not shown). In another approach, 
hmr-ss::URA3 (AEY4185) cells were not able to grow on 5-FOA under normal 
conditions, but the strain showed maximal growth when 6 mM nicotine was added to 
the medium (Figure 52A), indicating that HM silencing was improved by nicotine. 
These results were confirmed using a yeast strain that carries an ADE2 marker gene 
at the HMR locus (AEY1676), which was only slightly repressed under normal 
conditions (Figure 52B). Notably, HMR::ADE2 silencing was increased by the 
addition of 6 mM nicotine, causing reduced growth on YM medium lacking adenine. 
Again, it could be excluded that this effect was due to a general growth inhibition by 
nicotine, because the growth on YM containing adenine was not affected by this 
compound (Figure 52B). These results are comparable to those observed for 
hmr-URADE2-E cells (AEY743), which harbour an ADE2 marker gene under the 
control of an URA3 promoter at the HMR locus. In this strain, ADE2 is relatively 
strongly repressed, and the silencing was enhanced by nicotine (Figure 52B). The 
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effect of nicotine did not depend on the marker gene, because the growth of a strain 
with wild-type ADE2 (AEY3) was not affected (Figure 52B).  
 
 
Figure 52 Nicotine increased HM silencing in vivo 
(A) HM silencing of a strain that carries a synthetic silencer marked with an URA3 gene at the HMR 
locus (AEY4185) was tested by spotting a six-fold serial dilution of the cells on the indicated plates. 
Growth on the counter-selective 5-FOA medium with and without 6 mM nicotine was used to 
determine the repression of URA3. The strain TEL IX-L position 7::URA3 (AEY4168) served as 
positive control.  
(B) In second approach, wild-type (AEY3) cells as well as a strain harbouring an ADE2 gene at the 
HMR locus (AEY1676) were used. A third strain carries an ADE2 marker gene under the control of an 
URA3 promoter at the HMR locus (AEY743). The effect of 6 mM nicotine on the HM silencing of these 
three strains was analyzed by determining their ability to grow an YM plates with and without adenine. 
All plates were incubated at 30 °C for two days. 
 
One of the components involved in telomeric and HM silencing is Rap1. This DNA-
binding protein recruits Sir4, resulting in the binding of the SIR complex and 
subsequently to spreading of silencing (Rusche et al., 2003). The observation that 
nicotine increased both telomeric and HM silencing suggested that Rap1 could be 
the target of this compound. This hypothesis was tested in the next step. The yeast 
strain TEL VII-L::ADE2::URA3 (AEY3595) showed weak telomeric silencing, but 
mutation of RAP1 enhanced silencing. The addition of 6 mM nicotine led to an 
increase in telomeric silencing in both strains as indicated by reduced growth on 
medium lacking uracil and an improved growth on 5-FOA (Figure 53A). Notably, 
nicotine did not cause a significant change of the cell colour on full medium (data not 
shown), although repression of the ADE2 marker gene should result in red coloured 
cells. This was possibly due to the type of the medium. To determine whether the 
enhancement of HM silencing by nicotine was also Rap1-independent, hmr::TRP1 
rap1-12 cells (AEY567) were used. Since this strain carries a TRP1 marker gene at 
the HMR locus, it also offered an additional possibility to test whether the potential 
effect of the compound did not depend on the nature of the marker gene. Due to the 
mutation of RAP1, there was almost no repression of the TRP1 gene indicated by 
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maximum growth on YM medium lacking tryptophan and only minimal growth on 
plates containing 5-fluoroanthranilic acid (5-FAA), which is used for counter-selection 
of the tryptophan pathway (Figure 53B). However, the cells were able to grow on 
5-FAA when 6 mM nicotine was added. On the other hand, the cell growth was 
reduced on YM medium lacking tryptophan. In general, these results are comparable 
to those of the corresponding wild-type (AEY581). These cells displayed a strong 
repression of the TRP1 marker gene that was improved by the addition of nicotine 
(Figure 53B), indicating that Rap1 was not required for the enhancement of the HM 
silencing. In summary, the results indicated that nicotine increased not only telomeric 
but also HM silencing in vivo, and that this effect was independent of Rap1. 
 
 
Figure 53 The effect of nicotine was independent of Rap1 
(A) Telomeric silencing of a rap1-12 strain (AEY3590) and its corresponding wild-type (AEY3595), 
each carrying an ADE2 and URA3 marker gene at TEL VII-L, was analyzed. Their ability to grow on 
YM medium lacking uracil and on URA3-counter-selective 5-FOA medium, each with and without 
6 mM nicotine, was used to determine the strength of URA3 repression. A six-fold serial dilution of the 
cells was spotted on the indicated plates and subsequently incubated at 30 °C for two days. 
(B) In general, the same method like in (A) was used to determine the HM silencing of another rap1-12 
strain (AEY567) and its corresponding wild-type (AEY581), each harbouring a TRP1 marker gene at 
the HMR locus. In this case, plates containing 5-FAA were used for counter-selection of TRP1 
expression. 
 
3.2.4.4 Nicotine increased rDNA silencing in vivo 
In S. cerevisiae, there are four sirtuins (Sir1 - 4). While Sir1 plays only a role in HM 
silencing, Sir2 - 4 are also involved in the formation of heterochromatin at the 
telomeres. Furthermore, the HDAC Sir2 is important for rDNA silencing. After 
excluding Rap1 as a potential target of nicotine (see 3.2.4.3), Sir2 - 4 were the next 
logical candidates to be analyzed. The potential target could be limited to Sir3 and 
Sir4, if only telomeric and HM silencing, but not rDNA silencing were altered. On the 
other hand, enhancement of all three types of silencing would point to Sir2 as the 
target of nicotine. For this reason, the effect of nicotine on rDNA silencing was tested 
using the yeast strain RDN::Ty::MET15 (AEY160). These cells carry an MET15 
marker gene at the RDN1 locus, which encodes the ribosomal DNA in S. cerevisiae. 
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Increased repression of MET15 should change the colour of the cells from white to 
brown on lead indicator medium (Cost & Boeke, 1996), as it was already shown for 
sas2Δ cells (Meijsing & Ehrenhofer-Murray, 2001). Therefore, the strain was streaked 
on this medium with and without 6 mM nicotine using RDN::Ty::MET15 sas2Δ::TRP1 
cells (AEY1195) as positive control. However, there was no significant difference 
between the two strains or between the lead indicator plates with and without 
nicotine. All cells displayed a weak brown colour (data not shown). This was 
unexpected, because the “wild-type” cells should at least exhibit a white colour on the 
plate without the compound. Based on this result, the impact of nicotine on rDNA 
silencing could not be assessed. Therefore, two yeast strains carrying an URA3 
marker gene at the RDN1 locus were used in a second approach. The growth of 
RDN1::ty1-mURA3 (S2) (AEY1778) and RDN1::ty1-mURA3 (S6) (AEY1779) cells on 
5-FOA plates was equally good on medium lacking uracil indicating weak rDNA 
silencing (Figure 54, data not shown). The addition of 6 mM nicotine reduced the cell 
growth on both media, suggesting that the yeast strains were sensitive for this 
compound in general. However, in comparison to YM medium the growth was less 
reduced on 5-FOA indicating that the rDNA silencing may be increased by adding 
nicotine.  
 
 
Figure 54 Nicotine increased rDNA silencing in vivo 
rDNA silencing of the yeast strain RDN1::ty1-mURA3 (S6) (AEY1779) was analyzed as the ability to 
grow on YM medium and on URA3-counter-selective 5-FOA medium each with and without 6 mM 
nicotine. A six-fold serial dilution of the cells was spotted on the indicated plates and subsequently 
incubated at 30 °C for two days.  
 
3.2.4.5 Nicotine activated Sir2 at low concentrations in vitro and enhanced the 
loss of the marker gene in the absence of Sir2 and Sir3 in vivo 
The previous experiments suggested that nicotine increased telomeric, HM, and 
rDNA silencing. The only factor that is known to take part in all three types of 
silencing in S. cerevisiae is the NAD+-dependent HDAC Sir2. For this reason, Sir2 
was evaluated as a target of nicotine. To test this hypothesis, a fluorescence-based 
in vitro HDAC assay was performed by Gesine Hoffmann using 6xHIS-tagged yeast 
Sir2 protein purified from E. coli and different concentrations of nicotine. Based on 
the observation that the Sir2 inhibitor splitomicin reduced telomeric silencing, nicotine 
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was suggested to activate Sir2. Indeed, final concentrations of 2.5 nM up to 0.5 µM 
led to a weak activation of Sir2 HDAC activity in vitro, while higher concentrations 
resulted in inhibition (Figure 55). However, these concentrations are much lower than 
those in the in vivo assays, calling into question whether the in vivo effects were truly 
reflected in this in vitro assay. Furthermore, the scientific literature is controversial 
concerning the in vitro stimulation of sirtuins (Beher et al., 2009; Haigis & Sinclair, 
2010). Therefore, this result must be interpreted with caution. Nevertheless, it is 
possible that only low amounts of the high concentration used in the in vivo 
experiments enter the cell. 
 
 
Figure 55 Low concentrations of nicotine activated Sir2 in vitro 
Sir2 deacetylase activity was measured by Gesine Hoffmann using a fluorescence-based assay. In 
two consecutive reactions, deacetylation of the substrate MAL generates a fluorophore that is excited 
at 360 nm and light at 460 nm was emitted. The blank (DMSO) was defined as 100 %. 
 
If nicotine truly increases silencing, then its effect is expected to be abrogated by 
the deletion of SIR components. Therefore, telomeric silencing of TEL 
VII-L::gal4-URA3 cells (AEY3909) with deletions of SIR2 (AEY4017) or SIR3 
(AEY4019) was investigated. Notably, Sir2 - 4 are essential for silencing, because 
formation of heterochromatin at the HM loci and at the telomeres requires the activity 
of the SIR complex (Rusche et al., 2003). Accordingly, the analyzed sir2Δ and sir3Δ 
cells were not able to grow on 5-FOA, indicating a complete loss of telomeric 
silencing (Figure 56A). However, they showed maximal growth on 5-FOA when 6 mM 
nicotine was added. This was unexpected, because there was no Sir2 protein that 
could be activated by nicotine and therefore no telomeric silencing that could be 
improved. However, the same result was observed for a sir1Δ sir3Δ double mutant 
(AEY1018) that harbours a subtelomeric URA3 marker gene (Figure 56B). In order to 
exclude the possibility that these effects depend on the URA3 marker or the counter-
selective 5-FOA medium, SIR2 was deleted in TEL IX-L position 7::LYS2 cells 
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(AEY4580). As expected, the sir2Δ cells (AEY4583) failed to grow on LYS2-counter-
selective αAA medium (Figure 56C). Again, maximal growth was achieved by adding 
6 mM nicotine, indicating that this was an effect independent of silencing. Notably, 
the theory that nicotine did not affect (telomeric) silencing, but only improved growth 
on counter-selective medium by inhibiting the intake of 5-FOA or αAA had seemingly 
disproved earlier, because it was shown that nicotine enhanced telomeric silencing 
independently of 5-FOA (see 3.2.4.2). 
 
 
Figure 56 Nicotine improved growth on counter-selective medium even in the absence of Sir2 
or Sir3 
(A) Serial dilutions of sir2Δ (AEY4017) and sir3Δ (AEY4019) cells as well as of the corresponding wild-
type (AEY3909) were spotted on 5-FOA plates with and without 6 mM nicotine to measure the 
repression of the (sub-) telomeric URA3 marker gene. 
(B) Telomeric silencing of sir1Δ sir3Δ double mutants (AEY1018) and the corresponding wild-type 
strain (AEY1017) was analyzed like described in (A). 
(C) TEL IX-L position 7::LYS2 sir2Δ (AEY4583) cells were serially diluted and spotted on LYS2-
counter-selective αAA plates with and without 6 mM nicotine to determine telomeric silencing. 
All plates were incubated at 30 °C for two days. 
 
Another possible explanation for the results shown in Figure 56 could be the loss 
of the URA3/LYS2 marker gene/s upon nicotine treatment, which would lead to 
increased resistance against the counter-selective medium. To test this hypothesis, 
yeast strains shown in Figure 51 and Figure 56A were taken from 5-FOA plates 
containing 6 mM nicotine and were re-streaked on full medium and medium lacking 
uracil. The TEL VII-L::gal4-URA3 strain (AEY3909) was able to grow on both media. 
5-FOA-resistant sir3Δ derivates could only grow on full medium, but not on medium 
lacking uracil (Figure 57A), suggesting that they had lost their URA3 marker gene. 
The TEL XI-L position 1::URA3 (AEY4163) cells grew on both media, although 
growth on medium lacking uracil was slightly reduced (Figure 57B). As these results 
are in agreement to those shown in Figure 51, this indicated that the addition of 
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nicotine to counter-selective medium did not generally cause a loss of the marker 
gene, but only in the absence of Sir2 or Sir3. Since the formation of (sub-) telomeric 
heterochromatin by the SIR complex shields the chromosome ends for instance from 
homologous recombination (Smogorzewska & de Lange, 2004), nicotine might 
increase homologous recombination in the absence of Sir2 and Sir3, thereby leading 
to the loss of the marker gene. 
 
 
Figure 57 Nicotine enhanced the loss of marker genes in the absence of Sir2 or Sir3 
(A) The potential loss of the URA3 marker gene of the yeast strains shown in Figure 56A was 
analyzed by taking these cells from 5-FOA plates containing 6 mM nicotine and streaking them out on 
full medium and on YM medium lacking uracil. 
(B) Yeast strains shown in Figure 51 were taken from 5-FOA plates containing 6 mM nicotine and 
streaked out on YM medium with and without uracil. 
All plates were incubated at 30 °C for two days. 
 
3.2.4.6 Nicotine-mediated extension of CLS was Sir2-dependent 
As described previously, nicotine was not only found to increase telomeric silencing, 
but it was also a secondary candidate in the screen for compounds extending the 
CLS of S. pombe (see 3.1.2.1). Based on the observation that low concentrations of 
nicotine activated S. cerevisiae Sir2, while higher concentrations inhibited the 
enzyme in vitro (Figure 55), it was obvious to test whether there is a relationship 
between Sir2 activity and CLS. Sir2 is the S. pombe homolog that is most closely 
related to the S. cerevisiae Sir2 (Shankaranarayana et al., 2003). As in budding 
yeast, it is reported to be a NAD+-dependent HDAC that targets H3K9ac and 
H4K16ac in vitro. It is required for silencing at the heterochromatic regions and for 
the association of Swi6 with these loci in vivo (Freeman-Cook et al., 2005; 
Shankaranarayana et al., 2003), Interestingly, sir2Δ S. pombe cells treated with 
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DMSO displayed a reduced CLS compared to wild-type cells (AEP57) in our 
experiment (Figure 58). The addition of 6 mM nicotine increased the lifespan of wild-
type cells but had no effect on the lifespan of sir2Δ cells (Figure 58), indicating that 
the observed lifespan extension by nicotine might be due to an activation of Sir2.  
 
 
Figure 58 The reduced CLS of sir2Δ  cells was not extended by the addition of nicotine 
S. pombe wild-type (AEP57) and sir2Δ cells were grown in YM medium containing 3 % glucose and 
6 mM nicotine, each in five adjacent wells of a 96 well microplate. Cells treated with DMSO served as 
control. At the indicated time points, the aging cultures were spotted onto YES plates that were 
subsequently incubated for two days at 30 °C. 
 
As a consequence, this led to the question how increased Sir2 activity caused 
improved CLS. So far, the best-known way of Sir2 to promote longevity is by 
influencing rDNA recombination and thus ERC formation (Kaeberlein et al., 1999; 
Steinkraus et al., 2008) (see 1.7). Additionally, the carbonylation of proteins 
increases with age, and the asymmetric distribution of these oxidatively damaged 
proteins that are accumulated in the mother cell is Sir2-dependent and associated 
with accelerated aging in S. cerevisiae (Erjavec et al., 2007). Nevertheless, this only 
affects RLS but not CLS. Furthermore, the age-related accumulation of excised rDNA 
circles has not been detected in organisms other than budding yeast. In general, it 
seemed as if Sir2 of S. pombe functions differently of that from S. cerevisiae because 
the deletion of sir2+ shortened the CLS of fission yeast (Mutoh & Kitajima, 2007) 
(Figure 58), while Sir2 mutation does not reduce the CLS of budding yeast but even 
extends the lifespan of sch9Δ cells (Fabrizio et al., 2005). In addition, it has been 
reported that Sir2 deficiency does not affect the cellular oxidation state of S. pombe 
as measured by the amount of carbonylated proteins during exponential growth and 
in stationary phase (Mutoh & Kitajima, 2007). Therefore, one remaining possible 
explanation for lifespan extension by increased Sir2 activity is improved (telomeric) 
silencing. 
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4 Discussion 
The aim of this study was to gain new insights into the molecular mechanisms of the 
aging process by the identification of compounds and gene deletions that extend the 
CLS of S. pombe as well as of compounds that alter telomeric silencing in 
S. cerevisiae. To this end, novel high-throughput methods for the measurement of 
the CLS of fission yeast and the telomeric silencing in budding yeast were 
established. The former assay was used to screen a small compound library as well 
as a S. pombe deletion library. We obtained 20 compounds that extended lifespan, of 
which eight compounds were further analyzed to identify their potential molecular 
target/s. In the case of the deletion library, we found that it was an unknown factor in 
the strain background rather than the indicated gene deletions that affected lifespan. 
In the second approach, we identified nicotine to affect the telomeric silencing in 
S. cerevisiae. Further analyses showed that this compound also increased HM and 
rDNA silencing. Moreover, it was also identified to extend the CLS of S. pombe, and 
in vitro as well as in vivo experiments suggested that its effect on silencing and CLS 
is likely to be due to an activation of Sir2. 
 
4.1 Anti-oxidative properties of DIM and mangosteen as the cause 
of their lifespan-extending effect 
Two compounds that were identified in our screen to extend the CLS of S. pombe 
wild-type cells are 3,3’-diindolylmethane (DIM) and mangosteen (3.1.2.1). 
DIM is the major acid condensation product of indole-3-carbinol, which is found in 
Brassica vegetables, like broccoli and cauliflower. The supposed healthy effects of 
these vegetables are attributed at least in part to the activity of DIM. Several studies 
were performed to analyze its effects, and various potential targets have been 
identified. In one of these studies, estrogenic as well as anti-androgenic properties of 
DIM were discovered (Bovee et al., 2008). In addition, DIM was found to display an 
anti-inflammatory action by up-regulating the expression of interferon gamma (IFNγ) 
and IFNγ receptor (Riby et al., 2006; Xue et al., 2005) or reducing NF-κB signalling 
and/or AP-1 signalling (Cho et al., 2008; Kim et al., 2010; Kim et al., 2009). 
Furthermore, DIM was shown to inhibit the hypoxia inducible factor 1α (HIF-1α) (Riby 
et al., 2008). Notably, the HIF signalling cascade mediates the effects of hypoxia, the 
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state of low oxygen concentration, on the cell. Hypoxia promotes the formation of 
blood vessels and is important for the formation of a vascular system, for instance in 
cancer tumours. Therefore, DIM displays not only anti-angiogenesis but also anti-
cancer activity. The latter is supported by the finding that DIM induces apoptosis in 
human cancer cells (Ge et al., 1996) and that IFNγ signalling, which is up-regulated 
by DIM, contributes to the inhibition of primary and transplanted tumour development 
(Nastala et al., 1994; Street et al., 2001). Therefore, DIM represents a promising anti-
tumour agent. Notably, HIF-1α, estrogenic/anti-androgenic activity as well as the 
inhibition of inflammatory pathways (NF-κB, AP-1) have already been linked to a 
delay of aging (Leiser & Kaeberlein, 2010; Rodier & Campisi, 2011; Vina et al., 
2008). Importantly, no direct homologs of these proteins have been described in 
yeast so far, indicating that a different mechanism is involved in the observed DIM-
mediated extension of S. pombe CLS. 
However, DIM has been reported to increase the production of ROS (Xue et al., 
2008) but also to protect against oxidative stress (Fan et al., 2009). This seemed to 
be a contradiction, but both statements were in line with our results (3.1.2.2). One 
possible explanation could be that proteins involved in the oxidative stress response 
were expressed and/or activated as a result of a DIM-mediated formation of ROS, 
thereby leading to enhanced stress resistance and extended lifespan. This 
hypothesis was supported by our observation that cells treated with DIM displayed 
considerably increased ROS levels during exponential growth that were 
subsequently reduced in stationary phase (3.1.2.2). Furthermore, the increased ROS 
level seemed to be the cause at least of the slightly enlarged vacuoles of DIM-treated 
cells and possibly also of the fragmented acidic compartments (3.1.2.4.2), although 
the latter needs to be further investigated. Since increased stress resistance is also a 
result of CR, it was also possible that DIM promotes longevity in fission yeast by 
affecting the nutrient sensing pathways. This hypothesis was supported by the 
finding that DIM inhibits both mTOR and Akt in a prostate cancer cell line (Kong et 
al., 2008). However, the lifespan of wild-type cells treated with rapamycin as well as 
of pka1Δ and sck2Δ cells was further extended by the addition of DIM in our 
experiments (3.1.2.3), indicating that it does not act through the inhibition one of the 
two known nutrient sensing pathways. 
Mangosteen is not a single compound, but a compound mixture extracted from the 
exocarp the mangosteen fruit (Garcinia mangostana). According to present 
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knowledge, the mangosteen fruit contains the highest amount of naturally occurring 
xanthones. This type of flavonoids are broad-spectrum antioxidants that have been 
reported to be even more anti-oxidative than vitamin E, which in turn is one of the 
most effective antioxidants known so far (Yoshikawa et al., 1994). Since various 
parts of the mangsteen fruit were used in the folk medicine, mostly in Southeast Asia 
(Obolskiy et al., 2009), several studies were performed to analyze the containing 
xanthones in mangosteen. Several beneficial effects were reported: anti-
inflammatory (Gopalakrishnan et al., 1980), antimicrobial (Chen et al., 1996; 
Sundaram et al., 1983), antifungal (Jinsart et al., 1992), antiviral (Chen et al., 1996), 
anti-tumour (Peres et al., 2000), and anti-allergic properties (Marona et al., 2001). In 
our study, the four xanthones that are supposed to be the main constituents of the 
mangosteen fruit, namely α-mangostin, β-mangostin, gartanin, and 8-desoxygartanin 
did not alter the CLS of S. pombe wild-type cells (data not shown). Therefore, it could 
be assumed that it is probably the interplay of the single compounds or another 
unidentified component that leads to lifespan-extension. The results of mangosteen-
treated cells concerning ROS levels, oxidative stress response, and nutrient sensing 
pathways were similar to those of DIM-treated cells (see above). As a consequence, 
the same conclusions could be drawn, namely that the anti-oxidative properties of 
mangosteen are the most likely explanation for the CLS-extending effect of this 
compound mixture.  
 
4.2 Inhibition of Git3/PKA signalling and mitochondrial fission as a 
cause of PGJ2-mediated CLS-extension 
Prostaglandins are tissue hormones that are derived enzymatically from fatty acids 
and exert their effects by autocrine and paracrine mechanisms (Lupulescu, 1996). 
Importantly, prostaglandins are not produced by yeast cells, but in humans where 
they have been reported to inhibit G-protein coupled receptors (Narumiya et al., 
1999). Notably, the glucose receptor Git3, which is part of the nutrient sensing 
pathways in S. pombe, is such a transmembrane receptor. In our assay, PGJ2 failed 
to extend the CLS of git3Δ cells while it increased the lifespan of wild-type cells as 
well as of all other tested strains carrying deletions of G-protein coupled receptors 
(3.1.2.1, 3.1.2.4.1). In combination with the observation that the CLS of pka1Δ was 
also not extended by PGJ2 (3.1.2.3), this led to the suggestion that PGJ2 promotes 
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longevity by inhibiting Git3. This hypothesis was confirmed by the enhanced 
resistance of PGJ2-treated cells against oxidative stress (3.1.2.2), as a disruption of 
the Git3/PKA signalling pathway has been described to result in increased stress 
resistance (Roux et al., 2006).  
Importantly, PGJ2 was the only tested prostaglandin that extended CLS in our 
assay (3.1.2.4.1), indicating that it might differ from the other prostaglandins, as it 
was already stated for its derivative 15d-PGJ2 (Scher & Pillinger, 2005). 15d-PGJ2 
has been shown to inhibit NF-κB signalling (Scher & Pillinger, 2005) like DIM and 
mangosteen (4.1). Although the inhibition of inflammatory pathways, such as NF-κB, 
has already been associated with a delay of aging (Rodier & Campisi, 2011), this is 
probably not the reason for the life-extending effect of PGJ2, as there are no such 
inflammatory pathways known in fission yeast.  
Furthermore, 15d-PGJ2 has been shown to induce mitochondrial elongation 
(Mishra et al., 2010). Mitochondria are dynamic organelles that constantly fuse and 
divide. These processes are important for mitochondrial inheritance and for the 
maintenance of mitochondrial functions. The core components of the fusion and 
fission machineries are evolutionarily conserved. In mammals, the key molecules for 
mitochondrial fission are Fis1 and Drp1 (Scorrano, 2007). The reciprocal process, 
mitochondrial fusion, is controlled in mammalian cells by Mitofusin (Mfn) 1/2 and 
OPA1 (Scorrano, 2007), However, the functional mechanism by which these proteins 
cooperate to induce mitochondrial fission and fusion remains unidentified. The 
induction of mitochondrial fusion by 15d-PGJ2 was a result of the inhibition of 
mitochondrial fission by modifying Drp1 (Mishra et al., 2010). The homologs of Drp1 
and OPA1 in fission yeast are called Dnm1 and Msp1. Notably, PGJ2 increased the 
lifespan of msp1Δ cells comparable to wild-type cells, but failed to extend the CLS of 
dnm1Δ cells in our assay (3.1.2.4.1). This result indicated that Dnm1 is probably 
affected by PGJ2, but since dnm1Δ cells displayed a normal CLS (3.1.2.4.1), this 
might be not the primary cause for the life-extending effect of PGJ2. Nevertheless, 
this result was in line with a previous observation that the single deletion of the Dnm1 
homolog DRP-1 in C. elegans did not affect lifespan (Yang et al., 2011). However, 
loss of DRP-1 enhances the longevity phenotype of worms carrying mutations of the 
insulin/IGF-like signalling pathway (age-1Δ, daf-2Δ) in a DAF-16-dependent manner 
(Yang et al., 2011). Notably, it has been previously suggested that cells harbouring 
elongated mitochondria caused by the inhibition of mitochondrial fission show 
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increased ROS levels (Lee et al., 2007). This is in line with our hypothesis that PGJ2 
might inhibit the mitochondrial fission protein Dnm1, as wild-type cells treated with 
this compound displayed an increased ROS level in stationary phase (3.1.2.2).  
In summary, our results confirmed previous suggestions that there is probably a 
relationship between at least one nutrient sensing pathway and mitochondrial 
dynamics and that they cooperate to modulate aging (Yang et al., 2011). 
Furthermore, PGJ2 seemed to extend the CLS of S. pombe by inhibiting these 
processes. 
 
4.3 Monensin and Nigericin might promote longevity by affecting 
the V-ATPase 
In this study, the two antibiotics monensin and nigericin isolated from Streptomyces 
cinnamonensis (Haney & Hoehn, 1967) and Streptomyces hygroscopicus (DeBoer & 
Dietz, 1976), respectively, were identified to extend the CLS of S. pombe wild-type 
cells (3.1.2.1). Both have been shown to inhibit androgen receptor signalling, thereby 
leading to apoptosis in prostate cancer cells (Ketola et al., 2010; Mashima et al., 
2010). Since this type of signalling is not known in fission yeast, this is probably not 
the reason for their life-extending effect in yeast. Both compounds have been 
reported to be Golgi-disturbing agents (Dinter & Berger, 1998). However, this 
property might also not be the cause for the increased lifespan, as the CLS of wild-
type cells was not altered by brefeldin A, another compound that has been found to 
inhibit the Golgi apparatus. Furthermore, monensin has previously been shown to 
increase the generation of intracellular ROS and to induce a transcriptional profile 
characteristic of an oxidative stress response (Ketola et al., 2010). In line with this, 
monensin failed to extend the lifespan of pka1Δ cells (3.1.2.3), indicating that 
monensin might promote longevity through the Git3/PKA signalling pathway. 
However, this could not be confirmed by other experiments, as monensin did not lead 
to an increased stress resistance as reported for pka1Δ cells (Roux et al., 2006), but 
to a slight sensitivity against oxidative stress in our test (3.1.2.2). In addition, the 
ROS level of the cells treated with monensin or nigericin was reduced during 
exponential growth, while it was highly increased in stationary phase (3.1.2.1). 
Another conclusion from the epistasis analyses is that monensin and nigericin 
seemed to affect Sir2 homologs in fission yeast (3.1.2.3), an observation that has to 
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be further investigated. Notably, it was already known that nigericin enhances the 
antifungal activity of rapamycin in an unknown manner (Fang et al., 2000). In line 
with this, we found that nigericin as well as the other seven compounds enhanced 
also the longevity-promoting effect of rapamycin (3.1.2.3), thereby indicating that they 
act parallel to the TOR signalling pathway. 
Monensin is a Na+/H+-exchanger, while nigericin displays a higher affinity for 
potassium cations and acts as K+/H+-antiporter (Liu, 1982). Both compounds are 
polyether ionophores, which disrupt the membrane potential and affect the ionic 
gradient, which in turn is the motive force of many secondary active transports e.g. of 
metabolites. Both compounds did not change the extracellular pH-value (3.1.2.4.2), 
indicating that they do not act on the outer plasma membrane of S. pombe. This has 
already been shown for nigericin in S. cerevisiae (Kovac et al., 1982). Furthermore, 
nigericin has been reported to act selectively on the mitochondrial inner membrane of 
budding yeast (Kovac et al., 1982) and to induce the hydrolysis of ATP in 
mitochondria (Estrada et al., 1967). One enzyme that localizes at the inner 
membrane of mitochondria and is linked to ATP is the F-ATPase, which is also called 
ATP synthase as it primarily uses the proton gradient to synthesize ATP from ADP. 
On the other hand, it can also create a proton gradient using the energy gained from 
the hydrolysis of ATP (Nakanishi-Matsui & Futai, 2008). Therefore, it was possible 
that nigericin (and monensin) affect the F-ATPase activity. Notably, their impact on 
this enzyme could not be assessed, as the deletion of F-ATPase subunits (Tim11, 
Atp14) in strains originating from the S. pombe deletion library could not be verified 
by PCR (data not shown). However, there is a second proton pump, the V-ATPase, 
which is similar in subunit structure and mechanism, but has different physiological 
functions (Nakanishi-Matsui et al., 2010). This ATPase is found in the eukaryotic 
endomembrane system (vacuoles, Golgi apparatus, endosomes, lysosomes, clathrin-
coated vesicles). V-ATPases hydrolyse ATP to drive a proton pump, thereby 
generating a proton gradient, but can not synthesize ATP (Nelson et al., 2000). In 
general, V-ATPases are involved in a variety of cellular processes such as receptor-
mediated endocytosis, protein trafficking, active transport of metabolites, acidification 
of several intracellular organelles and neurotransmitter release. However, monensin 
and nigericin did not inhibit the V-ATPase, as they affected neither endocytosis nor 
the acidification of intracellular compartments compared to cells carrying a deletion of 
V-ATPase subunits (Vma1/3) (3.1.2.4.2). However, the deletion of vma1+ or vma3+ 
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led to a shortened lifespan (3.1.2.4.2). Furthermore, monensin and nigericin did not 
extend the CLS of these cells (3.1.2.4.2), suggesting that these compounds might 
promote longevity by activating the V-ATPase. One possible explanation could be as 
follows: The V-ATPase pumps protons into the lumen of e.g. acidic compartments 
(Figure 59 left). Based on diffusion, the ionophores monensin and nigericin transport 
protons into the cytoplasm (Figure 59 right). Thereby, they reduce the proton gradient 
generated by the V-ATPase and provide increased amounts of cytoplasmic protons 
that in turn could be actively transported across the intracellular membrane by the 
V-ATPase again. 
 
 
Figure 59 Simplified scheme of the potential interaction of monensin/nigericin and the 
V-ATPase 
The V-ATPase (green/blue) transports protons across the membrane (brown) into the lumen of e.g. 
acidic compartments in an ATP-dependent manner, thereby generating a proton gradient. Based on 
diffusion the ionophores monensin and nigericin (red) tranport protons back into the cytoplasm and in 
return sodium or potassium are transported into the lumen. Thus, the proton gradient is reduced and 
increased amounts of protons are available in the cytoplasm, which in turn could be actively 
transported by the V-ATPase again. 
 
4.4 Tschimganine might increase CLS through altering a novel 
pathway 
Tschimganine, which is also called tschimganin or chimganin, was identified to 
increase the CLS of S. pombe wild-type cells (3.1.2.1). It was first isolated from the 
roots of Ferula tschimganica, a plant of the Umbelliferae family that is native to 
Central Asia (Kadyrov et al., 1972). Except for an estrogenic activity (Nazrullaev et 
al., 2008), little is known about this compound. Tschimgine and tschimganidine are 
two compounds isolated from plants of the genus Ferula whose chemical structure is 
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similar to tschimganine (Figure 60), and both have been shown to display estrogenic 
activity (Ikeda et al., 2002; Nazrullaev et al., 2008). Importantly, neither 
tschimganidine nor tschimgin affected CLS in our assay (data not shown), indicating 
that the structural differences between tschimganine and tschimganidine/tschimgine 
play a role in their ability to affect lifespan. Another designation of tschimganine is 
bornyl vanillate, since it consists of vanillate and a bornyl group (Trusheva et al., 
2010) (Figure 60A). In comparison, tschimgine lacks the methoxy group of the 
vanillate (Figure 60B), thereby forming p-hydroxybenzoate, which displays an 
increased pro-oxidative function compared to vanillate (Simic et al., 2007). Since 
tschimgine did not increase CLS (data not shown), this indicates that the methoxy 
group is required for lifespan extension. However, tschimganidine contains this 
methoxy group (Figure 60C), but did not extend CLS (data not shown), suggesting 
that the bornyl group might also play a role in the longevity-promoting effect of 
tschimganine. Notably, the hydrophobic bornyl group of tschimganine might be 
required for entering the cells, as the hydrophobic effect is important for crossing the 
lipid bilayer of cell membranes. Since tschimganidine exhibits a more complex 
structure instead of the bornyl group (Figure 60C), one possible explanation for its 
missing effect on CLS could be that tschimganidine enters the cell to a lesser extent. 
Therefore, it could be useful to test higher concentrations of this compound.  
 
 
Figure 60 Chemical structures of tschimganine, tschimgine, and tschimganidine 
The chemical structures were created by using the software MarvinSketch. 
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Interestingly, higher levels of estrogens in females have been shown to protect 
them against aging by up-regulating the expression of anti-oxidative, longevity-
related genes and in turn lower ROS levels (Vina et al., 2008). In line with this, 
tschimganine-treated cells displayed reduced ROS levels during exponential growth 
as well as in stationary phase (3.1.2.2). However, no direct homologs of estrogen 
receptors have been described for fission yeast, indicating that it is probably not an 
estrogenic effect that leads to lifespan extension of tschimganine. Furthermore, this 
compound increased the resistance against heat and DNA damage, while the 
resistance against oxidative stress was slightly decreased (3.1.2.2). As tschimganine 
seemed to extend lifespan parallel to the known nutrient sensing pathways and also 
independently of the sirtuins Sir2 and Hst2 (3.1.2.3), it might act through a novel 
pathway. 
 
4.5 Inhibition of the de novo purine biosynthesis is not the cause 
for CLS extension by mycophenolic acid (MPA) and acivicin 
Mycophenolic acid (MPA), a product of several Penicillium species (Frisvad et al., 
2004) that was initially discovered as an antibiotic against Bacillus anthracis (Bentley, 
2000) is one of the compounds identified to extend the CLS of S. pombe wild-type 
cells in our screen (3.1.2.1). It has been reported to possess antiviral (Borroto-Esoda 
et al., 2004; Diamond et al., 2002), antifungal (Nicoletti et al., 2004), antibacterial 
(Kavanagh, 1947; Torrenegra et al., 2005), antitumor (Tressler et al., 1994; Tsuchiya 
et al., 2010), and antipsoriasis (Epinette et al., 1987) activities. Most importantly, 
MPA is a potent and reversible, non-competitive inhibitor of IMP dehydrogenase 
(IMPDH) (Nakamura et al., 1995), the enzyme that controls the rate of GMP in the de 
novo pathway of purine synthesis (Ransom, 1995) (Figure 61). Notably, B- and T-
cells rely entirely on the IMPDH dependent de novo pathway for purine biosynthesis, 
while most other cell types express the IMPDH-independent salvage pathway, which 
allows purine production despite inhibition of IMPDH by MPA. Therefore, MPA is an 
immunsuppresive drug used to prevent organ rejection (Morris et al., 1990), which is 
marketed under the brands CellCept (mycophenolate mofetil; Roche) and Myfortic 
(mycophenolate sodium; Novartis). 
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Figure 61 Inhibition of de novo GMP biosynthesis by MPA, 6-AU, and acivicin 
In the pathway of de novo guanosine monophosphate (GMP) biosynthesis, inosine monophosphate 
(IMP), the basis of adenosine monophosphate (AMP) and GMP, is converted to xanthosine 
monophosphate (XMP) by the IMP dehydrogenase (IMPDH), which is inhibited by mycophenolic acid 
(MPA) and 6-azauracil (6-AU). In the next step, GMP is generated from XMP by the GMP synthetase, 
which is inhibited by acivicin.  
 
Interestingly, there is a second compound identified to extend the CLS of 
S. pombe wild-type cells that also affects the de novo pathway for GMP biosynthesis. 
Acivicin was isolated from the actinobacterium Streptomyces sviceus (Martin et al., 
1973) and was first studied as an anti-cancer agent that inhibits various glutamine 
amidotransferases (Tso et al., 1980). However, acivicin is a glutamine analog that 
selectively and irreversibly abolishes the glutaminase activity of the GMP synthetase 
by a covalent modification (Nakamura et al., 1995). Notably, there are only two 
enzymes involved in converting IMP to GMP, namely IMPDH, which catalyzes the 
oxidation of IMP to XMP and is inhibited by MPA, and the GMP synthetase, which 
catalyzes the amination of XMP to GMP and is inhibited by acivicin (Figure 61). Since 
6-AU, another inhibitor of the IMPDH did not promote longevity (3.1.2.4.3), it is likely 
that the lifespan extension by MPA and acivicin is not due to an inhibition of the de 
novo purine biosynthesis. This was confirmed by an additional experiment using 
glutamine. Glutamine is required for the conversion of XMP to GMP by the GMP 
synthetase (Figure 61). Therefore, increased amounts of glutamine enhance purine 
synthesis. As this is the opposite effect of MPA and acivicin, it would be expected to 
reduce lifespan. Contrary to this notion, it led to an extension, which was even further 
extended by the addition of MPA and acivicin (3.1.2.4.3). This was not only contrary 
to our expectation, but also to previous studies that reported that reduced cellular 
glutamine levels increases both CLS and RLS of S. cerevisiae (Kaeberlein et al., 
2005b; Powers et al., 2006).  
In general, there is an additional way to produce purines besides the de novo 
biosynthesis. This so-called salvage pathway uses free guanine as a starting 
substrate to form GMP. However, as the addition of guanine did not affect the CLS 
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neither of the control nor the MPA- and acivicin-treated cells (3.1.2.4.3), it is probably 
not the GMP level that causes the lifespan extension by MPA and acivicin. 
Apart from its impact on the GMP synthetase, acivicin is also a specific and the 
most active inhibitor of γ-glutamyl transpeptidase (Allen et al., 1980), which is of 
central importance in the metabolism of glutathione (GSH), a pseudotripeptide 
consisting of glutamate, cysteine, and glycine (Tate, 1980). In this way, this 
compound inhibits the transmembrane GSH transport (Griffith & Meister, 1980) and 
thereby the release of the “bound” amino acids into the cytoplasm (Mehdi et al., 
2001). Therefore, acivicin might increase lifespan by depleting the level of these 
amino acids and thus exerting some degree of CR. In this context, it is notable that 
MPA has been shown to reduce Akt/mTOR signalling (He et al., 2011), indicating that 
it might also extend CLS by affecting nutrient signalling. In line with this, MPA and 
acivicin enhanced the resistance against oxidative stress (3.1.2.2) although the ROS 
level in exponential and stationary phase was increased by treatment with these 
compounds (3.1.2.2). However, MPA as well as acivicin delayed the growth of pka1Δ 
cells (3.1.2.3). As these cells already displayed a slowed growth, this result 
suggested that MPA and acivicin might act parallel to the Git3/PKA signalling 
pathway. Both compounds seemed to increase lifespan independently of the TOR 
signalling pathway, since CLS of sck2Δ cells and of rapamycin-treated wild-type cells 
was further increased by MPA and acivicin (3.1.2.3). The latter compounds also 
delayed the growth of sir2Δ and hst2Δ cells, indicating that it might additionally act 
parallel to these sirtuins. 
In summary, our results suggest that MPA and acivicin might not extend CLS by 
decreasing GMP levels. Nevertheless, they might lead to some kind of CR without 
affecting the known nutrient sensing pathways. Furthermore, acivicin seemed to act 
parallel to the sirtuins Sir2 and Hst2. The exact mechanisms of CLS extension by 
these compounds remained unclear. 
 
4.6 An unknown factor altered the CLS of strains originating from 
the S. pombe deletion library 
In this study, we established a novel high-throughput screen to measure the CLS of 
many S. pombe strains in parallel (3.1.1). Since this assay recapitulated lifespan 
analyses using the traditional CFU method (3.1.1), we used this new assay to screen 
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the S. pombe deletion library (Bioneer) for gene deletions that extend lifespan. After 
the primary screen and validation, we found several deletion strains that displayed an 
increased CLS compared to the control wild-type cells (3.1.3.1). Among these 
candidates, there were also 13 deletions in genes altering nutrient uptake and 
sensing. Notably, only lysine and arginine biosynthetic genes were affected (3.1.3.1). 
This implies that these strains of the deletion library, which are auxotrophic for uracil, 
adenine, and leucine, carried an additional auxotrophy. Our finding that these 
mutants exhibited an increased lifespan was consistent with the notion that the 
deletions impart some kind of CR upon the cells, which was already well established 
to extend lifespan (Fontana et al., 2010; Roux et al., 2010). We assumed this to be 
an indication that our new assay identified lifespan-affecting genes and did not 
further analyze these gene deletions, as similar effects of CR are already known. 
We focused our further experiments on the group of strains carrying deletions of 
genes coding for proteins involved in DNA repair, since lifespan extension caused by 
defects in DNA repair has not been described so far. However, when mutants were 
generated by genetic crosses, we observed a strong variability in the CLS of 
segregants displaying the same genotype (3.1.3.5), indicating that there might be an 
unknown, non-Mendelian factor that affected the CLS of fission yeast. In line with 
this, a recent study has shown that there is also a great variance in the RLS of 
S. cerevisiae spores arising from the same tetrad (Unal et al., 2011), although the 
reason for this variability remained unexplained in that study. Therefore, mixing the 
segregants with the same genotype might be a possibility to determine their average 
CLS. After careful analyses, we found that the CLS extension was not caused by the 
deletion of the DNA repair genes (3.1.3.6). This was also the case for cells where 
ppk4+, a gene coding for an protein involved in UPRER, was deleted (3.1.3.6), 
indicating that it was not an effect specific for DNA repair mutants. This was 
unexpected, as it should make no difference whether a deletion is generated in a 
certain strain by genetic cross, PCR-mediated knock-out or the like.  
In summary, our results suggest that there was something in the background of 
the deletion library that affects lifespan independently of the indicated gene deletions. 
Possible explanations could be differences in mitochondrial DNA and/or epigenetic 
modifications, like PTMs on histones. Nevertheless, the strains originating from the 
S. pombe deletion library could be used for a screen in the future to identify the 
potential molecular target of the compounds found to extend CLS (3.1.2.1). In this 
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case, the CLS of the deletion strain treated with the compound/s could be compared 
to that of the same strain treated with DMSO. If no lifespan extension is observed, 
one could conclude that the compound acts in the same pathway as the respective 
gene. 
 
4.7 Nicotine increases silencing in S. cerevisiae and extends the 
CLS of S. pombe, possibly by activating Sir2 
Nicotine is an anti-inflammatory alkaloid found in the nightshade family of plants 
(Solanaceae). Since it functions as an anti-herbivore chemical with particular 
specificity to insects, it was widely used as an insecticide in the past (Rodgman & 
Perfetti, 2009). Today, it is best known as a component of cigarettes, where it is 
responsible for the potential addiction to cigarette smoking, as it binds to nicotinic 
acetylcholine receptors, thereby increasing the levels of several neurotransmitters. 
Nicotine has been shown to delay the onset of Parkinson's disease in studies 
involving monkeys and humans (Quik et al., 2006; Quik et al., 2007). Furthermore, 
recent studies have reported a protective effect of nicotine itself on neurons due to 
activation of nicotinic acetylcholine receptors and the PI3K/Akt pathway, thereby 
reducing inflammation and cell death (Lakhan & Kirchgessner, 2011; Yu et al., 2011). 
The latter results in decreased degradation of cells containing damaged DNA that 
may eventually become cancerous. Nevertheless, nicotine on its own does not 
promote the development of cancer in healthy tissue and to have no mutagenic 
properties (Doolittle et al., 1995).  
However, reduced apoptosis/cell death might also be an explanation for our 
observation that nicotine increased the CLS of S. pombe (3.1.2.1). Our results 
suggest that this lifespan extension is Sir2-dependent, as nicotine did not affect the 
CLS of sir2Δ cells (3.2.4.6) and low concentrations of this compound activated Sir2 in 
the in vitro fluorescence assay (3.2.4.5). Notably, these concentrations are much 
lower than those used in the in vivo assays. Therefore, this result must be interpreted 
with caution, especially because the in vitro stimulation of sirtuins is controversially 
discussed (Beher et al., 2009; Haigis & Sinclair, 2010). Nevertheless, it is possible 
that only low amounts of the high nicotine concentration used in the in vivo 
experiments enter the cell, and that the effective intracellular concentration is thus in 
the range of Sir2 activation. 
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Also, increased Sir2 activity can explain our results concerning the impact of 
nicotine on the silencing of S. cerevisisae. Initially, nicotine was found in our high-
throughput screen to increase telomeric silencing (3.2.3). The silencing effect was 
not caused by nicotine-N-oxide, a degradation product of nicotine (3.2.4.1), indicating 
that it was an effect of nicotine itself and not of a degradation product. Further 
experiments showed that nicotine also enhanced HM silencing, and that this effect 
was independent of Rap1 (3.2.4.3). Additionally, rDNA silencing was increased by 
nicotine (3.2.4.4). Since Sir2 is the only factor present at all three heterochromatic 
loci in S. cerevisiae (Rusche et al., 2003), this HDAC was discussed as a potential 
target of nicotine.  
Notably, Sir2 is an NAD+-dependent HDAC that releases nicotinamide (NAM), 
2’-O-acetyl-ADP-ribose (OAADPR), and the deacetylated substrate (Haigis & 
Sinclair, 2010). It is known that sirtuins are inhibited by NAM, which could be 
converted to NAD+ by Pnc1 (Haigis & Sinclair, 2010). Based on the structural 
similarity between NAM and nicotine (Figure 62), one could argue that nicotine might 
act by replacing NAM. Although this would be in line with the inhibition of Sir2 by 
higher nicotine concentrations in vitro (3.2.4.5), NAM itself as well as nicotinic acid 
did not increase the telomeric silencing of S. cerevisiae in our assay (10 µM –
 12 mM, data not shown), indicating that nicotine might act differently from NAM. In 
agreement with this, other studies have reported no increase, but a reduction of 
silencing by 5 mM NAM (Anderson et al., 2003; Gallo et al., 2004). 
 
 
Figure 62 Chemical structures of NAM and nicotine 
The chemical structures were created by using the software MarvinSketch. 
 
However, it was remarkable that nicotine improved growth of all S. cerevisiae 
strains, including sir2Δ cells, on different types of counter-selective medium (5-FOA, 
αAA, FAA), regardless of how poorly the cells grew on this medium without nicotine 
(3.2.4.2 – 3.2.4.5). Importantly, there were also several experiments, where the 
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increased silencing by nicotine was confirmed independently of counter-selective 
medium. In these experiments, nicotine reduced the growth on YM medium lacking 
the supplement corresponding to the marker gene of the analyzed yeast strain 
(3.2.4.2 - 3.2.4.3), thereby excluding a general improvement of growth. However, 
cells where SIR2 is deleted display no silencing, as Sir2 is essential for this process, 
and they are not able to grow on counter-selective medium. As a consequence, 
nicotine should have no effect and not improve their growth on this medium. 
Nevertheless, their growth on counter-selective medium was enabled by the addition 
of nicotine (3.2.4.5). In contrast to the other tested strains, this was caused by the 
loss of the marker gene (3.2.4.5), which could be explained by the lack of 
heterochromatin formation in the absence of Sir2. As a consequence, the repetitive 
sequences at the telomeres were not protected against homologous recombination, 
which might be increased by nicotine under these conditions in an unknown manner.  
So far, deletion of SIR2 has primarily been known to reduce the RLS of 
S. cerevisiae by the lack of rDNA silencing leading to the formation of ERCs. 
However, there were also some hints that link Sir2 and CLS. In this context, SIR2 
deletion in S. cerevisiae did not alter the CLS of wild type cells, but extends lifespan 
of long-lived mutants, like sch9Δ (Fabrizio et al., 2005), indicating that there are 
opposite effects of Sir2 on CLS and RLS. Furthermore, there are differences 
between S. cerevisiae and S. pombe, as the deletion of sir2+ shortened the CLS of 
fission yeast (3.2.4.6). In contrast to S. pombe wild-type cells, nicotine did not extend 
the CLS of sir2Δ cells (3.2.4.6), suggesting that its longevity-promoting effect in 
fission yeast is Sir2-dependent. 
In summary, our results indicate that nicotine enhanced Sir2 activity, thereby 
leading to increased silencing at all three heterochromatic loci in S. cerevisiae and 
extended CLS of S. pombe. Notably, CLS extension by increased Sir2 activity would 
confirm that there is another function of Sir2 apart from inhibiting the formation of 
ERCs that affects yeast lifespan. 
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4.8 Summary and outlook 
In this study, we identified 20 compounds that increased the CLS of S. pombe. Eight 
of them were further investigated. Based on our analyses, we have a concrete 
hypothesis concerning the molecular targets responsible for the life-extending effect 
of three of them. To identify the potential targets of the remaining compounds, for 
instance tschimganine, a haploinsufficiency assay (Giaever et al., 1999) or 
microarray analysis could be performed using yeast cells treated with the 
corresponding compound/s. Furthermore, the S. pombe deletion library could be 
screened for potential targets as long as the CLS of the deletion strains treated with 
the compound/s is only compared to the one of DMSO-treated deletion cells. 
Notably, for these experiments, high amounts of the compound/s are required. 
However, the identification of the molecular targets of the longevity-promoting 
compounds will allow new insights into the mechanisms that regulate the aging 
process. 
We found that PGJ2 extended the CLS of S. pombe wild-type cells but not of 
pka1Δ, git3Δ, and dnm1Δ cells (3.1.2.3, 3.1.2.4.1). Therefore, we hypothesized that 
PGJ2 promoted longevity by inhibiting the Git3/PKA signalling pathway as well as the 
mitochondrial fission protein Dnm1. To confirm the relationship of nutrient sensing 
pathways and mitochondrial dynamics in lifespan-extension, the CLS of double 
mutants carrying deletions of Dnm1 and components of the Git3/PKA signalling 
pathway could be measured. Notably, it is known that the loss of DRP-1, the worm 
homolog of Dnm1, increases the CLS of C. elegans in a DAF-16 dependent manner 
(Yang et al., 2011). Since DAF-16 is a stress resistance transcription factor, whose 
exact homolog in fission yeast is unknown, it could be useful to delete components of 
the Wis4/Wis1/Sty1 MAP kinase cascade, which is thought to mediate stress 
resistance, in dnm1Δ S. pombe cells and to determine the lifespan of these cells.  
Two other compounds identified to extend the CLS of S. pombe were the 
ionophores monensin and nigericin. Based on the observation that strains carrying a 
deletion of genes coding for V-ATPase subunits displayed a shortened lifespan that 
was not increased by these compounds (3.1.2.4.2), we suggested that monensin and 
nigericin might extend CLS through activating the V-ATPase. To verify this 
hypothesis, the CLS of a S. pombe strain overexpressing vma1+ or vma3+ could be 
measured, the expectation being an increased lifespan upon overexpression.  
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Interestingly, nicotine was not only found in the screen for compounds that extend 
the CLS of S. pombe, but also in the screen for compounds increasing telomeric 
silencing in S. cerevisiae (3.1.2.1, 3.2.3). Further analyses showed that it enhanced 
the silencing at all three heterochromatic loci in budding yeast (telomeres, HM loci, 
and rDNA locus) (3.2.4.1, 3.2.4.3, 3.2.4.4). Since Sir2 is the only factor involved in all 
three types of silencing, it was obvious to test whether nicotine affected the activity of 
this HDAC. The results of the in vitro fluorescence assay showed that low 
concentrations of this compound activated Sir2 (3.2.4.5). The hypothesis that nicotine 
might act through an activation of Sir2 was supported by the finding that sir2Δ 
S. pombe cells displayed a shortened CLS that was not extended by the addition of 
nicotine (3.2.4.6). However, to ensure the relationship of increased (telomeric) 
silencing and extended lifespan by a suggested activation of Sir2 through nicotine-
treatment, it would be useful to analyze the effect of nicotine on the CLS and/or RLS 
of sir2Δ S. cerevisiae cells. Increased telomeric silencing could be a hint for longer 
telomeres, which in turn are linked to extended lifespan in large eukaryotes. In 
contrast, there is an inverse correlation between lifespan and telomere length in 
budding yeast, meaning that cells with longer telomeres displayed a reduced RLS 
(Austriaco & Guarente, 1997). Therefore, it could be useful to determine the telomere 
length of S. pombe and S. cerevisiae cells treated with nicotine. Furthermore, the 
impact of nicotine on the (telomeric) silencing in S. pombe could be examined, as 
Sir2 is also essential for full transcriptional silencing at the telomeres of fission yeast 
(Freeman-Cook et al., 2005). To verify that the life-extending effect of nicotine is due 
to improved Sir2 activity, the CLS of sir2+ overexpressing S. pombe cells could be 
analyzed, where one expects an increased lifespan. 
Importantly, the factors and pathways that affect aging, like the nutrient signalling 
pathways, are highly conserved throughout evolution (Fontana et al., 2010). 
Therefore, it is likely that the life-extending effect of the identified compounds is 
conserved in higher eukaryotes. To test this, their impact on the lifespan of other 
organisms, like C. elegans and/or D. melanogaster, could be analyzed. Notably, it 
would make no sense to use human cell lines, since they are already immortalized. 
Finally, the S. pombe deletion library should be investigated to identify the 
unknown factor/s that affect CLS independently of the indicated gene deletions. After 
doing so, the data obtained from the CLS screen of the deletion library could be re-
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evaluated, to eventually identify novel factors that are involved in the regulation of 
(chronological) lifespan. 
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